<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Nanomaterials (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Nanomaterials (Basel)</journal-id><journal-id journal-id-type="pmc-domain-id">3130</journal-id><journal-id journal-id-type="pmc-domain">nanomat</journal-id><journal-id journal-id-type="publisher-id">nanomaterials</journal-id><journal-title-group><journal-title>Nanomaterials</journal-title></journal-title-group><issn pub-type="epub">2079-4991</issn><publisher><publisher-name>Multidisciplinary Digital Publishing Institute  (MDPI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12430390</article-id><article-id pub-id-type="pmcid-ver">PMC12430390.1</article-id><article-id pub-id-type="pmcaid">12430390</article-id><article-id pub-id-type="pmcaiid">12430390</article-id><article-id pub-id-type="pmid">40938019</article-id><article-id pub-id-type="doi">10.3390/nano15171340</article-id><article-id pub-id-type="publisher-id">nanomaterials-15-01340</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Current Status and Future Aspects of Gadolinium Oxide Nanoparticles as Positive Magnetic Resonance Imaging Contrast Agents</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2869-0934</contrib-id><name name-style="western"><surname>Mulugeta</surname><given-names initials="E">Endale</given-names></name><xref rid="af1-nanomaterials-15-01340" ref-type="aff">1</xref><xref rid="fn1-nanomaterials-15-01340" ref-type="author-notes">&#8224;</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-7730-5636</contrib-id><name name-style="western"><surname>Tegafaw</surname><given-names initials="T">Tirusew</given-names></name><xref rid="af1-nanomaterials-15-01340" ref-type="aff">1</xref><xref rid="fn1-nanomaterials-15-01340" ref-type="author-notes">&#8224;</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0008-2826-6536</contrib-id><name name-style="western"><surname>Liu</surname><given-names initials="Y">Ying</given-names></name><xref rid="af1-nanomaterials-15-01340" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0002-0785-049X</contrib-id><name name-style="western"><surname>Zhao</surname><given-names initials="D">Dejun</given-names></name><xref rid="af1-nanomaterials-15-01340" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chen</surname><given-names initials="X">Xiaoran</given-names></name><xref rid="af1-nanomaterials-15-01340" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6941-8259</contrib-id><name name-style="western"><surname>Baek</surname><given-names initials="A">Ahrum</given-names></name><xref rid="af2-nanomaterials-15-01340" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5119-6627</contrib-id><name name-style="western"><surname>Kim</surname><given-names initials="J">Jihyun</given-names></name><xref rid="af3-nanomaterials-15-01340" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chang</surname><given-names initials="Y">Yongmin</given-names></name><xref rid="af4-nanomaterials-15-01340" ref-type="aff">4</xref><xref rid="c1-nanomaterials-15-01340" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-7451-6366</contrib-id><name name-style="western"><surname>Lee</surname><given-names initials="GH">Gang Ho</given-names></name><xref rid="af1-nanomaterials-15-01340" ref-type="aff">1</xref><xref rid="c1-nanomaterials-15-01340" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Bronstein</surname><given-names initials="LM">Lyudmila M.</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-nanomaterials-15-01340"><label>1</label>Department of Chemistry, College of Natural Sciences, Kyungpook National University, Taegu 41566, Republic of Korea; <email>endexindex05@gmail.com</email> (E.M.); <email>tirukorea@gmail.com</email> (T.T.); <email>ly1124161@gmail.com</email> (Y.L.); <email>djzhao.chem@gmail.com</email> (D.Z.); <email>tsukiyovo@gmail.com</email> (X.C.)</aff><aff id="af2-nanomaterials-15-01340"><label>2</label>Institute of Biomedical Engineering Research, Kyungpook National University, Taegu 41944, Republic of Korea; <email>baxun@naver.com</email></aff><aff id="af3-nanomaterials-15-01340"><label>3</label>Department of Chemistry Education, Teachers&#8217; College, Kyungpook National University, Taegu 41566, Republic of Korea; <email>jkim23@knu.ac.kr</email></aff><aff id="af4-nanomaterials-15-01340"><label>4</label>Department of Molecular Medicine, School of Medicine, Kyungpook National University, Taegu 41944, Republic of Korea</aff><author-notes><corresp id="c1-nanomaterials-15-01340"><label>*</label>Correspondence: <email>ychang@knu.ac.kr</email> (Y.C.); <email>ghlee@mail.knu.ac.kr</email> (G.H.L.)</corresp><fn id="fn1-nanomaterials-15-01340"><label>&#8224;</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>01</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2025</year></pub-date><volume>15</volume><issue>17</issue><issue-id pub-id-type="pmc-issue-id">496802</issue-id><elocation-id>1340</elocation-id><history><date date-type="received"><day>30</day><month>7</month><year>2025</year></date><date date-type="rev-recd"><day>25</day><month>8</month><year>2025</year></date><date date-type="accepted"><day>29</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>13</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-13 11:25:14.803"><day>13</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nanomaterials-15-01340.pdf"/><abstract><p>Although numerous studies have investigated gadolinium oxide (Gd<sub>2</sub>O<sub>3</sub>) nanoparticles (NPs) as positive (T<sub>1</sub>) magnetic resonance imaging (MRI) contrast agents (CAs), comprehensive reviews on this topic remain scarce. Therefore, it is essential to evaluate their current status and outline prospects. Despite promising physicochemical properties such as considerably higher relaxivities compared to 3&#8211;5 s<sup>&#8722;1</sup>mM<sup>&#8722;1</sup> of clinically approved Gd(III)-chelate contrast agents and encouraging results from in vivo animal studies such as highly improved contrast enhancements, drug loading, and tumor targeting, extensive in vivo toxicity assessments including long-term toxicity and formulation advancements suitable for renal excretion (d &lt; ~3 nm) are still required for clinical translation. This review summarizes the synthesis, characterization, in vitro and in vivo toxicity, and in vivo MRI applications of surface-modified Gd<sub>2</sub>O<sub>3</sub> NPs as T<sub>1</sub> MRI CAs. Finally, future perspectives on the development of surface-modified Gd<sub>2</sub>O<sub>3</sub> NPs as potential next-generation T<sub>1</sub> MRI CAs are discussed.</p></abstract><kwd-group><kwd>gadolinium oxide nanoparticle</kwd><kwd>surface modification</kwd><kwd>MRI</kwd><kwd>contrast agent</kwd><kwd>future aspects</kwd></kwd-group><funding-group><award-group><funding-source>Basic Science Research Program of the National Research Foundation (NRF)</funding-source><funding-source>Korea government (Ministry of Science, and Information and Communications Technology: MSIT)</funding-source><award-id>RS-2024-00406209</award-id></award-group><award-group><funding-source>Ministry of Education</funding-source><award-id>RS-2024-00459895</award-id></award-group><funding-statement>This research was funded by the Basic Science Research Program of the National Research Foundation (NRF) funded by the Korea government (Ministry of Science, and Information and Communications Technology: MSIT) (Basic Research Laboratory, No. RS-2024-00406209) and the NRF funded by the Ministry of Education (Post-Doc. Growth Type Cooperational Research, No. RS-2024-00459895).</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-nanomaterials-15-01340"><title>1. Introduction</title><p>Molecular imaging plays a critical role in medical treatments by providing detailed anatomical information through high-resolution imaging [<xref rid="B1-nanomaterials-15-01340" ref-type="bibr">1</xref>,<xref rid="B2-nanomaterials-15-01340" ref-type="bibr">2</xref>]. Various imaging modalities have been developed, including fluorescence imaging (FI), magnetic resonance imaging (MRI), X-ray computed tomography (CT), positron emission tomography (PET), ultrasound imaging (USI), and single-photon emission computed tomography (SPECT) [<xref rid="B3-nanomaterials-15-01340" ref-type="bibr">3</xref>,<xref rid="B4-nanomaterials-15-01340" ref-type="bibr">4</xref>]. These techniques enable the detection, diagnosis, and monitoring of diseases. Among them, MRI is particularly valued for its non-invasive nature as it employs non-ionizing radiofrequency radiation and allows for whole-body imaging with unlimited penetration depth in soft tissues, making it a widely adopted modality [<xref rid="B5-nanomaterials-15-01340" ref-type="bibr">5</xref>]. However, MRI suffers from relatively low sensitivity due to the small population difference between the two proton spin states [<xref rid="B6-nanomaterials-15-01340" ref-type="bibr">6</xref>,<xref rid="B7-nanomaterials-15-01340" ref-type="bibr">7</xref>], which limits its ability to detect small or early-stage lesions. This limitation can be mitigated by the use of contrast agents (CAs), which enhance signal intensity by accelerating proton spin relaxation processes, thereby improving detection sensitivity [<xref rid="B8-nanomaterials-15-01340" ref-type="bibr">8</xref>,<xref rid="B9-nanomaterials-15-01340" ref-type="bibr">9</xref>].</p><p>Various types of MRI CAs have been investigated, including Gd(III)- and Mn(II)-chelates [<xref rid="B10-nanomaterials-15-01340" ref-type="bibr">10</xref>,<xref rid="B11-nanomaterials-15-01340" ref-type="bibr">11</xref>], Gd- [<xref rid="B12-nanomaterials-15-01340" ref-type="bibr">12</xref>] and Mn-containing nanoparticles (NPs) [<xref rid="B13-nanomaterials-15-01340" ref-type="bibr">13</xref>] for positive (T<sub>1</sub>) MRI, and superparamagnetic iron oxide nanoparticles (SPIONs) [<xref rid="B14-nanomaterials-15-01340" ref-type="bibr">14</xref>,<xref rid="B15-nanomaterials-15-01340" ref-type="bibr">15</xref>] for negative (T<sub>2</sub>) MRI. Currently, only Gd(III)-chelates are approved for clinical use as T<sub>1</sub> MRI CAs [<xref rid="B16-nanomaterials-15-01340" ref-type="bibr">16</xref>,<xref rid="B17-nanomaterials-15-01340" ref-type="bibr">17</xref>]. Although SPIONs were previously commercialized, their use is now minimal [<xref rid="B18-nanomaterials-15-01340" ref-type="bibr">18</xref>]. Gd<sup>3+</sup>, with seven unpaired 4f-electrons and a high spin magnetic moment (s = 7/2), is ideal for use in T<sub>1</sub> MRI CAs [<xref rid="B19-nanomaterials-15-01340" ref-type="bibr">19</xref>]. Consequently, Gd<sub>2</sub>O<sub>3</sub> NPs can induce stronger T<sub>1</sub> proton spin relaxations than Mn-and Fe-based NPs owing to lower electron spin magnetic moments of Mn<sup>2+</sup> (s = 5/2) and Fe<sup>3+</sup> (s = 5/2) than Gd<sup>3+</sup> [<xref rid="B16-nanomaterials-15-01340" ref-type="bibr">16</xref>,<xref rid="B20-nanomaterials-15-01340" ref-type="bibr">20</xref>,<xref rid="B21-nanomaterials-15-01340" ref-type="bibr">21</xref>,<xref rid="B22-nanomaterials-15-01340" ref-type="bibr">22</xref>,<xref rid="B23-nanomaterials-15-01340" ref-type="bibr">23</xref>,<xref rid="B24-nanomaterials-15-01340" ref-type="bibr">24</xref>,<xref rid="B25-nanomaterials-15-01340" ref-type="bibr">25</xref>]. For example, this can be noticed from the r<sub>1</sub> value (33.4 s<sup>&#8722;1</sup>mM<sup>&#8722;1</sup>) of free Gd<sup>3+</sup> ions-grafted NDs [<xref rid="B26-nanomaterials-15-01340" ref-type="bibr">26</xref>], which is higher than that (13.5 s<sup>&#8722;1</sup>mM<sup>&#8722;1</sup>) of free Mn<sup>2+</sup> ions-grafted NDs [<xref rid="B27-nanomaterials-15-01340" ref-type="bibr">27</xref>]. However, after PVP coating, r<sub>1</sub> value of free Gd<sup>3+</sup> ions-grafted NDs dropped to 15.9 s<sup>&#8722;1</sup>mM<sup>&#8722;1</sup> [<xref rid="B28-nanomaterials-15-01340" ref-type="bibr">28</xref>]. T<sub>1</sub> MRI CAs are generally preferred over T<sub>2</sub> MRI CAs because signal enhancement is easier to detect than signal loss [<xref rid="B29-nanomaterials-15-01340" ref-type="bibr">29</xref>]. Moreover, SPIONs can cause signal darkening and susceptibility-induced artifacts, which may complicate image interpretation [<xref rid="B30-nanomaterials-15-01340" ref-type="bibr">30</xref>,<xref rid="B31-nanomaterials-15-01340" ref-type="bibr">31</xref>,<xref rid="B32-nanomaterials-15-01340" ref-type="bibr">32</xref>,<xref rid="B33-nanomaterials-15-01340" ref-type="bibr">33</xref>]. In contrast, Gd<sub>2</sub>O<sub>3</sub> NPs produce the high-quality positive contrast images with less artificial signal voids, thereby offering clearer diagnostic outcomes [<xref rid="B34-nanomaterials-15-01340" ref-type="bibr">34</xref>].</p><p>However, Gd<sup>3+</sup> ions are inherently toxic and non-biodegradable through metabolic processes [<xref rid="B35-nanomaterials-15-01340" ref-type="bibr">35</xref>]. To mitigate this toxicity, they are commonly administered as Gd(III)-chelates [<xref rid="B35-nanomaterials-15-01340" ref-type="bibr">35</xref>,<xref rid="B36-nanomaterials-15-01340" ref-type="bibr">36</xref>,<xref rid="B37-nanomaterials-15-01340" ref-type="bibr">37</xref>,<xref rid="B38-nanomaterials-15-01340" ref-type="bibr">38</xref>,<xref rid="B39-nanomaterials-15-01340" ref-type="bibr">39</xref>]. Although Gd(III)-chelates effectively enhance positive contrasts in MRI, they exhibit low sensitivity due to their low longitudinal proton spin relaxivity (r<sub>1</sub>) values and lack of specificity. Moreover, they have been associated with serious adverse effects, including nephrogenic systemic fibrosis (NSF) in patients with renal impairment, a condition characterized by skin and organ thickening and darkening, ultimately impairing organ function [<xref rid="B40-nanomaterials-15-01340" ref-type="bibr">40</xref>,<xref rid="B41-nanomaterials-15-01340" ref-type="bibr">41</xref>,<xref rid="B42-nanomaterials-15-01340" ref-type="bibr">42</xref>]. Recent studies have also indicated that repeated administration of Gd(III)-chelates can lead to gadolinium deposition in the brain, potentially causing neurotoxicity [<xref rid="B43-nanomaterials-15-01340" ref-type="bibr">43</xref>,<xref rid="B44-nanomaterials-15-01340" ref-type="bibr">44</xref>].</p><p>With advancements in nanotechnology, Gd<sub>2</sub>O<sub>3</sub> NPs have emerged as promising alternatives to Gd(III)-chelates, offering several advantages. These NPs exhibit a high density of Gd<sup>3+</sup> ions per NP, resulting in higher r<sub>1</sub> values [<xref rid="B45-nanomaterials-15-01340" ref-type="bibr">45</xref>,<xref rid="B46-nanomaterials-15-01340" ref-type="bibr">46</xref>,<xref rid="B47-nanomaterials-15-01340" ref-type="bibr">47</xref>,<xref rid="B48-nanomaterials-15-01340" ref-type="bibr">48</xref>], compared to 3&#8211;5 s<sup>&#8722;1</sup>mM<sup>&#8722;1</sup> [<xref rid="B17-nanomaterials-15-01340" ref-type="bibr">17</xref>,<xref rid="B38-nanomaterials-15-01340" ref-type="bibr">38</xref>] of Gd(III)-chelates. They also demonstrate prolonged blood circulation times due to the enhanced permeability and retention (EPR) effect [<xref rid="B46-nanomaterials-15-01340" ref-type="bibr">46</xref>], enabling extended imaging and diagnosing windows [<xref rid="B47-nanomaterials-15-01340" ref-type="bibr">47</xref>]. Furthermore, their high surface-to-volume ratios facilitate drug loading and conjugation of targeting ligands, making them suitable for theranostic applications [<xref rid="B48-nanomaterials-15-01340" ref-type="bibr">48</xref>,<xref rid="B49-nanomaterials-15-01340" ref-type="bibr">49</xref>,<xref rid="B50-nanomaterials-15-01340" ref-type="bibr">50</xref>]. However, their drawback is potential toxicity, which needs to be clearly and thoroughly investigated for clinical translations. For biomedical applications, Gd<sub>2</sub>O<sub>3</sub> NPs must be surface-modified with hydrophilic and biocompatible ligands to ensure colloidal stability, biocompatibility, and functionalization potential. Various synthesis methods have been reported, including polyol [<xref rid="B51-nanomaterials-15-01340" ref-type="bibr">51</xref>,<xref rid="B52-nanomaterials-15-01340" ref-type="bibr">52</xref>], dimethyl sulfoxide (DMSO) [<xref rid="B53-nanomaterials-15-01340" ref-type="bibr">53</xref>,<xref rid="B54-nanomaterials-15-01340" ref-type="bibr">54</xref>], thermal decomposition [<xref rid="B55-nanomaterials-15-01340" ref-type="bibr">55</xref>], and hydrothermal methods [<xref rid="B56-nanomaterials-15-01340" ref-type="bibr">56</xref>]. Surface modifications have employed a range of biocompatible and hydrophilic ligands such as polyacrylic acid (PAA) [<xref rid="B51-nanomaterials-15-01340" ref-type="bibr">51</xref>,<xref rid="B57-nanomaterials-15-01340" ref-type="bibr">57</xref>], poly(methyl vinyl ether-alt-maleic acid) (PMVEMA) [<xref rid="B58-nanomaterials-15-01340" ref-type="bibr">58</xref>,<xref rid="B59-nanomaterials-15-01340" ref-type="bibr">59</xref>,<xref rid="B60-nanomaterials-15-01340" ref-type="bibr">60</xref>], poly(acrylic acid-co-maleic acid) (PAAMA) [<xref rid="B61-nanomaterials-15-01340" ref-type="bibr">61</xref>,<xref rid="B62-nanomaterials-15-01340" ref-type="bibr">62</xref>], polyaspartic acid (PASA) [<xref rid="B63-nanomaterials-15-01340" ref-type="bibr">63</xref>], D-glucuronic acid [<xref rid="B64-nanomaterials-15-01340" ref-type="bibr">64</xref>], citric acid (CA) [<xref rid="B65-nanomaterials-15-01340" ref-type="bibr">65</xref>], dextran [<xref rid="B66-nanomaterials-15-01340" ref-type="bibr">66</xref>], polyethylene glycol (PEG) [<xref rid="B67-nanomaterials-15-01340" ref-type="bibr">67</xref>], or polyvinylpyrrolidone (PVP) [<xref rid="B68-nanomaterials-15-01340" ref-type="bibr">68</xref>]. These ligand coatings are critical not only for stability and functionality but also for reducing toxicity by preventing the release of free Gd<sup>3+</sup> ions from the NPs.</p><p>To date, few comprehensive reviews have focused specifically on surface-coated Gd<sub>2</sub>O<sub>3</sub> NPs as T<sub>1</sub> MRI CAs. However, as illustrated in <xref rid="nanomaterials-15-01340-f001" ref-type="fig">Figure 1</xref>, a substantial number of research articles have been reported on surface-coated Gd<sub>2</sub>O<sub>3</sub> NPs as T<sub>1</sub> MRI CAs and their biomedical applications. Therefore, it is both timely and necessary to evaluate the current status of this research and to discuss future directions. As shown in <xref rid="nanomaterials-15-01340-f001" ref-type="fig">Figure 1</xref>, the annual growth rate of publications increased up to 2019 and then decreased afterwards. This trend reflects the increase in the development of various types of gadolinium NP formulations, in vivo MRI, and biotoxicity studies up to 2019, and then the decrease afterwards. This review covers key aspects, including synthesis methods, physicochemical characterization, in vitro and in vivo toxicity assessments, and in vivo MRI applications. Finally, future perspectives for clinical translation of surface-coated Gd<sub>2</sub>O<sub>3</sub> NPs are outlined.</p></sec><sec id="sec2-nanomaterials-15-01340"><title>2. Synthesis of Surface-Modified Gd<sub>2</sub>O<sub>3</sub> NPs</title><p>To date, various synthetic approaches have been employed to prepare surface-modified Gd<sub>2</sub>O<sub>3</sub> NPs for biomedical applications. These include polyol [<xref rid="B51-nanomaterials-15-01340" ref-type="bibr">51</xref>,<xref rid="B52-nanomaterials-15-01340" ref-type="bibr">52</xref>], DMSO [<xref rid="B53-nanomaterials-15-01340" ref-type="bibr">53</xref>], thermal decomposition [<xref rid="B55-nanomaterials-15-01340" ref-type="bibr">55</xref>], and hydrothermal methods [<xref rid="B56-nanomaterials-15-01340" ref-type="bibr">56</xref>]. As summarized in <xref rid="nanomaterials-15-01340-t001" ref-type="table">Table 1</xref>, each method presents distinct advantages and limitations in terms of synthesis complexity, scalability, and environmental impact.</p><sec id="sec2dot1-nanomaterials-15-01340"><title>2.1. Polyol Method</title><p>The polyol method is effective for synthesizing ultrasmall Gd<sub>2</sub>O<sub>3</sub> NPs, with average particle diameters of approximately 2.0 nm, via a one-pot process that simultaneously enables surface modification with hydrophilic and biocompatible ligands [<xref rid="B34-nanomaterials-15-01340" ref-type="bibr">34</xref>,<xref rid="B51-nanomaterials-15-01340" ref-type="bibr">51</xref>,<xref rid="B58-nanomaterials-15-01340" ref-type="bibr">58</xref>,<xref rid="B61-nanomaterials-15-01340" ref-type="bibr">61</xref>,<xref rid="B63-nanomaterials-15-01340" ref-type="bibr">63</xref>,<xref rid="B64-nanomaterials-15-01340" ref-type="bibr">64</xref>,<xref rid="B69-nanomaterials-15-01340" ref-type="bibr">69</xref>,<xref rid="B70-nanomaterials-15-01340" ref-type="bibr">70</xref>,<xref rid="B71-nanomaterials-15-01340" ref-type="bibr">71</xref>,<xref rid="B72-nanomaterials-15-01340" ref-type="bibr">72</xref>,<xref rid="B73-nanomaterials-15-01340" ref-type="bibr">73</xref>,<xref rid="B74-nanomaterials-15-01340" ref-type="bibr">74</xref>,<xref rid="B75-nanomaterials-15-01340" ref-type="bibr">75</xref>]. High boiling point polyols, such as ethylene glycol (EG), diethylene glycol (DEG), triethylene glycol (TEG), and polyethylene glycol (PEG), are commonly used as solvents. These polyols also function as stabilizing agents, preventing particle aggregation. A general scheme for the one-pot polyol synthesis of surface-coated Gd<sub>2</sub>O<sub>3</sub> NPs is displayed in <xref rid="nanomaterials-15-01340-f002" ref-type="fig">Figure 2</xref>a. The process involves a Gd<sup>3+</sup> precursor, surface-coating ligands, NaOH, and a polyol solvent, all reacted under atmospheric conditions with magnetic stirring. Initially, the Gd<sup>3+</sup> precursor solution is prepared by dissolving Gd<sup>3+</sup> salt, such as GdCl<sub>3</sub>&#183;xH<sub>2</sub>O, and ligands such as PAA in a polyol such as TEG within a three-necked round-bottom flask. This mixture is stirred magnetically at room temperature under atmospheric conditions until complete dissolution. Separately, a NaOH solution is prepared by dissolving NaOH in TEG in a beaker and is then slowly added to the precursor solution until the pH reaches 8&#8211;10. The resulting mixture is stirred at ~110 &#176;C for ~12 h to yield ligand-coated Gd<sub>2</sub>O<sub>3</sub> NPs.</p><p>For example, Lee&#8217;s group synthesized ultrasmall Gd<sub>2</sub>O<sub>3</sub> NPs using various hydrophilic ligands, such as PAA, PMVEMA, PAAMA, PASA, CA, and D-glucuronic acid, via the one-pot polyol method [<xref rid="B51-nanomaterials-15-01340" ref-type="bibr">51</xref>,<xref rid="B58-nanomaterials-15-01340" ref-type="bibr">58</xref>,<xref rid="B61-nanomaterials-15-01340" ref-type="bibr">61</xref>,<xref rid="B63-nanomaterials-15-01340" ref-type="bibr">63</xref>,<xref rid="B64-nanomaterials-15-01340" ref-type="bibr">64</xref>]. In another study, Guleria et al. synthesized Gd<sub>2</sub>O<sub>3</sub> NPs using polyols of varying chain lengths, including DEG, TEG, tetraethylene glycol (TeEG), and PEG-200, and observed a linear correlation between the glycol chain length and the resulting NP size [<xref rid="B70-nanomaterials-15-01340" ref-type="bibr">70</xref>].</p></sec><sec id="sec2dot2-nanomaterials-15-01340"><title>2.2. DMSO Method</title><p>The DMSO method is suitable for low-temperature synthesis (&lt;60 &#176;C), enabling the production of ultrasmall Gd<sub>2</sub>O<sub>3</sub> NPs with uniform particle size and simultaneous one-pot surface modification using hydrophilic and biocompatible ligands [<xref rid="B53-nanomaterials-15-01340" ref-type="bibr">53</xref>,<xref rid="B76-nanomaterials-15-01340" ref-type="bibr">76</xref>,<xref rid="B77-nanomaterials-15-01340" ref-type="bibr">77</xref>]. As shown in <xref rid="nanomaterials-15-01340-f002" ref-type="fig">Figure 2</xref>b, Gd<sup>3+</sup> precursor such as Gd(acetate)<sub>3</sub>&#183;xH<sub>2</sub>O is dissolved in DMSO under atmospheric conditions with magnetic stirring until a transparent solution is obtained. Tetramethylammonium hydroxide (TMAH) solution is then added dropwise to adjust the pH to ~8, resulting in a cloudy solution. This mixture is stirred magnetically for 24 h to allow the formation of ultrasmall Gd<sub>2</sub>O<sub>3</sub> NPs. For surface coating, a hydrophilic ligand such as PAA is added to the reaction mixture, followed by the addition of TMAH to maintain pH at ~8. The solution is stirred for another 24 h to ensure uniform ligand surface coating. The resulting ligand-coated Gd<sub>2</sub>O<sub>3</sub> NPs are purified by repeated ethanol washing and centrifugation to remove unreacted reagents and solvents. Finally, the surface-coated NPs are dispersed in triple-distilled water and subjected to dialysis against water to eliminate residual impurities.</p><p>For example, Uvdal and co-workers synthesized Gd<sub>2</sub>O<sub>3</sub> NPs (d = 4&#8211;5 nm) by dissolving Gd(acetate)<sub>3</sub>&#183;xH<sub>2</sub>O in DMSO and adding TMAH in ethanol under ambient conditions with magnetic stirring [<xref rid="B53-nanomaterials-15-01340" ref-type="bibr">53</xref>]. In another example, Cui et al. synthesized Gd<sub>2</sub>O<sub>3</sub> NPs using Gd(acetate)<sub>3</sub>&#183;xH<sub>2</sub>O and TMAH in DMSO at room temperature and subsequently conjugated the NPs with carboxyfluorescein [FI]-polyethylene glycol [PEG]-bombesin (BBN), resulting in NPs with a particle diameter of 52.3 nm [<xref rid="B77-nanomaterials-15-01340" ref-type="bibr">77</xref>].</p></sec><sec id="sec2dot3-nanomaterials-15-01340"><title>2.3. Thermal Decomposition</title><p>The thermal decomposition method yields monodispersed Gd<sub>2</sub>O<sub>3</sub> NPs with controlled particle size; however, it requires high temperatures, organic solvents such as OA and OM, and an inert gas atmosphere, rendering the synthesis costly and environmentally unfriendly [<xref rid="B55-nanomaterials-15-01340" ref-type="bibr">55</xref>,<xref rid="B78-nanomaterials-15-01340" ref-type="bibr">78</xref>,<xref rid="B79-nanomaterials-15-01340" ref-type="bibr">79</xref>,<xref rid="B80-nanomaterials-15-01340" ref-type="bibr">80</xref>,<xref rid="B81-nanomaterials-15-01340" ref-type="bibr">81</xref>,<xref rid="B82-nanomaterials-15-01340" ref-type="bibr">82</xref>]. Additionally, this method does not permit one-pot synthesis for surface modification. As shown in <xref rid="nanomaterials-15-01340-f002" ref-type="fig">Figure 2</xref>(cI), Gd<sup>3+</sup> precursor is added to a mixture of OA and OM in a three-neck round-bottom flask and heated to ~110 &#176;C under a flow of argon or nitrogen to remove moisture and dissolved gases. The reaction mixture is then refluxed at 290&#8211;340 &#176;C for 1&#8211;6 h. After cooling to room temperature, the Gd<sub>2</sub>O<sub>3</sub> NPs are precipitated by adding ethanol, collected by centrifugation, and redispersed in toluene: this washing procedure is repeated three times. The purified NPs are subsequently dispersed and stored in hexane or chloroform. For surface coating, the hydrophobic ligands on the NP surfaces, primarily OA, with a minor contribution from OM due to the stronger binding affinity of the -COOH group than the -NH<sub>2</sub> group, are replaced with hydrophilic ligands such as polyvinyl pyrrolidone (PVP) through ligand exchange (<xref rid="nanomaterials-15-01340-f002" ref-type="fig">Figure 2</xref>(cII)). The resulting hydrophilic ligand-coated Gd<sub>2</sub>O<sub>3</sub> NPs are dispersed in water and further purified through dialysis against water.</p><p>For example, Fang et al. synthesized monodispersed ultrasmall Gd<sub>2</sub>O<sub>3</sub> NPs (d = 2.9 nm) capped with hydrophobic OA, via thermal decomposition of a Gd(OA)<sub>3</sub> precursor in a mixture of OA and OM, which acted as both solvent and surfactant [<xref rid="B78-nanomaterials-15-01340" ref-type="bibr">78</xref>]. The OA-capped Gd<sub>2</sub>O<sub>3</sub> NPs were subsequently converted to PVP-Gd<sub>2</sub>O<sub>3</sub> NPs through ligand exchange with PVP for use as T<sub>1</sub> MRI CAs. Similarly, Cai et al. prepared OA/OM-capped Gd<sub>2</sub>O<sub>3</sub> nanoplates (length &#215; thickness = 10 &#215; 1 nm) via thermal decomposition of Gd(OA)<sub>3</sub> at 340 &#176;C using OA and OM as solvent and capping agents. These nanoplates were encapsulated with <italic toggle="yes">N</italic>-dodecyl-polyethylene imine (PEI)-PEG polymers to form hydrophilic nanoplate clusters (d = 95 nm) for application as T<sub>1</sub> MRI CAs [<xref rid="B55-nanomaterials-15-01340" ref-type="bibr">55</xref>].</p></sec><sec id="sec2dot4-nanomaterials-15-01340"><title>2.4. Hydrothermal Method</title><p>The hydrothermal method is considered environmentally friendly as it utilizes water as the solvent. The synthesis is controlled by adjusting temperature and pressure [<xref rid="B46-nanomaterials-15-01340" ref-type="bibr">46</xref>,<xref rid="B56-nanomaterials-15-01340" ref-type="bibr">56</xref>,<xref rid="B83-nanomaterials-15-01340" ref-type="bibr">83</xref>,<xref rid="B84-nanomaterials-15-01340" ref-type="bibr">84</xref>,<xref rid="B85-nanomaterials-15-01340" ref-type="bibr">85</xref>,<xref rid="B86-nanomaterials-15-01340" ref-type="bibr">86</xref>]. As illustrated in <xref rid="nanomaterials-15-01340-f002" ref-type="fig">Figure 2</xref>d, the Gd<sup>3+</sup> precursor is dissolved in deionized water. Separately, a hydrophilic ligand is dissolved in deionized water at room temperature and added to the Gd<sup>3+</sup> solution under magnetic stirring. An aqueous solution of NaOH or urea is then added dropwise under magnetic stirring to adjust the pH to 9&#8211;10. The resulting solution is transferred into an autoclave and subjected to hydrothermal treatment at elevated temperatures (typically above 150 &#176;C) for 6&#8211;24 h. The final precipitates are washed three times with ethanol, dispersed in triple-distilled water, and further purified via dialysis against water.</p><p>For example, Wu et al. synthesized hyaluronic acid (HA)-coated Gd<sub>2</sub>O<sub>3</sub> NPs (d = 105 nm) using the hydrothermal method [<xref rid="B46-nanomaterials-15-01340" ref-type="bibr">46</xref>]. In this procedure, HA was dissolved in water under vigorous magnetic stirring at ambient temperature overnight. GdCl<sub>3</sub>&#183;6H<sub>2</sub>O and NaOH were then added, followed by magnetic stirring for 5 min to form a homogeneous clear solution. The mixture was transferred to an autoclave, sealed, and heated at 120 &#176;C for 6 h. The resulting HA-coated Gd<sub>2</sub>O<sub>3</sub> NPs were purified through dialysis against water to remove impurities.</p></sec></sec><sec id="sec3-nanomaterials-15-01340"><title>3. Various Characterizations</title><p>Following synthesis, various characterization techniques can be employed to determine the physicochemical properties of surface-modified Gd<sub>2</sub>O<sub>3</sub> NPs, as summarized in <xref rid="nanomaterials-15-01340-t002" ref-type="table">Table 2</xref> [<xref rid="B51-nanomaterials-15-01340" ref-type="bibr">51</xref>,<xref rid="B53-nanomaterials-15-01340" ref-type="bibr">53</xref>,<xref rid="B61-nanomaterials-15-01340" ref-type="bibr">61</xref>,<xref rid="B87-nanomaterials-15-01340" ref-type="bibr">87</xref>]. These include high-resolution transmission electron microscopy (HRTEM) to determine particle size and morphology; dynamic light scattering (DLS) to measure hydrodynamic diameter; X-ray diffraction (XRD) to determine the crystal structure; Fourier transform-infrared (FT-IR) absorption spectroscopy to analyze surface coating; and thermogravimetric analysis (TGA) to estimate the surface-coating content. Additional methods include zeta potential measurements to assess the surface charge; inductively coupled plasma-atomic emission spectroscopy (ICP-AES) to quantify Gd concentration in solution; and vibrating sample magnetometry (VSM) or magnetic property measurement system (MPMS) to measure magnetic properties. MRI is used to determine the r<sub>1</sub> and r<sub>2</sub> relaxivities. In vitro cellular toxicity is assessed using standard assays such as methyl thiazolyl tetrazolium (MTT), cell counting kit (CCK)-8, and water-soluble tetrazolium (WST)-1 to evaluate cell viability. Collectively, these methods constitute a standard characterization protocol for surface-coated Gd<sub>2</sub>O<sub>3</sub> NPs.</p><sec id="sec3dot1-nanomaterials-15-01340"><title>3.1. Particle Size and Morphology</title><p>Particle size and morphology are critical parameters for biomedical applications. These features are typically characterized using HRTEM operated at acceleration voltages above 200 kV. For TEM imaging, NPs are dispersed onto a copper grid coated with a carbon film by drop-casting a solution sample prepared in water or a water/ethanol mixture. High-resolution imaging also enables measurement of lattice fringes, which can aid in NP identification. In addition, elemental mapping provides the spatial distribution of constituent elements, allowing identification of both the NPs and their surface-coating ligands.</p><p>For example, Miao et al. synthesized PAA-coated ultrasmall Gd<sub>2</sub>O<sub>3</sub> NPs (d<sub>avg</sub> = 2.0 &#177; 0.1 nm) using a one-pot polyol method; the NPs remained colloidally stable in aqueous media without precipitation (<xref rid="nanomaterials-15-01340-f003" ref-type="fig">Figure 3</xref>a) [<xref rid="B51-nanomaterials-15-01340" ref-type="bibr">51</xref>]. Ahr&#233;n et al. prepared Gd<sub>2</sub>O<sub>3</sub> NPs with particle diameters of 4&#8211;5 nm via the DMSO method at room temperature (<xref rid="nanomaterials-15-01340-f003" ref-type="fig">Figure 3</xref>b) [<xref rid="B53-nanomaterials-15-01340" ref-type="bibr">53</xref>]. These NPs exhibited good aqueous stability, with a zeta potential of +34.7 mV due to the presence of ammonium acetate on their surfaces. Cai et al. prepared OA/OM-capped Gd<sub>2</sub>O<sub>3</sub> square nanoplates (thickness &#215; length = 1 &#215; 10 nm) via thermal decomposition of Gd(OA)<sub>3</sub> at 340 &#176;C, using OA and OM as both solvent and capping agent (<xref rid="nanomaterials-15-01340-f003" ref-type="fig">Figure 3</xref>c) [<xref rid="B55-nanomaterials-15-01340" ref-type="bibr">55</xref>]. Yang et al. synthesized Gd(OH)<sub>3</sub> nanorods by hydrothermal treatment of GdCl<sub>3</sub> and triethylamine in water at 160 &#176;C for 8 h in an autoclave [<xref rid="B56-nanomaterials-15-01340" ref-type="bibr">56</xref>]. <xref rid="nanomaterials-15-01340-f003" ref-type="fig">Figure 3</xref>d displays the TEM image of the as-synthesized Gd(OH)<sub>3</sub> nanorods (length &#215; width = 200 &#215; 10 nm).</p></sec><sec id="sec3dot2-nanomaterials-15-01340"><title>3.2. Crystal Structure</title><p>XRD analysis provides critical information on the crystal structure of NPs and allows identification of the synthesized products. Powder samples are typically used, and the 2&#952; scan range is set between 10 and 100&#176;. Diffraction peaks are indexed using Miller indices (hkl), and the unit cell parameters (a, b, c, &#945;, &#946;, &#947;) are calculated using Bragg&#8217;s law, in combination with interplanar spacing equations derived from the assigned crystal system. In addition, the average particle diameter can be roughly estimated using the Scherrer equation, which employs the full width at half maximum (FWHM) of selected XRD peaks [<xref rid="B88-nanomaterials-15-01340" ref-type="bibr">88</xref>]. Ultrasmall NPs (d &lt; 3 nm) often exhibit poor crystallinity and may appear amorphous in XRD due to their limited long-range order. The pair distribution function analysis is recommended for ultrasmall NPs with amorphous XRD patterns because it offers the short-range local atomic structure of amorphous NPs [<xref rid="B89-nanomaterials-15-01340" ref-type="bibr">89</xref>]. However, heat treatment can induce particle growth and crystallization, allowing crystal structure determination [<xref rid="B90-nanomaterials-15-01340" ref-type="bibr">90</xref>].</p><p>For example, the XRD patterns corresponding to the gadolinium-based nanomaterials displayed in the TEM images in <xref rid="nanomaterials-15-01340-f003" ref-type="fig">Figure 3</xref>a&#8211;d are provided in <xref rid="nanomaterials-15-01340-f003" ref-type="fig">Figure 3</xref>e&#8211;h, respectively. The ultrasmall Gd<sub>2</sub>O<sub>3</sub> NPs synthesized via the polyol and DMSO methods (TEM images in <xref rid="nanomaterials-15-01340-f003" ref-type="fig">Figure 3</xref>a and <xref rid="nanomaterials-15-01340-f003" ref-type="fig">Figure 3</xref>b, respectively) displayed broad, amorphous XRD patterns, indicating poor crystallinity (bottom spectra in <xref rid="nanomaterials-15-01340-f003" ref-type="fig">Figure 3</xref>e,f) [<xref rid="B51-nanomaterials-15-01340" ref-type="bibr">51</xref>,<xref rid="B53-nanomaterials-15-01340" ref-type="bibr">53</xref>]. After thermal treatment, the NPs exhibited diffraction peaks corresponding to the cubic phase of Gd<sub>2</sub>O<sub>3</sub> (top spectrum in <xref rid="nanomaterials-15-01340-f003" ref-type="fig">Figure 3</xref>e) [<xref rid="B51-nanomaterials-15-01340" ref-type="bibr">51</xref>]. The top spectrum in <xref rid="nanomaterials-15-01340-f003" ref-type="fig">Figure 3</xref>f represents the reference pattern of commercial bulk cubic Gd<sub>2</sub>O<sub>3</sub> [<xref rid="B53-nanomaterials-15-01340" ref-type="bibr">53</xref>]. The Gd<sub>2</sub>O<sub>3</sub> nanoplates synthesized via the thermal decomposition method (TEM image in <xref rid="nanomaterials-15-01340-f003" ref-type="fig">Figure 3</xref>c), displayed broad peaks in the XRD pattern (top spectrum in <xref rid="nanomaterials-15-01340-f003" ref-type="fig">Figure 3</xref>g) [<xref rid="B55-nanomaterials-15-01340" ref-type="bibr">55</xref>], which were indexed to a poorly developed monoclinic phase of Gd<sub>2</sub>O<sub>3</sub> (JCPDS No 43-1015) [<xref rid="B80-nanomaterials-15-01340" ref-type="bibr">80</xref>,<xref rid="B82-nanomaterials-15-01340" ref-type="bibr">82</xref>,<xref rid="B91-nanomaterials-15-01340" ref-type="bibr">91</xref>], as shown in the reference pattern (bottom spectrum in <xref rid="nanomaterials-15-01340-f003" ref-type="fig">Figure 3</xref>g). The XRD pattern of the Gd(OH)<sub>3</sub> nanorods synthesized via the hydrothermal method (TEM image in <xref rid="nanomaterials-15-01340-f003" ref-type="fig">Figure 3</xref>d) is presented in the top spectrum of <xref rid="nanomaterials-15-01340-f003" ref-type="fig">Figure 3</xref>h and matches well with the reference pattern for the hexagonal phase of Gd(OH)<sub>3</sub> (JCPDS No. 83-2037) (bottom spectrum in <xref rid="nanomaterials-15-01340-f003" ref-type="fig">Figure 3</xref>h) [<xref rid="B56-nanomaterials-15-01340" ref-type="bibr">56</xref>].</p></sec><sec id="sec3dot3-nanomaterials-15-01340"><title>3.3. Hydrodynamic Diameter</title><p>The hydrodynamic diameters (a<sub>avg</sub>) of NPs are measured using samples dispersed in water. The a<sub>avg</sub> values are typically larger than the corresponding d<sub>avg</sub> values due to the presence of surface-coating ligands and the hydration layer formed by adsorbed water molecules. The a<sub>avg</sub> is influenced by particle size, morphology, and hydrophilicity of the surface ligands. Larger and more hydrophilic ligands attract more water molecules, thereby increasing the a<sub>avg</sub> and enhancing colloidal stability. In particular, polymer ligands tend to attract more water molecules than small molecules, resulting in larger a<sub>avg</sub> values and improved colloidal stability [<xref rid="B92-nanomaterials-15-01340" ref-type="bibr">92</xref>].</p><p>For example, Miao et al. synthesized ultrasmall Gd<sub>2</sub>O<sub>3</sub> NPs (d = 2.0 nm) coated with PAA of varying molecular weight by the polyol method. They observed an increase in a<sub>avg</sub> values (10.3 &#8594; 11.1 &#8594; 11.3 nm) with increasing PAA size (1200 &#8594; 5100 &#8594; 15,000 amu) (<xref rid="nanomaterials-15-01340-f004" ref-type="fig">Figure 4</xref>a) [<xref rid="B75-nanomaterials-15-01340" ref-type="bibr">75</xref>]. Cui et al. synthesized Gd<sub>2</sub>O<sub>3</sub> NPs (d = 52.3 nm) grafted with carboxyfluorescein (FI)-polyethylene glycol (PEG)-bombesin (BBN) via the DMSO method [<xref rid="B77-nanomaterials-15-01340" ref-type="bibr">77</xref>], and reported a large a<sub>avg</sub> of 90.6 nm (<xref rid="nanomaterials-15-01340-f004" ref-type="fig">Figure 4</xref>b), attributed to the combination of large particle size and bulky polymeric and biomolecular coating. Similarly, Cai et al. synthesized Gd<sub>2</sub>O<sub>3</sub>@<italic toggle="yes">N</italic>-dodecyl-PEI-PEG nanoplates (thickness &#215; length = 1 &#215; 10 nm), which exhibited a large a<sub>avg</sub> value of 95 nm (<xref rid="nanomaterials-15-01340-f004" ref-type="fig">Figure 4</xref>c) owing to the thick polymer coating [<xref rid="B55-nanomaterials-15-01340" ref-type="bibr">55</xref>]. Siribbal et al. synthesized CA-coated hollow Gd<sub>2</sub>O<sub>3</sub> NPs (d = 100 nm) using a hydrothermal method [<xref rid="B93-nanomaterials-15-01340" ref-type="bibr">93</xref>], reporting a very large a<sub>avg</sub> value of 233.7 nm, due to the large particle size and surface modification (<xref rid="nanomaterials-15-01340-f004" ref-type="fig">Figure 4</xref>d).</p></sec><sec id="sec3dot4-nanomaterials-15-01340"><title>3.4. Surface-Coating Analysis</title><p>The surface coating of surface-modified Gd<sub>2</sub>O<sub>3</sub> NPs can be analyzed using FT-IR absorption spectroscopy and TGA [<xref rid="B94-nanomaterials-15-01340" ref-type="bibr">94</xref>,<xref rid="B95-nanomaterials-15-01340" ref-type="bibr">95</xref>]. Dried powder samples are used for both measurements to minimize the influence of water. Characteristic absorption peaks of surface-coating ligands in the FT-IR absorption spectra provide direct evidence of their presence on the Gd<sub>2</sub>O<sub>3</sub> NP surfaces. Additionally, their coating amount can be estimated from TGA data, as most organic ligands undergo thermal decomposition below 450 &#176;C via oxidation in a flow of hot air during TGA [<xref rid="B96-nanomaterials-15-01340" ref-type="bibr">96</xref>,<xref rid="B97-nanomaterials-15-01340" ref-type="bibr">97</xref>,<xref rid="B98-nanomaterials-15-01340" ref-type="bibr">98</xref>]. The coating amount is typically expressed in weight percent (wt.%), calculated from the mass loss observed in the TGA curve, excluding the initial mass loss between room temperature and ~100 &#176;C due to desorption of water and air.</p><p>For example, Ho et al. synthesized arginylglycylaspartic acid (RGD)-PAA-coated ultrasmall Gd<sub>2</sub>O<sub>3</sub> NPs (denoted as RGD-PAA-UGNPs) for cancer imaging using in vivo T<sub>1</sub> MRI in tumor-model mice [<xref rid="B95-nanomaterials-15-01340" ref-type="bibr">95</xref>]. They confirmed the successful coating of RGD-PAA onto UGNPs by recording FT-IR absorption spectra of PAA-UGNPs, RGD-PAA-UGNPs, free PAA, and free RGD (<xref rid="nanomaterials-15-01340-f005" ref-type="fig">Figure 5</xref>a). The C=O stretching peak at 1553 cm<sup>&#8722;1</sup> in both the PAA-UGNP and RGD&#8211;PAA&#8211;UGNP spectra confirmed the successful coordination of PAA ligands to the UGNP surfaces. This peak exhibited a red shift from that of free PAA at ~1700 cm<sup>&#8722;1</sup> due to electrostatic interactions between the COO<sup>&#8722;</sup> groups of PAA and surface Gd<sup>3+</sup> ions of UGNP. Furthermore, the FT&#8211;IR absorption spectrum of RGD&#8211;PAA&#8211;UGNPs showed characteristic RGD peaks, including N&#8211;H bending at 1544 cm<sup>&#8722;1</sup> and C&#8211;N stretching at 1390 cm<sup>&#8722;1</sup>, confirming successful conjugation of RGD to PAA through amide bond formation.</p><p>For surface-coating amount estimation, Park et al. measured TGA curves of ultrasmall Gd<sub>2</sub>O<sub>3</sub> NPs coated with five different kinds of ligands: PEI, pimelic acid, azelaic acid, suberic acid, and sebacic acid (<xref rid="nanomaterials-15-01340-f005" ref-type="fig">Figure 5</xref>b) [<xref rid="B99-nanomaterials-15-01340" ref-type="bibr">99</xref>]. The water and air desorption from the NPs occurred between room temperature and ~105 &#176;C. Mass drops between ~105 and ~450 &#176;C were attributed to the thermal decomposition or oxidative combustion of the coating ligands. The residual mass in TGA curves corresponded to Gd<sub>2</sub>O<sub>3</sub> NPs. The measured surface-coating amounts were 52.3% for pimelic acid, 60.9% for suberic acid, 55.7% for azelaic acid, 63.1% for sebacic acid, and 30.5% for PEI-70000.</p></sec><sec id="sec3dot5-nanomaterials-15-01340"><title>3.5. Zeta Potentials</title><p>The zeta potential (&#950;) of surface-coated Gd<sub>2</sub>O<sub>3</sub> NPs dispersed in water provides insight into their surface charge in aqueous media. Negative zeta potentials indicate the presence of negatively charged functional groups such as -OH and -COOH on NP surfaces, whereas positive zeta potentials reflect the presence of positively charged functional groups such as -NH<sub>2</sub>. Zwitterionic ligands such as amino acids typically result in low zeta potential values [<xref rid="B100-nanomaterials-15-01340" ref-type="bibr">100</xref>]. High absolute zeta potential values are needed to ensure good colloidal stability [<xref rid="B101-nanomaterials-15-01340" ref-type="bibr">101</xref>,<xref rid="B102-nanomaterials-15-01340" ref-type="bibr">102</xref>].</p><p>For example, Marasini et al. reported polyaspartic acid (PSA)-coated Gd<sub>2</sub>O<sub>3</sub> NPs as a dual-modal T<sub>1</sub> and T<sub>2</sub> MRI CA [<xref rid="B63-nanomaterials-15-01340" ref-type="bibr">63</xref>]. <xref rid="nanomaterials-15-01340-f005" ref-type="fig">Figure 5</xref>c shows a highly negative zeta potential of &#8722;28.0 mV in aqueous media, consistent with their observed good colloidal stability, evidenced by the absence of NP precipitation following synthesis.</p></sec><sec id="sec3dot6-nanomaterials-15-01340"><title>3.6. Magnetic Properties</title><p>The magnetic properties of surface-coated Gd<sub>2</sub>O<sub>3</sub> NPs are typically assessed by recording magnetization (M) versus applied magnetic field (H) (M&#8211;H curves) and M versus temperature (T) (M&#8211;T curves) using either VSM or MPMS. The M&#8211;H curves provide saturation magnetization, coercivity, and remanence, while the M&#8211;T curves yield the blocking temperature. These curves are measured using 10&#8211;20 mg of powdered samples. Notably, M values of surface-coated Gd<sub>2</sub>O<sub>3</sub> NPs arises predominantly from the spin magnetic moment of Gd<sup>3+</sup> (s = 7/2), and is largely independent of both ligand type and particle size [<xref rid="B21-nanomaterials-15-01340" ref-type="bibr">21</xref>].</p><p>For example, Guleria et al. measured M&#8211;H and M&#8211;T curves of various polyol-coated Gd<sub>2</sub>O<sub>3</sub> NPs [<xref rid="B70-nanomaterials-15-01340" ref-type="bibr">70</xref>]. <xref rid="nanomaterials-15-01340-f006" ref-type="fig">Figure 6</xref>a and <xref rid="nanomaterials-15-01340-f006" ref-type="fig">Figure 6</xref>b show the M&#8211;H curves of DEG-, TEG-, TeEG-, and PEG-coated Gd<sub>2</sub>O<sub>3</sub> NPs at 5 and 300 K, respectively. The higher M values at 5 K are attributed to enhanced spin alignment of 4f-electron spins (s = 7/2) at lower temperatures, due to reduced thermal fluctuation. Consistent with the absence of hysteresis in the M&#8211;H curves, no magnetic transitions were observed in the M&#8211;T curves as depicted in <xref rid="nanomaterials-15-01340-f006" ref-type="fig">Figure 6</xref>c,d, confirming the paramagnetic nature of the Gd<sub>2</sub>O<sub>3</sub> NPs down to T = 2 K. Moreover, the negligible variation in magnetization among the DEG-, TEG-, TeEG-, and PEG-coated Gd<sub>2</sub>O<sub>3</sub> NPs confirms that the magnetic moment originates primarily from the paramagnetic Gd<sub>2</sub>O<sub>3</sub> core, as the surface-coating ligands are nonmagnetic and have minimal influence on the magnetic behavior.</p></sec><sec id="sec3dot7-nanomaterials-15-01340"><title>3.7. Water Proton Spin Relaxivities (r<sub>1</sub> and r<sub>2</sub> Values)</title><p>In MRI, T<sub>1</sub> (longitudinal or spin-lattice) and T<sub>2</sub> (transverse or spin-spin) relaxation times indicate how quickly the excited proton spins return to their equilibrium state. T<sub>1</sub> describes the recovery time of the longitudinal (i.e., z-component) magnetization along the main magnetic field. T<sub>2</sub> describes the decay time of the transverse (i.e., x-y component) magnetization perpendicular to the main magnetic field [<xref rid="B103-nanomaterials-15-01340" ref-type="bibr">103</xref>,<xref rid="B104-nanomaterials-15-01340" ref-type="bibr">104</xref>].</p><p>The positive (T<sub>1</sub>) contrast efficacy increases with increasing r<sub>1</sub> value while keeping r<sub>2</sub>/r<sub>1</sub> ratio close to one, whereas negative (T<sub>2</sub>) contrast efficacy increases with increasing r<sub>2</sub> value with r<sub>2</sub>/r<sub>1</sub> ratio as large as possible. The r<sub>1</sub> and r<sub>2</sub> values are determined by measuring T<sub>1</sub> and T<sub>2</sub> water proton spin relaxation times at various Gd concentrations in aqueous solution samples using an MRI scanner. The inverse 1/T<sub>1</sub> and 1/T<sub>2</sub> relaxation times are plotted as a function of Gd concentration, and r<sub>1</sub> and r<sub>2</sub> values are obtained from the corresponding slopes. The r<sub>2</sub> value is always greater than r<sub>1</sub> because T<sub>1</sub> relaxation always accompanies T<sub>2</sub> relaxation whereas the opposite does not happen, making r<sub>2</sub>/r<sub>1</sub> ratio always greater one. Therefore, positive (T<sub>1</sub>) contrast efficacy increases with increasing r<sub>1</sub> value with r<sub>2</sub>/r<sub>1</sub> ratio close to one, which are preferred to T<sub>1</sub> MRI contrast agents. As shown in <xref rid="nanomaterials-15-01340-f007" ref-type="fig">Figure 7</xref>, T<sub>1</sub> relaxation is primarily induced by the interaction between the Gd<sup>3+</sup> ion on Gd<sub>2</sub>O<sub>3</sub> NP surface and water molecule (called inner sphere interaction model), whereas T<sub>2</sub> relaxation is induced by the interaction between NP magnetic moment and water molecule (called outer sphere interaction model) [<xref rid="B104-nanomaterials-15-01340" ref-type="bibr">104</xref>].</p><p>For example, Guleria et al. measured the r<sub>1</sub> and r<sub>2</sub> values of Gd<sub>2</sub>O<sub>3</sub> NPs coated with various ligands [<xref rid="B70-nanomaterials-15-01340" ref-type="bibr">70</xref>]. <xref rid="nanomaterials-15-01340-f008" ref-type="fig">Figure 8</xref>a and <xref rid="nanomaterials-15-01340-f008" ref-type="fig">Figure 8</xref>b depict the plots of 1/T<sub>1</sub> and 1/T<sub>2</sub> relaxation times, respectively, for DEG-, TEG-, TeEG-, and PEG-coated Gd<sub>2</sub>O<sub>3</sub> NPs dispersed in water as function of Gd concentration. Both r<sub>1</sub> and r<sub>2</sub> values increased with increasing glycol chain length, as displayed in <xref rid="nanomaterials-15-01340-f008" ref-type="fig">Figure 8</xref>c and <xref rid="nanomaterials-15-01340-f008" ref-type="fig">Figure 8</xref>d, respectively, suggesting that proton relaxation rates are proportional to the thickness of the hydrophilic coating layer, probably due to enhanced access of outer-sphere water molecules facilitated by the thicker coating.</p></sec><sec id="sec3dot8-nanomaterials-15-01340"><title>3.8. Toxicity of Surface-Modified Gd<sub>2</sub>O<sub>3</sub> NPs</title><p>Gd<sub>2</sub>O<sub>3</sub> NPs have demonstrated significant potential as T<sub>1</sub> MRI CAs due to their considerably higher r<sub>1</sub> and r<sub>2</sub> values compared to Gd(III)-chelates [<xref rid="B47-nanomaterials-15-01340" ref-type="bibr">47</xref>,<xref rid="B97-nanomaterials-15-01340" ref-type="bibr">97</xref>,<xref rid="B105-nanomaterials-15-01340" ref-type="bibr">105</xref>,<xref rid="B106-nanomaterials-15-01340" ref-type="bibr">106</xref>,<xref rid="B107-nanomaterials-15-01340" ref-type="bibr">107</xref>,<xref rid="B108-nanomaterials-15-01340" ref-type="bibr">108</xref>,<xref rid="B109-nanomaterials-15-01340" ref-type="bibr">109</xref>,<xref rid="B110-nanomaterials-15-01340" ref-type="bibr">110</xref>,<xref rid="B111-nanomaterials-15-01340" ref-type="bibr">111</xref>,<xref rid="B112-nanomaterials-15-01340" ref-type="bibr">112</xref>]. However, their clinical translation is hindered by concerns over toxicity, primarily because free Gd<sup>3+</sup> ions are toxic and cannot be metabolized by the body [<xref rid="B113-nanomaterials-15-01340" ref-type="bibr">113</xref>,<xref rid="B114-nanomaterials-15-01340" ref-type="bibr">114</xref>]. Therefore, complete excretion of injected Gd<sub>2</sub>O<sub>3</sub> NPs, preferably via the renal system, without the release of free Gd<sup>3+</sup> ions is essential. For clinically approved Gd(III)-chelates, clinical acute and chronic toxicities are well reported [<xref rid="B113-nanomaterials-15-01340" ref-type="bibr">113</xref>,<xref rid="B114-nanomaterials-15-01340" ref-type="bibr">114</xref>]: acute toxicity includes immediate hypersensitivity allergic-like reactions and physiologic reactions such as coldness, warmth, or pain at the injection site, nausea with or without vomiting, headache, paresthesia, and dizziness and chronic toxicity includes NSF, kidney disease, neurotoxicity, and gadolinium deposition disease such as bone pain and skin and subcutaneous tissue burning pain. However, there exist no clinical studies on acute and chronic toxicity for surface-modified Gd<sub>2</sub>O<sub>3</sub> NPs. Therefore, we discussed in vitro cellular and in vivo animal toxicity studies reported so far in this section. Notably, free Gd<sup>3+</sup> ion has an ionic radius comparable to that of Ca<sup>2+</sup>, enabling them to interfere with Ca<sup>2+</sup>-dependent metabolic process and potentially cause adverse effects [<xref rid="B115-nanomaterials-15-01340" ref-type="bibr">115</xref>,<xref rid="B116-nanomaterials-15-01340" ref-type="bibr">116</xref>]. To mitigate this risk, Gd<sub>2</sub>O<sub>3</sub> NPs must be coated with hydrophilic and biocompatible ligands such as PAA, PMVEMA, PAAMA, PASA, D-glucuronic acid, CA, dextran, PEG, and PVP [<xref rid="B51-nanomaterials-15-01340" ref-type="bibr">51</xref>,<xref rid="B58-nanomaterials-15-01340" ref-type="bibr">58</xref>,<xref rid="B61-nanomaterials-15-01340" ref-type="bibr">61</xref>,<xref rid="B63-nanomaterials-15-01340" ref-type="bibr">63</xref>,<xref rid="B64-nanomaterials-15-01340" ref-type="bibr">64</xref>,<xref rid="B66-nanomaterials-15-01340" ref-type="bibr">66</xref>,<xref rid="B68-nanomaterials-15-01340" ref-type="bibr">68</xref>,<xref rid="B73-nanomaterials-15-01340" ref-type="bibr">73</xref>,<xref rid="B75-nanomaterials-15-01340" ref-type="bibr">75</xref>,<xref rid="B93-nanomaterials-15-01340" ref-type="bibr">93</xref>]. This review addresses both in vitro cellular toxicity and in vivo toxicity (i.e., histological analysis, body weight variation, biodistribution, clearance, and immune response).</p><p>Although there is a dose conversion formula for drugs between animals and human [<xref rid="B117-nanomaterials-15-01340" ref-type="bibr">117</xref>], the FDA-approved dose for gadolinium-based MRI contrast agents is 0.1 mmol/kg for human as well as animals, except for the liver-specific gadoxetic acid dose (0.025 mmol/kg) [<xref rid="B118-nanomaterials-15-01340" ref-type="bibr">118</xref>].</p><sec id="sec3dot8dot1-nanomaterials-15-01340"><title>3.8.1. In Vitro Cellular Toxicity</title><p>In vitro cellular toxicity studies should be conducted prior to in vivo animal experiments to ensure that the surface-coated Gd<sub>2</sub>O<sub>3</sub> NPs are nontoxic at the cellular level. Experimental evidence indicates that bare Gd<sub>2</sub>O<sub>3</sub> NPs are inherently toxic; thus, surface coating with hydrophilic and biocompatible ligands is necessary to reduce cytotoxicity [<xref rid="B69-nanomaterials-15-01340" ref-type="bibr">69</xref>,<xref rid="B93-nanomaterials-15-01340" ref-type="bibr">93</xref>,<xref rid="B119-nanomaterials-15-01340" ref-type="bibr">119</xref>].</p><p>Common techniques for assessing cell viability include MTT, WST-1, and CCK-8 assays [<xref rid="B120-nanomaterials-15-01340" ref-type="bibr">120</xref>,<xref rid="B121-nanomaterials-15-01340" ref-type="bibr">121</xref>]. The MTT assay is a colorimetric method based on the metabolic activity of the cells, whereby mitochondrial dehydrogenases enzymes reduce the tetrazolium salt MTT into water-insoluble formazan crystals. After incubating cells with surface-coated Gd<sub>2</sub>O<sub>3</sub> NPs (typically for 48 h at 37 &#176;C), the resulting formazan crystals are solubilized using an organic solvent or detergent, and absorbance is measured at 570 nm. The WST-1 assay operates on a similar principle, but uses the tetrazolium salt WST-1, which is converted into a highly water-soluble formazan product by mitochondrial dehydrogenase enzymes; absorbance is measured at 450 nm following incubation with NP samples. The CCK-8 assay employs the water-soluble tetrazolium salt WST-8, which is reduced by viable cells into a water-soluble formazan product that also absorbs at 450 nm. Among these assays, WST-8 has been reported as the most sensitive.</p><p>For example, Ahmad et al. demonstrated the nontoxicity of PAA-coated Gd<sub>2</sub>O<sub>3</sub> NPs in normal human embryonic kidney (HEK293) and human liver cancer (HepG2) cell lines [<xref rid="B120-nanomaterials-15-01340" ref-type="bibr">120</xref>]. As shown in <xref rid="nanomaterials-15-01340-f009" ref-type="fig">Figure 9</xref>a, PAA-coated Gd<sub>2</sub>O<sub>3</sub> NPs exhibited high cell viability in both cell lines up to a Gd concentration of 500 &#956;M. <xref rid="nanomaterials-15-01340-f009" ref-type="fig">Figure 9</xref>b presents the in vitro cytotoxicity results of PAAMA-coated ultrasmall Gd<sub>2</sub>O<sub>3</sub> NPs in human prostate cancer (DU145) and normal mouse hepatocyte (NCTC1469) cell lines, showing no toxicity up to 500 &#181;M Gd [<xref rid="B61-nanomaterials-15-01340" ref-type="bibr">61</xref>]. Similarly, Cui et al. evaluated the in vitro cytotoxicity of Gd<sub>2</sub>O<sub>3</sub>-FI-PEG and Gd<sub>2</sub>O<sub>3</sub>-FI-PEG-BBN NPs in the prostate cancer (PC)-3 cell line [<xref rid="B77-nanomaterials-15-01340" ref-type="bibr">77</xref>]. As shown in <xref rid="nanomaterials-15-01340-f009" ref-type="fig">Figure 9</xref>c, cells treated with various Gd concentrations for both 24 and 48 h, demonstrated good viability for both types of surface-coated NPs. These findings consistently confirm the nontoxicity of surface-coated Gd<sub>2</sub>O<sub>3</sub> NPs and underscore the importance of hydrophilic and biocompatible ligand surface coatings in mitigating cytotoxicity.</p></sec><sec id="sec3dot8dot2-nanomaterials-15-01340"><title>3.8.2. In Vivo Toxicity</title><sec><title>Histology</title><p>Histological analysis enables the investigation of the in vivo toxicity of ligand-coated Gd<sub>2</sub>O<sub>3</sub> NPs in organs and muscles at the cellular levels. To perform histological studies, mice are intravenously (IV) injected with ligand-coated Gd<sub>2</sub>O<sub>3</sub> NPs and sacrificed at designated time points after injection to extract relevant organs and muscles. The harvested tissues are sectioned and imaged using an optical microscope, and the results are compared with those of control animals that did not receive NP injections.</p><p>For example, Sun et al. conducted a histological assessment of major organs such as the liver, kidney, spleen, and heart 30 days after IV administration of Gd<sub>2</sub>O<sub>3</sub>@BSA NPs [<xref rid="B102-nanomaterials-15-01340" ref-type="bibr">102</xref>]. As shown in <xref rid="nanomaterials-15-01340-f010" ref-type="fig">Figure 10</xref>, no significant alterations or signs of toxicity were observed compared to control tissues, indicating the nontoxicity of Gd<sub>2</sub>O<sub>3</sub>@BSA NPs.</p></sec><sec><title>Body Weight Change</title><p>Body weight is another important indicator of in vivo toxicity and is measured using a balance before and at regular intervals after IV injection of surface-coated Gd<sub>2</sub>O<sub>3</sub> NPs into mice tails. In the absence of NP-induced toxicity, body weight should remain stable over time. As shown in <xref rid="nanomaterials-15-01340-f011" ref-type="fig">Figure 11</xref>a, no significant weight loss or gain was observed in mice at any of the tested injection doses (25, 50, and 100 mg/kg) compared to the control group without NP injection, indicating that the Gd<sub>2</sub>O<sub>3</sub>@BSA NPs did not induce toxicity [<xref rid="B102-nanomaterials-15-01340" ref-type="bibr">102</xref>].</p></sec><sec><title>Biodistribution</title><p>Biodistribution studies enable the tracking of injected NPs within the body. A solution of Gd-containing NPs is IV injected into mice tails, which are then sacrificed at specific time points after injection to extract organs and muscle for quantification of accumulated Gd concentrations. The biodistribution profile of injected NPs depends on particle size, morphology, and the nature of surface-coating ligands. Ideally, the NPs should be completely excreted from the body via the renal system, similar to Gd(III)-chelates, as free Gd<sup>3+</sup> ions are toxic and cannot be eliminated through normal metabolic processes [<xref rid="B123-nanomaterials-15-01340" ref-type="bibr">123</xref>].</p><p>For example, Dai et al. investigated the biodistribution of PEG-Gd<sub>2</sub>O<sub>3</sub> NPs (hydrodynamic diameter = 30&#8211;40 nm) in comparison with commercial Magnetist (Gd-DTPA) as control. They measured Gd accumulation in the heart, lung, liver, spleen, and kidneys at 1 and 12 h after IV injection into mice tails (injection dose = 15 &#956;mol Gd/kg) [<xref rid="B124-nanomaterials-15-01340" ref-type="bibr">124</xref>]. As shown in <xref rid="nanomaterials-15-01340-f011" ref-type="fig">Figure 11</xref>b, Magnevist exhibited considerably higher accumulation in the kidneys compared to other organs at 1 h post-injection, indicating rapid renal clearance. Additionally, the Gd concentration in all organs was higher for Magnevist than for PEG-Gd<sub>2</sub>O<sub>3</sub> NPs, suggesting faster systemic circulation. At 12 h post-injection, Gd levels in all organs for Magnevist were very low, confirming efficient renal excretion. In contrast, PEG-Gd<sub>2</sub>O<sub>3</sub> NPs showed considerable hepatic accumulation at 12 h, with Gd levels in the liver approximately 7.53 times higher than at 1 h. While the Gd concentration in the heart decreased over time, it increased in the lung, spleen and kidneys, indicating prolonged circulation and predominant hepatic clearance of PEG-Gd<sub>2</sub>O<sub>3</sub> NPs. As another example, Ashouri et al. investigated the biodistribution of &#946;-cyclodextrin-coated Gd<sub>2</sub>O<sub>3</sub> (Gd<sub>2</sub>O<sub>3</sub>@PCD) NPs (d &lt; 100 nm, a = 967.6 nm), using Omniscan (Gd-DTPA-BMA) and Dotarem (Gd-DOTA) as commercial controls in renally impaired rats [<xref rid="B125-nanomaterials-15-01340" ref-type="bibr">125</xref>]. As shown in <xref rid="nanomaterials-15-01340-f011" ref-type="fig">Figure 11</xref>c, Gd<sub>2</sub>O<sub>3</sub>@PCD NPs exhibited only slightly higher Gd accumulation in all organs compared to Omniscan but considerably higher Gd accumulation than Dotarem, 7 days after tail vein injection (total Gd dose: 1.2 mmol Gd/kg for Gd<sub>2</sub>O<sub>3</sub>@PCD NPs; 30 mmol Gd/kg for Omniscan and Dotarem, administered as 0.2 or 5.0 mmol/kg per week for 6 weeks). These findings indicate that Dotarem was efficiently excreted through the renal system even in renally impaired rats, whereas both Gd<sub>2</sub>O<sub>3</sub>@PCD NPs and Omniscan showed notable organ accumulation, particularly in the skin. Yang et al. investigated the long-term biodistribution of the Gd(OH)<sub>3</sub> nanorods in mice up to 150 days post-injection [<xref rid="B56-nanomaterials-15-01340" ref-type="bibr">56</xref>]. The Gd(OH)<sub>3</sub> nanorods predominantly accumulated in the liver, spleen, and lungs. They showed that most Gd(OH)<sub>3</sub> nanorods were rapidly cleared from the circulating blood, with accumulation in these organs increasing initially and then decreasing over time.</p></sec><sec><title>Clearance</title><p>Surface-modified Gd<sub>2</sub>O<sub>3</sub> NPs should be completely cleared from the body within appropriate time frames after injection owing to their inherent toxicity. Clearance occurs via two primary pathways: renal excretion and hepatobiliary excretion, with the renal excretion being the preferred route. The feasibility of renal excretion primarily depends on particle size and hydrodynamic diameter. Gd<sub>2</sub>O<sub>3</sub> NPs with diameters smaller than 5 nm and hydrodynamic diameter below 10 nm can be efficiently excreted through the renal system [<xref rid="B123-nanomaterials-15-01340" ref-type="bibr">123</xref>,<xref rid="B126-nanomaterials-15-01340" ref-type="bibr">126</xref>,<xref rid="B127-nanomaterials-15-01340" ref-type="bibr">127</xref>], whereas larger NPs are typically sequestered by macrophages in the liver and spleen and cleared via the hepatobiliary pathway [<xref rid="B128-nanomaterials-15-01340" ref-type="bibr">128</xref>,<xref rid="B129-nanomaterials-15-01340" ref-type="bibr">129</xref>,<xref rid="B130-nanomaterials-15-01340" ref-type="bibr">130</xref>].</p><p>For instance, for ultrasmall NPs (d &lt; 5 nm), Wu et al. synthesized polymaleic acid (PMA)-coated extremely small gadolinium oxide NPs (ES-GON-PMA) (d = 2.1 nm) and evaluated their clearance following IV tail injection at a dosage of 5.0 mg/kg [<xref rid="B128-nanomaterials-15-01340" ref-type="bibr">128</xref>]. Gd levels were measured in urine and feces over a 24 h period. As shown in <xref rid="nanomaterials-15-01340-f011" ref-type="fig">Figure 11</xref>d, urinary Gd content decreased rapidly over time, while fecal Gd levels remained negligible, indicating predominant renal excretion due to the ultrasmall particle size of ES-GdON-PMA. In contrast, for large NPs (d &gt; 5 nm), Tian et al. investigated the excretion profile of larger Gd<sub>2</sub>O<sub>3</sub>@SiO<sub>2</sub> NPs (d = 37.29 &#177; 1.03 nm) after IV administration into mice tails (15 &#181;mol/kg) [<xref rid="B129-nanomaterials-15-01340" ref-type="bibr">129</xref>]. As shown in <xref rid="nanomaterials-15-01340-f011" ref-type="fig">Figure 11</xref>e, excretion was monitored weekly in both feces and urine over a period of 12 weeks. The results exhibited considerably higher Gd content in feces than in urine, indicating that the large NPs were primarily cleared via the hepatobiliary pathway due to their insufficient renal clearance.</p><fig position="anchor" id="nanomaterials-15-01340-f011" orientation="portrait"><label>Figure 11</label><caption><p>(<bold>a</bold>) Body weight variation over time in mice (<italic toggle="yes">N</italic> = 4) following injection with different doses of Gd<sub>2</sub>O<sub>3</sub>@BSA NPs (25, 50, and 100 mg/kg) compared to a control group (no injection), monitored for 30 days [<xref rid="B102-nanomaterials-15-01340" ref-type="bibr">102</xref>]. (<bold>b</bold>) Biodistribution of Magnevist and PEG-Gd<sub>2</sub>O<sub>3</sub> NPs in the heart, lung, liver, spleen, and kidney at 1 and 12 h after IV injection (15 &#956;mol Gd/kg) (<italic toggle="yes">N</italic> = 3; statistical significance <italic toggle="yes">p</italic> ** &lt; 0.001 compared with the other group in the same organ; ID = percentage of injection dose per gram of organ) [<xref rid="B124-nanomaterials-15-01340" ref-type="bibr">124</xref>]. (<bold>c</bold>) Biodistribution of Gd<sub>2</sub>O<sub>3</sub>@PCD NPs, Omniscan, and Dotarem 7 days after tail vein injection (0.2 mmol/kg per week &#215; 6 weeks = total 1.2 mmol Gd/kg for Gd<sub>2</sub>O<sub>3</sub>@PCD NPs; 5.0 mmol/kg per week &#215; 6 weeks = total 30 mmol Gd/kg for Omniscan and Dotarem) (<italic toggle="yes">N</italic> = 5) [<xref rid="B125-nanomaterials-15-01340" ref-type="bibr">125</xref>]. (<bold>d</bold>) Time-dependent excretion of ES-GdON-PMA-9 (d = 2.1 nm) via urine and feces after IV injection (5.0 mg Gd/kg) (<italic toggle="yes">N</italic> = 3; I.D.%/g = percentage of injected dose per gram of urine or feces) [<xref rid="B128-nanomaterials-15-01340" ref-type="bibr">128</xref>]. (<bold>e</bold>) Excretion profile of Gd<sub>2</sub>O<sub>3</sub>@SiO<sub>2</sub> NPs (d = 37.29 &#177; 1.03 nm) through feces and urine up to 12 weeks after mice tail vein injection (15 &#181;mol/kg) (<italic toggle="yes">N</italic> = 3) [<xref rid="B129-nanomaterials-15-01340" ref-type="bibr">129</xref>].</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nanomaterials-15-01340-g011.jpg"/></fig></sec><sec><title>Immunotoxicity</title><p>The immunotoxicity assay involves the measurements of (1) ROS in neutrophils from peripheral blood, (2) innate immunity cluster of differentiation (CD) markers such as CD40, CD206, CD11b, and CD80/CD86 in monocytes/macrophages in peripheral blood, (3) adaptive immunity CD markers such as CD69 in lymphocytes from peripheral blood and lymph node, and (4) cytokines including IL-1&#946;, IL-2, and IL-4 in serum [<xref rid="B129-nanomaterials-15-01340" ref-type="bibr">129</xref>,<xref rid="B131-nanomaterials-15-01340" ref-type="bibr">131</xref>].</p><p>For example, Tian et al. evaluated the immunotoxicity of Gd<sub>2</sub>O<sub>3</sub>@SiO<sub>2</sub> NPs (Gd-NPs; d = 37.29 &#177; 1.03 nm) by quantifying ROS production, CD maker expression, and cytokine levels in BALB/c mice divided into three groups: PBS (100 &#181;L, negative control), Gd-DTPA (15 &#181;mol/kg), and Gd-NP (15 &#181;mol Gd/kg), with <italic toggle="yes">N</italic> = 5 for each group [<xref rid="B129-nanomaterials-15-01340" ref-type="bibr">129</xref>]. As shown in <xref rid="nanomaterials-15-01340-f012" ref-type="fig">Figure 12</xref>a&#8211;c, a statistically significant difference was observed between the Gd-NP and PBS groups in the expression levels of CD206, CD40, IL-1&#946;, IL-2, and IL-4. However, no significant difference were found between the Gd-NP and Gd-DTPA groups, except ROS generation. As shown in <xref rid="nanomaterials-15-01340-f012" ref-type="fig">Figure 12</xref>c, the Gd-DTPA and Gd-NP groups exhibited increased ROS production of 29% and 75%, respectively, relative to the PBS group. Although the Gd-NP group showed the highest ROS generation, this result is not critical, as ROS is a nonspecific mediator of immune response, capable of promoting either pathogen clearance or immunosuppression during tissue repair. Therefore, the data suggest that Gd-NPs induce minimal immunotoxicity. Similarly, Zheng et al. investigated the immunotoxicity of Gd<sub>2</sub>O<sub>3</sub>:Eu<sup>3+</sup> NPs (d = 7.4 nm) in BALB/c mice using PBS and Gd-DTPA as controls [<xref rid="B131-nanomaterials-15-01340" ref-type="bibr">131</xref>] and obtained comparable results, further supporting that Gd<sub>2</sub>O<sub>3</sub>:Eu<sup>3+</sup> NPs exhibit minimal immunotoxicity.</p></sec></sec></sec></sec><sec id="sec4-nanomaterials-15-01340"><title>4. Factors Affecting r<sub>1</sub> and r<sub>2</sub> Values</title><p>The r<sub>1</sub> and r<sub>2</sub> values of surface-coated Gd<sub>2</sub>O<sub>3</sub> NPs are key factors determining their performance as MRI CAs [<xref rid="B5-nanomaterials-15-01340" ref-type="bibr">5</xref>]. These values are influenced by several factors, such as particle diameter, surface-coating ligands, solution pH, temperature, and applied MR field strength [<xref rid="B64-nanomaterials-15-01340" ref-type="bibr">64</xref>,<xref rid="B97-nanomaterials-15-01340" ref-type="bibr">97</xref>,<xref rid="B132-nanomaterials-15-01340" ref-type="bibr">132</xref>,<xref rid="B133-nanomaterials-15-01340" ref-type="bibr">133</xref>,<xref rid="B134-nanomaterials-15-01340" ref-type="bibr">134</xref>,<xref rid="B135-nanomaterials-15-01340" ref-type="bibr">135</xref>]. <xref rid="nanomaterials-15-01340-t003" ref-type="table">Table 3</xref> lists r<sub>1</sub> and r<sub>2</sub> values of various surface-coated Gd<sub>2</sub>O<sub>3</sub> NPs prepared by different methods and measured under diverse conditions, illustrating the dependence of r<sub>1</sub> and r<sub>2</sub> values on these factors. This dependence highlights the potential to optimize the efficacy of surface-coated Gd<sub>2</sub>O<sub>3</sub> NPs as T<sub>1</sub> MRI CAs through controlled tuning of these variables. Notably, as provided in <xref rid="nanomaterials-15-01340-t003" ref-type="table">Table 3</xref>, r<sub>1</sub> values of surface-modified Gd<sub>2</sub>O<sub>3</sub> NPs are considerably higher than 3&#8211;5 s<sup>&#8722;1</sup>mM<sup>&#8722;1</sup> [<xref rid="B17-nanomaterials-15-01340" ref-type="bibr">17</xref>,<xref rid="B38-nanomaterials-15-01340" ref-type="bibr">38</xref>] of clinically approved T<sub>1</sub> MRI contrast agents, Gd(III)-chelates.</p><sec id="sec4dot1-nanomaterials-15-01340"><title>4.1. Particle Diameter</title><p>Monodispersed ultrasmall Gd<sub>2</sub>O<sub>3</sub> NPs are preferred for T<sub>1</sub> MRI applications because a higher proportion of surface Gd<sup>3+</sup> ions is available to interact with surrounding water molecules, thereby enhancing the r<sub>1</sub> value. Previous studies have consistently shown that the r<sub>1</sub> value increases with decreasing particle diameter [<xref rid="B80-nanomaterials-15-01340" ref-type="bibr">80</xref>,<xref rid="B109-nanomaterials-15-01340" ref-type="bibr">109</xref>,<xref rid="B143-nanomaterials-15-01340" ref-type="bibr">143</xref>] and that ultrasmall Gd<sub>2</sub>O<sub>3</sub> NPs have higher r<sub>1</sub> values than Gd(III)-chelates, suggesting the existence of an optimal particle size for maximizing r<sub>1</sub> value. This was demonstrated by Park et al. [<xref rid="B64-nanomaterials-15-01340" ref-type="bibr">64</xref>] and Rahman et al. [<xref rid="B143-nanomaterials-15-01340" ref-type="bibr">143</xref>]. According to Solomon-Bloembergen-Morgan theory [<xref rid="B38-nanomaterials-15-01340" ref-type="bibr">38</xref>,<xref rid="B134-nanomaterials-15-01340" ref-type="bibr">134</xref>], the T<sub>1</sub> relaxation is due to interaction between Gd<sup>3+</sup> ion and proton spins. As the number of surface Gd<sup>3+</sup> ions of NPs increases, T<sub>1</sub> relaxation (or r<sub>1</sub> value) increases for ultrasmall d &lt; ~2.5 nm [<xref rid="B64-nanomaterials-15-01340" ref-type="bibr">64</xref>,<xref rid="B143-nanomaterials-15-01340" ref-type="bibr">143</xref>] because majority of Gd<sup>3+</sup> ions in NPs exist on NP surface due to high surface-to-volume (S/V) ratios, whereas T<sub>1</sub> relaxation (or r<sub>1</sub> value) decreases as d increases for d &gt; ~2.5 nm because of low S/V ratios at which majority of Gd<sup>3+</sup> ions in NPs are internal inactive ones for T<sub>1</sub> relaxations.</p><p>Rahman et al. reported that the r<sub>1</sub> value of CA-coated Gd<sub>2</sub>O<sub>3</sub> NPs increased as particle size decreased below 3.0&#8201;nm at 7 T, reaching a maximum value at approximately 2.3&#8201;nm; further size reduction led to a decline in r<sub>1</sub> value (<xref rid="nanomaterials-15-01340-f013" ref-type="fig">Figure 13</xref>a) [<xref rid="B143-nanomaterials-15-01340" ref-type="bibr">143</xref>]. Park et al. roughly estimated the optimal particle size to lie between 1.1 and 2.5 nm [<xref rid="B64-nanomaterials-15-01340" ref-type="bibr">64</xref>]. In another study, the r<sub>1</sub> values of PAA-octylamine-coated Gd<sub>2</sub>O<sub>3</sub> NPs (d = 2, 5, 8, 11, and 22 nm) [<xref rid="B80-nanomaterials-15-01340" ref-type="bibr">80</xref>] and PEG-polysiloxane-coated Gd<sub>2</sub>O<sub>3</sub> NPs (d = 2.2, 3.8, and 4.6 nm) [<xref rid="B109-nanomaterials-15-01340" ref-type="bibr">109</xref>] decreased with increasing particle diameter at 1.41 and 7 T, respectively (<xref rid="nanomaterials-15-01340-f013" ref-type="fig">Figure 13</xref>b). This trend likely results from particle diameters exceeding the optimal range. Conversely, the r<sub>2</sub> value, which is influenced by the NP magnetic moment, tends to increase with particle size due to the corresponding increase in magnetic moment per NP [<xref rid="B64-nanomaterials-15-01340" ref-type="bibr">64</xref>].</p></sec><sec id="sec4dot2-nanomaterials-15-01340"><title>4.2. Surface-Coating Ligands</title><p>Surface coating is another critical factor influencing the r<sub>1</sub> and r<sub>2</sub> values of Gd<sub>2</sub>O<sub>3</sub> NPs [<xref rid="B71-nanomaterials-15-01340" ref-type="bibr">71</xref>,<xref rid="B75-nanomaterials-15-01340" ref-type="bibr">75</xref>,<xref rid="B97-nanomaterials-15-01340" ref-type="bibr">97</xref>]. Appropriate selection of coating ligands can enhance the accessibility of water molecules near the Gd<sub>2</sub>O<sub>3</sub> NP surface, thereby increasing the r<sub>1</sub> and r<sub>2</sub> values.</p><p>For example, Tegafaw et al. investigated the relaxometric properties of Gd<sub>2</sub>O<sub>3</sub> NPs coated with various ligands, including small diacids with hydrophobic chains (succinic acid, glutaric acid, and terephthalic acid) and large PEIs (PEI-1300 and PEI-10,000) with hydrophilic chains [<xref rid="B71-nanomaterials-15-01340" ref-type="bibr">71</xref>]. As shown in <xref rid="nanomaterials-15-01340-f013" ref-type="fig">Figure 13</xref>c, both r<sub>1</sub> and r<sub>2</sub> values decreased with increasing ligand size. This indicates that small, hydrophilic ligands promote closer interaction between water molecules and the NP surface, thereby enhancing r<sub>1</sub> and r<sub>2</sub> values. Similarly, Miao et al. reported that the r<sub>1</sub> and r<sub>2</sub> values of ultrasmall Gd<sub>2</sub>O<sub>3</sub> NPs decreased as the molecular weight of PAA (M<sub>w</sub>&#8201; = &#8201;1200, 5100, 15,000&#8201;Da) increased (<xref rid="nanomaterials-15-01340-f013" ref-type="fig">Figure 13</xref>c) [<xref rid="B75-nanomaterials-15-01340" ref-type="bibr">75</xref>]. Kim et al. also observed a reduction in r<sub>1</sub> and r<sub>2</sub> values as the molecular weight of PEGD (M<sub>w</sub>&#8201; = &#8201;250 and 600 Da) increased (<xref rid="nanomaterials-15-01340-f013" ref-type="fig">Figure 13</xref>c) [<xref rid="B97-nanomaterials-15-01340" ref-type="bibr">97</xref>]. These results indicate that smaller, hydrophilic ligands are preferable for achieving higher r<sub>1</sub> and r<sub>2</sub> values.</p></sec><sec id="sec4dot3-nanomaterials-15-01340"><title>4.3. Solution pH</title><p>The solution pH influences the surface charge and colloidal stability of surface-coated Gd<sub>2</sub>O<sub>3</sub> NPs, thereby affecting their r<sub>1</sub> and r<sub>2</sub> values. pH can be adjusted by adding acid or base. For example, in the case of PAA-coated Gd<sub>2</sub>O<sub>3</sub> NPs, the carboxyl groups on PAA ligands become protonated under acidic conditions, potentially leading to NP aggregation. Aggregation increases particle size and reduces the surface-to-volume ratios, which may limit water exchange between bulk water and the Gd<sub>2</sub>O<sub>3</sub> NP surface, thereby decreasing the r<sub>1</sub> value. Conversely, under basic conditions, the carboxyl groups are deprotonated, resulting in negatively charged surfaces that promote electrostatic repulsion between NPs. This enhanced repulsion improves colloidal stability and increases water accessibility to the NP surface, potentially enhancing r<sub>1</sub> values. In contrast, the r<sub>2</sub> value, which increases with the NP magnetic moment [<xref rid="B64-nanomaterials-15-01340" ref-type="bibr">64</xref>], may rise with NP aggregation due to the increase in the magnetic moment per NP. However, excessive aggregation can still compromise colloidal stability, which may in turn limit this effect.</p></sec><sec id="sec4dot4-nanomaterials-15-01340"><title>4.4. Temperature</title><p>The r<sub>1</sub> and r<sub>2</sub> values are also influenced by temperature, as key parameters such as the diffusion coefficient (D) and rotational correlation time (&#964;<sub>R</sub>) of water molecules and CAs are temperature-dependent [<xref rid="B133-nanomaterials-15-01340" ref-type="bibr">133</xref>,<xref rid="B134-nanomaterials-15-01340" ref-type="bibr">134</xref>,<xref rid="B144-nanomaterials-15-01340" ref-type="bibr">144</xref>,<xref rid="B145-nanomaterials-15-01340" ref-type="bibr">145</xref>]. As temperature increases, D increases and &#964;<sub>R</sub> decreases, thereby shortening the interaction time between water proton spins and the NPs. This reduction in interaction time leads to decreased r<sub>1</sub> and r<sub>2</sub> values. For example, Goussuin et al. demonstrated that the r<sub>1</sub> and r<sub>2</sub> values of Gd(OH)<sub>3</sub> NPs decreased with increasing temperature at 1.41 T, as shown in <xref rid="nanomaterials-15-01340-f013" ref-type="fig">Figure 13</xref>d [<xref rid="B144-nanomaterials-15-01340" ref-type="bibr">144</xref>].</p></sec><sec id="sec4dot5-nanomaterials-15-01340"><title>4.5. Applied Magnetic Field Strength (H)</title><p>Roch et al. theoretically investigated the r<sub>1</sub> and r<sub>2</sub> values of superparamagnetic NPs (d = 5 nm) as a function of the applied magnetic field strength (H) or proton Larmor frequency [<xref rid="B133-nanomaterials-15-01340" ref-type="bibr">133</xref>]. As shown in <xref rid="nanomaterials-15-01340-f013" ref-type="fig">Figure 13</xref>e, three distinct regions were identified: Region 1, where r<sub>1</sub> and r<sub>2</sub> values remain nearly constant at H &lt; 1 MHz; Region 2, where r<sub>1</sub> and r<sub>2</sub> values increase with H between 1 and 10 MHz; and Region 3, where r<sub>1</sub> and r<sub>2</sub> values decrease at H &gt; 10 MHz (the clinical region).</p><p>For example, Carniato et al. synthesized CA-coated GdF<sub>3</sub> NPs (d = 2.2&#8211;2.3 nm) and observed three regions in the r<sub>1</sub> nuclear magnetic resonance dispersion (NMRD) profile, as shown in <xref rid="nanomaterials-15-01340-f013" ref-type="fig">Figure 13</xref>f [<xref rid="B135-nanomaterials-15-01340" ref-type="bibr">135</xref>], in agreement with theoretical prediction [<xref rid="B133-nanomaterials-15-01340" ref-type="bibr">133</xref>]. Additional experimental r<sub>1</sub> value plots as a function of H in Region 3 are displayed in <xref rid="nanomaterials-15-01340-f013" ref-type="fig">Figure 13</xref>g, demonstrating that the r<sub>1</sub> values of various ligand-coated Gd<sub>2</sub>O<sub>3</sub> NPs and Gd(III)-chelates decrease with increasing H in this region [<xref rid="B73-nanomaterials-15-01340" ref-type="bibr">73</xref>,<xref rid="B107-nanomaterials-15-01340" ref-type="bibr">107</xref>,<xref rid="B140-nanomaterials-15-01340" ref-type="bibr">140</xref>,<xref rid="B146-nanomaterials-15-01340" ref-type="bibr">146</xref>]. Therefore, the proton signal enhancement by T<sub>1</sub> MRI CAs diminishes with increasing H in the clinical region. However, due to enhanced proton spin alignment along H at higher field strengths, resulting in a larger proton spin population difference, the net proton signal enhancement at high H remains considerably greater than that predicted solely from the T<sub>1</sub> MRI CA contribution.</p><fig position="anchor" id="nanomaterials-15-01340-f013" orientation="portrait"><label>Figure 13</label><caption><p>Plot of r<sub>1</sub> values of (<bold>a</bold>) CA-coated Gd<sub>2</sub>O<sub>3</sub> NPs as a function of particle diameter (1.5&#8211;194.0 nm) at 7 T [<xref rid="B143-nanomaterials-15-01340" ref-type="bibr">143</xref>] and (<bold>b</bold>) PAA-octylamine- [<xref rid="B80-nanomaterials-15-01340" ref-type="bibr">80</xref>] and PEG-polysiloxane- [<xref rid="B109-nanomaterials-15-01340" ref-type="bibr">109</xref>] coated Gd<sub>2</sub>O<sub>3</sub> NPs as a function of particle diameter at 1.41 and 7 T, respectively. (<bold>c</bold>) Plot of r<sub>1</sub> values of various ligand-coated Gd<sub>2</sub>O<sub>3</sub> NPs as a function of ligand size at 1.5 T [<xref rid="B71-nanomaterials-15-01340" ref-type="bibr">71</xref>,<xref rid="B75-nanomaterials-15-01340" ref-type="bibr">75</xref>,<xref rid="B97-nanomaterials-15-01340" ref-type="bibr">97</xref>]. (<bold>d</bold>) Plot of r<sub>1</sub> values of Gd(OH)<sub>3</sub> NPs as a function of temperature at 1.41 T [<xref rid="B144-nanomaterials-15-01340" ref-type="bibr">144</xref>]. (<bold>e</bold>) Theoretical NMRD profile of superparamagnetic NPs (d = 5 nm) [<xref rid="B133-nanomaterials-15-01340" ref-type="bibr">133</xref>]. (<bold>f</bold>) NMRD profile of CA-coated GdF<sub>3</sub> NPs (d = 2.2&#8211;2.3 nm) [<xref rid="B135-nanomaterials-15-01340" ref-type="bibr">135</xref>]. (<bold>g</bold>) Plots of r<sub>1</sub> values of various ligand-coated Gd<sub>2</sub>O<sub>3</sub> NPs and Gd(III)-DTPA as a function of H [<xref rid="B73-nanomaterials-15-01340" ref-type="bibr">73</xref>,<xref rid="B107-nanomaterials-15-01340" ref-type="bibr">107</xref>,<xref rid="B140-nanomaterials-15-01340" ref-type="bibr">140</xref>,<xref rid="B146-nanomaterials-15-01340" ref-type="bibr">146</xref>].</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nanomaterials-15-01340-g013.jpg"/></fig></sec></sec><sec id="sec5-nanomaterials-15-01340"><title>5. In Vivo MRI Applications</title><sec id="sec5dot1-nanomaterials-15-01340"><title>5.1. Imaging in Normal Mice</title><p>The FDA-approved dose for gadolinium-based MRI contrast agents is 0.1 mmol/kg for human as well as animals, except for the liver-specific gadoxetic acid dose (0.025 mmol/kg) [<xref rid="B118-nanomaterials-15-01340" ref-type="bibr">118</xref>]. Numerous in vivo studies have reported the use of surface-coated Gd<sub>2</sub>O<sub>3</sub> NPs as T<sub>1</sub> MRI CAs, demonstrating their strong potential as T<sub>1</sub> MRI CAs. For example, Ahmad et al. investigated PMVEMA-coated ultrasmall Gd<sub>2</sub>O<sub>3</sub> NPs (d = 1.9 nm) as a T<sub>1</sub> MRI CA [<xref rid="B58-nanomaterials-15-01340" ref-type="bibr">58</xref>]. Following IV administration of the aqueous NP solution into mice tails, positive (i.e., bright) contrast enhancement was observed in the liver and kidneys, as shown in <xref rid="nanomaterials-15-01340-f014" ref-type="fig">Figure 14</xref>a. Signal-to-noise ratios (SNRs) of regions of interest (ROIs) in these organs initially increased, reached maxima, and then decreased over time, indicating accumulation followed by excretion of the NPs, predominantly through the renal pathway, thus confirming their role as T<sub>1</sub> MRI CAs (<xref rid="nanomaterials-15-01340-f014" ref-type="fig">Figure 14</xref>b). In another example, Yue et al. reported carbon-coated Gd<sub>2</sub>O<sub>3</sub> (Gd<sub>2</sub>O<sub>3</sub>@C) NPs (d = 3.1 nm) as a T<sub>1</sub> MRI CA [<xref rid="B69-nanomaterials-15-01340" ref-type="bibr">69</xref>]. Upon IV administration into mice tails, the NPs produced positive contrast enhancement in the liver, kidneys, and bladder (<xref rid="nanomaterials-15-01340-f014" ref-type="fig">Figure 14</xref>c). The SNR-ROIs in these organs, plotted as a function of time (<xref rid="nanomaterials-15-01340-f014" ref-type="fig">Figure 14</xref>d), showed that the contrast enhancements peaked between the point of administration and 30 min post-injection, and subsequently declined. These results further confirm the function of the NPs as a T<sub>1</sub> MRI CA.</p></sec><sec id="sec5dot2-nanomaterials-15-01340"><title>5.2. Imaging in Cancer Model Mice</title><p>Owing to the EPR effects, NPs can accumulate more readily in cancer cells than in normal cells (called passive targeting) [<xref rid="B147-nanomaterials-15-01340" ref-type="bibr">147</xref>]. Furthermore, the accumulation of NPs in cancer cells can be considerably enhanced by conjugating cancer-targeting ligands onto the NP surface (called active targeting).</p><p>Dai et al. showed that PEG-Gd<sub>2</sub>O<sub>3</sub> NPs (r<sub>1</sub> = 29.0 s<sup>&#8722;1</sup> mM<sup>&#8722;1</sup>) displayed stronger contrast enhancement of the tumor in in vivo MR images than Magnevist (r<sub>1</sub> = 4.2 s<sup>&#8722;1</sup> mM<sup>&#8722;1</sup>) at the same amount of Gd injection, demonstrating the superiority of PEG-Gd<sub>2</sub>O<sub>3</sub> NPs to commercial molecular contrast agent Magnevist [<xref rid="B124-nanomaterials-15-01340" ref-type="bibr">124</xref>]. Shen et al. evaluated T<sub>1</sub> MR images of U87MG tumor model nude mice using exceedingly small (ES), RGD2-conjugated PAA-coated Gd<sub>2</sub>O<sub>3</sub> (simply referred to as ES-GON5-PAA@RGD2) NPs [<xref rid="B107-nanomaterials-15-01340" ref-type="bibr">107</xref>]. As shown in <xref rid="nanomaterials-15-01340-f015" ref-type="fig">Figure 15</xref>a, the tumor region exhibited a very weak MRI signal prior to IV injection. Following injection, signal intensity increased markedly, peaking at 2 h post-administration. Quantitative analysis in <xref rid="nanomaterials-15-01340-f015" ref-type="fig">Figure 15</xref>b revealed a maximum &#916;SNR [=100% &#215; (SNRpost &#8722; SNRpre)/SNRpre] of 372 &#177; 56%, which is considerably higher than the &#916;SNR of &lt;80% of typically observed value with conventional Gd(III)-chelates. This remarkably enhanced tumor &#916;SNR can be attributed to the combined effects of the high relaxivity value of the NPs (r<sub>1</sub> = 68.7 &#177; 2.3 mM<sup>&#8211;1</sup>s<sup>&#8211;1</sup>, r<sub>2</sub>/r<sub>1</sub> = 1.03 &#177; 0.03 at 1.5 T), the active targeting capability of RGD2 toward integrin &#945;v&#946;3-overexpressed on tumor cells, and the EPR effect.</p></sec></sec><sec sec-type="conclusions" id="sec6-nanomaterials-15-01340"><title>6. Conclusions and Future Outlook</title><p>Considerable research progress has been made on surface-coated Gd<sub>2</sub>O<sub>3</sub> NPs as promising T<sub>1</sub> MRI CAs. However, no comprehensive review on this subject has been reported to data. Therefore, a thorough overview addressing current status and future perspectives of surface-coated Gd<sub>2</sub>O<sub>3</sub> NPs as T<sub>1</sub> MRI CAs is highly warranted. Such a review would substantially advance research in this field and assist researchers in understanding the current state of the art and identifying future research directions.</p><p>This review has covered synthesis methods (i.e., polyol, DMSO, thermal decomposition, and hydrothermal techniques); characterization techniques (i.e., TEM, DLS, XRD, FTIR, TGA, zeta potential, VSM, and MRI); in vitro cellular and in vivo toxicity assessments (i.e., histology, biodistribution, body weight change, clearance, and immunotoxicity); and in vivo MRI applications of surface-modified Gd<sub>2</sub>O<sub>3</sub> NPs. In addition, the influence of various factors (i.e., particle diameter, surface-coating ligands, solution pH, temperature, and applied MR field) on performance parameters of MRI CAs (i.e., r<sub>1</sub> and r<sub>2</sub> values) was discussed, as this information is critical for the rational design of optimized Gd<sub>2</sub>O<sub>3</sub> NPs for specific applications. By comparing the strengths and limitations of each synthesis method, researchers can select the most appropriate approach for their intended application. The characterization protocols described herein may also serve as standard procedures for studies. Although previous studies have demonstrated the strong potential of surface-modified Gd<sub>2</sub>O<sub>3</sub> NPs as T<sub>1</sub> MRI CAs, further development of advanced formulations that fully meet in vivo toxicity criteria is essential for clinical translation. For instance, nontoxic, renally excretable formulations that prevent the release of free Gd<sup>3+</sup> ions should be pursued.</p><p>While remarkable progress has been achieved in surface-modified Gd<sub>2</sub>O<sub>3</sub> NPs, successful translation to clinical trial phases demands standardized methodologies. Future research should focus on conducting comprehensive toxicity assessments, including acute, sub-chronic, and chronic studies aligned with Food and Drug Administration (FDA) and European Medicines Agency (EMA) guidelines [<xref rid="B148-nanomaterials-15-01340" ref-type="bibr">148</xref>,<xref rid="B149-nanomaterials-15-01340" ref-type="bibr">149</xref>]. Standardized protocols for evaluating renal clearance and nephrotoxicity are also needed for clinical trial phases. Additionally, scalable manufacturing processes compliant with Good Manufacturing Practices (GMPs) are necessary for commercialization. GMP-compliant scale-up strategies involve a systematic approach to increasing production volume while maintaining product quality and regulatory compliance. Key aspects include facility design, process validation, quality control, supply chain management, and workforce training; all tailored to meet GMP requirements.</p><p>The surfaced-modified Gd<sub>2</sub>O<sub>3</sub> NPs exhibited higher r<sub>1</sub> values compared to surfaced-modified Mn and Fe-based NPs owing to the higher electron spin magnetic moment of Gd<sup>3+</sup> (s = 7/2) compared to Mn<sup>2+</sup> (s = 5/2) and Fe<sup>3+</sup> (s = 5/2). The only disadvantage of surfaced-modified Gd<sub>2</sub>O<sub>3</sub> NPs compared to surfaced-modified Mn- and Fe-based NPs is their higher potential toxicity. Therefore, advancement in biocompatible ligand coatings is critical to ensure the safety profile of surfaced-modified Gd<sub>2</sub>O<sub>3</sub> NPs. Several studies assessed colloidal stability of surface-modified lanthanide oxide NPs in water, phosphate-buffered saline (PBS), or serum-containing media [<xref rid="B51-nanomaterials-15-01340" ref-type="bibr">51</xref>,<xref rid="B69-nanomaterials-15-01340" ref-type="bibr">69</xref>,<xref rid="B150-nanomaterials-15-01340" ref-type="bibr">150</xref>], demonstrating good colloidal stability overtime and thus, good coating stability.</p><p>Over the past decade, extensive efforts have been devoted to developing new T<sub>1</sub> MRI CAs as alternatives to Gd(III)-chelates, which suffer from low sensitivity due to their low r<sub>1</sub> values, as well as non-specificity and short imaging windows resulting from rapid blood clearance. These limitations often necessitate the administration of large doses. Surface-modified Gd<sub>2</sub>O<sub>3</sub> NPs have emerged as promising alternatives, offering improved performance by overcoming the shortcomings of Gd(III)-chelates. Moreover, surface-modified Gd<sub>2</sub>O<sub>3</sub> NPs can be easily conjugated with cancer-targeting ligands and therapeutic drugs, enabling targeted theranostic applications. They can be further functionalized via integration with other imaging agents such as FI, CT, PET, and SPECT agents to promote their application as multimodal imaging agents. While many of these advantages have been demonstrated in in vivo animal studies, considerable challenges remain in translating these systems into clinical practice. As discussed above, the development of advanced formulations and comprehensive in vivo toxicity evaluations are critical next steps. Achieving clinical translation will require sustained interdisciplinary research efforts.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#8217;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, E.M. and T.T.; methodology, T.T. and E.M.; validation, Y.L., D.Z., A.B., J.K. and X.C.; writing&#8212;original draft preparation, E.M. and T.T.; writing&#8212;review and editing, Y.C. and G.H.L.; funding acquisition, J.K., Y.C. and G.H.L. All authors have read and agreed to the published version of the manuscript.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The data presented in this study are contained within the article.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-nanomaterials-15-01340"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Shu</surname><given-names>J.</given-names></name></person-group><article-title>Multimodal Molecular Imaging: Current Status and Future Directions</article-title><source>Contrast Media Mol. Imaging</source><year>2018</year><volume>2018</volume><fpage>1382183</fpage><pub-id pub-id-type="doi">10.1155/2018/1382183</pub-id><pub-id pub-id-type="pmid">29967571</pub-id><pub-id pub-id-type="pmcid">PMC6008764</pub-id></element-citation></ref><ref id="B2-nanomaterials-15-01340"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Z.-Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.-X.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J.-S.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Q.-L.</given-names></name><name name-style="western"><surname>Liao</surname><given-names>Y.-Y.</given-names></name></person-group><article-title>Advance of Molecular Imaging Technology and Targeted Imaging Agent in Imaging and Therapy</article-title><source>BioMed Res. Int.</source><year>2014</year><volume>2014</volume><elocation-id>819324</elocation-id><pub-id pub-id-type="doi">10.1155/2014/819324</pub-id><pub-id pub-id-type="pmid">24689058</pub-id><pub-id pub-id-type="pmcid">PMC3943245</pub-id></element-citation></ref><ref id="B3-nanomaterials-15-01340"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Han</surname><given-names>X.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>K.</given-names></name><name name-style="western"><surname>Taratula</surname><given-names>O.</given-names></name><name name-style="western"><surname>Farsad</surname><given-names>K.</given-names></name></person-group><article-title>Applications of Nanoparticles in Biomedical Imaging</article-title><source>Nanoscale</source><year>2019</year><volume>11</volume><fpage>799</fpage><lpage>819</lpage><pub-id pub-id-type="doi">10.1039/C8NR07769J</pub-id><pub-id pub-id-type="pmid">30603750</pub-id><pub-id pub-id-type="pmcid">PMC8112886</pub-id></element-citation></ref><ref id="B4-nanomaterials-15-01340"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>H.-Y.</given-names></name></person-group><article-title>In Vivo Molecular Imaging in Preclinical Research</article-title><source>Lab. Anim. Res.</source><year>2022</year><volume>38</volume><fpage>31</fpage><pub-id pub-id-type="doi">10.1186/s42826-022-00142-3</pub-id><pub-id pub-id-type="pmid">36266669</pub-id><pub-id pub-id-type="pmcid">PMC9585739</pub-id></element-citation></ref><ref id="B5-nanomaterials-15-01340"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ni</surname><given-names>D.</given-names></name><name name-style="western"><surname>Bu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Ehlerding</surname><given-names>E.B.</given-names></name><name name-style="western"><surname>Cai</surname><given-names>W.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>J.</given-names></name></person-group><article-title>Engineering of Inorganic Nanoparticles as Magnetic Resonance Imaging Contrast Agents</article-title><source>Chem. Soc. Rev.</source><year>2017</year><volume>46</volume><fpage>7438</fpage><lpage>7468</lpage><pub-id pub-id-type="doi">10.1039/C7CS00316A</pub-id><pub-id pub-id-type="pmid">29071327</pub-id><pub-id pub-id-type="pmcid">PMC5705441</pub-id></element-citation></ref><ref id="B6-nanomaterials-15-01340"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chouliaras</surname><given-names>L.</given-names></name><name name-style="western"><surname>O&#8217;Brien</surname><given-names>J.T.</given-names></name></person-group><article-title>The Use of Neuroimaging Techniques in the Early and Differential Diagnosis of Dementia</article-title><source>Mol. Psychiatry</source><year>2023</year><volume>28</volume><fpage>4084</fpage><lpage>4097</lpage><pub-id pub-id-type="doi">10.1038/s41380-023-02215-8</pub-id><pub-id pub-id-type="pmid">37608222</pub-id><pub-id pub-id-type="pmcid">PMC10827668</pub-id></element-citation></ref><ref id="B7-nanomaterials-15-01340"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McCarthy</surname><given-names>J.</given-names></name><name name-style="western"><surname>Collins</surname><given-names>D.L.</given-names></name><name name-style="western"><surname>Ducharme</surname><given-names>S.</given-names></name></person-group><article-title>Morphometric MRI as a Diagnostic Biomarker of Frontotemporal Dementia: A Systematic Review to Determine Clinical Applicability</article-title><source>NeuroImage Clin.</source><year>2018</year><volume>20</volume><fpage>685</fpage><lpage>696</lpage><pub-id pub-id-type="doi">10.1016/j.nicl.2018.08.028</pub-id><pub-id pub-id-type="pmid">30218900</pub-id><pub-id pub-id-type="pmcid">PMC6140291</pub-id></element-citation></ref><ref id="B8-nanomaterials-15-01340"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Iyad</surname><given-names>N.</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Alkhatib</surname><given-names>S.G.</given-names></name><name name-style="western"><surname>Hjouj</surname><given-names>M.</given-names></name></person-group><article-title>Gadolinium contrast agents- challenges and opportunities of a multidisciplinary approach: Literature review</article-title><source>Eur. J. Radiol. Open</source><year>2023</year><volume>11</volume><fpage>100503</fpage><pub-id pub-id-type="doi">10.1016/j.ejro.2023.100503</pub-id><pub-id pub-id-type="pmid">37456927</pub-id><pub-id pub-id-type="pmcid">PMC10344828</pub-id></element-citation></ref><ref id="B9-nanomaterials-15-01340"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Z.-R.</given-names></name></person-group><article-title>Gadolinium-Based Contrast Agents for MR Cancer Imaging</article-title><source>Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol.</source><year>2013</year><volume>5</volume><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1002/wnan.1198</pub-id><pub-id pub-id-type="pmid">23047730</pub-id><pub-id pub-id-type="pmcid">PMC3552562</pub-id></element-citation></ref><ref id="B10-nanomaterials-15-01340"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Palagi</surname><given-names>L.</given-names></name><name name-style="western"><surname>Longo</surname><given-names>D.L.</given-names></name><name name-style="western"><surname>Toth</surname><given-names>E.</given-names></name><name name-style="western"><surname>Quattrocchi</surname><given-names>C.C.</given-names></name><name name-style="western"><surname>van der Molen</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Aime</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gianolio</surname><given-names>E.</given-names></name></person-group><article-title>Molecular and supramolecular routes to enhance Gadolinium-based contrast agents relaxivity: How far are we from the theoretical optimal value?</article-title><source>Eur. J. Med. Chem.</source><year>2025</year><volume>292</volume><fpage>117668</fpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2025.117668</pub-id><pub-id pub-id-type="pmid">40288123</pub-id></element-citation></ref><ref id="B11-nanomaterials-15-01340"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wan</surname><given-names>F.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>L.</given-names></name></person-group><article-title>Research progress on manganese complexes as contrast agents for magnetic resonance imaging</article-title><source>Polyhedron</source><year>2023</year><volume>242</volume><fpage>116489</fpage><pub-id pub-id-type="doi">10.1016/j.poly.2023.116489</pub-id></element-citation></ref><ref id="B12-nanomaterials-15-01340"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>D.</given-names></name><name name-style="western"><surname>Baek</surname><given-names>A.</given-names></name><name name-style="western"><surname>Tegafaw</surname><given-names>T.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>T.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>T.</given-names></name><name name-style="western"><surname>Yue</surname><given-names>H.</given-names></name><name name-style="western"><surname>Mulugeta</surname><given-names>E.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Park</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Poly(acrylic acid)-Grafted Bi<italic toggle="yes"><sub>x</sub></italic>Gd<sub>2&#8211;<italic toggle="yes">x</italic></sub>O<sub>3</sub> Nanoparticles as Multimodal <italic toggle="yes">T</italic><sub>1</sub>/<italic toggle="yes">T</italic><sub>2</sub> MRI and X-ray CT Contrast Agents</article-title><source>ACS Appl. Nano Mater.</source><year>2025</year><volume>8</volume><fpage>13663</fpage><lpage>13675</lpage><pub-id pub-id-type="doi">10.1021/acsanm.5c01443</pub-id></element-citation></ref><ref id="B13-nanomaterials-15-01340"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marasini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yue</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ho</surname><given-names>S.-L.</given-names></name><name name-style="western"><surname>Park</surname><given-names>J.-A.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J.-U.</given-names></name><name name-style="western"><surname>Cha</surname><given-names>H.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tegafaw</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>M.Y.</given-names></name><etal/></person-group><article-title>In vivo positive magnetic resonance imaging of brain cancer (U87MG) using folic acid-conjugated polyacrylic acid-coated ultrasmall manganese oxide nanoparticles</article-title><source>Appl. Sci.</source><year>2021</year><volume>11</volume><elocation-id>2596</elocation-id><pub-id pub-id-type="doi">10.3390/app11062596</pub-id></element-citation></ref><ref id="B14-nanomaterials-15-01340"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yue</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>D.</given-names></name><name name-style="western"><surname>Tegafaw</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>M.Y.</given-names></name><name name-style="western"><surname>Saidi</surname><given-names>A.K.A.A.</given-names></name><name name-style="western"><surname>Ying</surname><given-names>L.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.</given-names></name><name name-style="western"><surname>Cha</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>B.W.</given-names></name><name name-style="western"><surname>Chae</surname><given-names>K.S.</given-names></name><etal/></person-group><article-title>Core-Shell Fe<sub>3</sub>O<sub>4</sub>@C Nanoparticles as Highly Effective T<sub>2</sub> Magnetic Resonance Imaging Contrast Agents: In Vitro and In Vivo Studies</article-title><source>Nanomaterials</source><year>2024</year><volume>14</volume><elocation-id>177</elocation-id><pub-id pub-id-type="doi">10.3390/nano14020177</pub-id><pub-id pub-id-type="pmid">38251140</pub-id><pub-id pub-id-type="pmcid">PMC10819740</pub-id></element-citation></ref><ref id="B15-nanomaterials-15-01340"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ho</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Tegafaw</surname><given-names>T.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>D.</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>M.Y.</given-names></name><name name-style="western"><surname>Saidi</surname><given-names>A.K.A.A.</given-names></name><name name-style="western"><surname>Cha</surname><given-names>H.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>H.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Clustered ultra-small iron oxide nanoparticles as potential <italic toggle="yes">T</italic><sub>1</sub>/<italic toggle="yes">T</italic><sub>2</sub> dual&#8211;modal magnetic resonance imaging contrast agents and application to tumor model</article-title><source>Nanotechnology</source><year>2024</year><volume>35</volume><fpage>505101</fpage><pub-id pub-id-type="doi">10.1088/1361-6528/ad8203</pub-id><pub-id pub-id-type="pmid">39353465</pub-id></element-citation></ref><ref id="B16-nanomaterials-15-01340"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Geraldes</surname><given-names>C.F.G.C.</given-names></name></person-group><article-title>Rational Design of Magnetic Nanoparticles as T<sub>1</sub>&#8211;T<sub>2</sub> Dual-Mode MRI Contrast Agents</article-title><source>Molecules</source><year>2024</year><volume>29</volume><elocation-id>1352</elocation-id><pub-id pub-id-type="doi">10.3390/molecules29061352</pub-id><pub-id pub-id-type="pmid">38542988</pub-id><pub-id pub-id-type="pmcid">PMC10974227</pub-id></element-citation></ref><ref id="B17-nanomaterials-15-01340"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wahsner</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gale</surname><given-names>E.M.</given-names></name><name name-style="western"><surname>Rodr&#237;guez-Rodr&#237;guez</surname><given-names>A.</given-names></name><name name-style="western"><surname>Caravan</surname><given-names>P.</given-names></name></person-group><article-title>Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers</article-title><source>Chem. Rev.</source><year>2019</year><volume>119</volume><fpage>957</fpage><lpage>1057</lpage><pub-id pub-id-type="doi">10.1021/acs.chemrev.8b00363</pub-id><pub-id pub-id-type="pmid">30350585</pub-id><pub-id pub-id-type="pmcid">PMC6516866</pub-id></element-citation></ref><ref id="B18-nanomaterials-15-01340"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>L.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>K.</given-names></name><name name-style="western"><surname>Song</surname><given-names>H.</given-names></name><name name-style="western"><surname>Lan</surname><given-names>F.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Gu</surname><given-names>Z.</given-names></name></person-group><article-title>Superparamagnetic Iron Oxide Nanoparticles as MRI contrast agents for Non-invasive Stem Cell Labeling and Tracking</article-title><source>Theranostics</source><year>2013</year><volume>3</volume><fpage>595</fpage><lpage>615</lpage><pub-id pub-id-type="doi">10.7150/thno.5366</pub-id><pub-id pub-id-type="pmid">23946825</pub-id><pub-id pub-id-type="pmcid">PMC3741608</pub-id></element-citation></ref><ref id="B19-nanomaterials-15-01340"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scarciglia</surname><given-names>A.</given-names></name><name name-style="western"><surname>Papi</surname><given-names>C.</given-names></name><name name-style="western"><surname>Romiti</surname><given-names>C.</given-names></name><name name-style="western"><surname>Leone</surname><given-names>A.</given-names></name><name name-style="western"><surname>Di Gregorio</surname><given-names>E.</given-names></name><name name-style="western"><surname>Ferrauto</surname><given-names>G.</given-names></name></person-group><article-title>Gadolinium-Based Contrast Agents (GBCAs) for MRI: A Benefit&#8211;Risk Balance Analysis from a Chemical, Biomedical, and Environmental Point of View</article-title><source>Glob. Chall.</source><year>2025</year><volume>9</volume><fpage>2400269</fpage><pub-id pub-id-type="doi">10.1002/gch2.202400269</pub-id><pub-id pub-id-type="pmid">40071223</pub-id><pub-id pub-id-type="pmcid">PMC11891575</pub-id></element-citation></ref><ref id="B20-nanomaterials-15-01340"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Antwi-Baah</surname><given-names>R.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>K.</given-names></name></person-group><article-title>Metal-Based Nanoparticle Magnetic Resonance Imaging Contrast Agents: Classifications, Issues, and Countermeasures toward Their Clinical Translation</article-title><source>Adv. Mater. Interfaces</source><year>2022</year><volume>9</volume><fpage>2101710</fpage><pub-id pub-id-type="doi">10.1002/admi.202101710</pub-id></element-citation></ref><ref id="B21-nanomaterials-15-01340"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tegafaw</surname><given-names>T.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>M.Y.</given-names></name><name name-style="western"><surname>Saidi</surname><given-names>A.K.A.A.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>D.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Nam</surname><given-names>S.-W.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>G.H.</given-names></name></person-group><article-title>Magnetic Nanoparticle-Based High-Performance Positive and Negative Magnetic Resonance Imaging Contrast Agents</article-title><source>Pharmaceutics</source><year>2023</year><volume>15</volume><elocation-id>1745</elocation-id><pub-id pub-id-type="doi">10.3390/pharmaceutics15061745</pub-id><pub-id pub-id-type="pmid">37376193</pub-id><pub-id pub-id-type="pmcid">PMC10304637</pub-id></element-citation></ref><ref id="B22-nanomaterials-15-01340"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Caspani</surname><given-names>S.</given-names></name><name name-style="western"><surname>Magalh&#227;es</surname><given-names>R.</given-names></name><name name-style="western"><surname>Ara&#250;jo</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Sousa</surname><given-names>C.T.</given-names></name></person-group><article-title>Magnetic Nanomaterials as Contrast Agents for MRI</article-title><source>Materials</source><year>2020</year><volume>13</volume><elocation-id>2586</elocation-id><pub-id pub-id-type="doi">10.3390/ma13112586</pub-id><pub-id pub-id-type="pmid">32517085</pub-id><pub-id pub-id-type="pmcid">PMC7321635</pub-id></element-citation></ref><ref id="B23-nanomaterials-15-01340"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>B.H.</given-names></name><name name-style="western"><surname>Na</surname><given-names>H.B.</given-names></name><name name-style="western"><surname>Hyeon</surname><given-names>T.</given-names></name></person-group><article-title>Paramagnetic inorganic nanoparticles as T<sub>1</sub> MRI contrast agents</article-title><source>Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol.</source><year>2014</year><volume>6</volume><fpage>196</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1002/wnan.1243</pub-id><pub-id pub-id-type="pmid">24123961</pub-id></element-citation></ref><ref id="B24-nanomaterials-15-01340"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>F.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y.S.</given-names></name></person-group><article-title>Inorganic nanoparticle-based T<sub>1</sub> and T<sub>1</sub>/T<sub>2</sub> magnetic resonance contrast probes</article-title><source>Nanoscale</source><year>2012</year><volume>4</volume><fpage>6235</fpage><lpage>6243</lpage><pub-id pub-id-type="doi">10.1039/c2nr31865b</pub-id><pub-id pub-id-type="pmid">22971876</pub-id></element-citation></ref><ref id="B25-nanomaterials-15-01340"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pellico</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ellis</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Davis</surname><given-names>J.J.</given-names></name></person-group><article-title>Nanoparticle-Based Paramagnetic Contrast Agents for Magnetic Resonance Imaging</article-title><source>Contrast Media Mol. Imaging</source><year>2019</year><volume>2019</volume><fpage>1845637</fpage><pub-id pub-id-type="doi">10.1155/2019/1845637</pub-id><pub-id pub-id-type="pmid">31191182</pub-id><pub-id pub-id-type="pmcid">PMC6525923</pub-id></element-citation></ref><ref id="B26-nanomaterials-15-01340"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Panich</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Shames</surname><given-names>A.I.</given-names></name><name name-style="western"><surname>Goren</surname><given-names>S.D.</given-names></name><name name-style="western"><surname>Yudina</surname><given-names>E.B.</given-names></name><name name-style="western"><surname>Aleksenskii</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>Vul</surname><given-names>A.Y.</given-names></name></person-group><article-title>Examining relaxivities in suspensions of nanodiamonds grafted by magnetic entities: Comparison of two approaches</article-title><source>Magn. Reson. Mater. Phys. Biol. Med.</source><year>2020</year><volume>33</volume><fpage>885</fpage><lpage>888</lpage><pub-id pub-id-type="doi">10.1007/s10334-020-00847-3</pub-id><pub-id pub-id-type="pmid">32347397</pub-id></element-citation></ref><ref id="B27-nanomaterials-15-01340"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Panich</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Salti</surname><given-names>M.</given-names></name><name name-style="western"><surname>Aleksenskii</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>Kulvelis</surname><given-names>Y.V.</given-names></name><name name-style="western"><surname>Chizhikova</surname><given-names>A.</given-names></name><name name-style="western"><surname>Vul</surname><given-names>A.Y.</given-names></name><name name-style="western"><surname>Shames</surname><given-names>A.I.</given-names></name></person-group><article-title>Suspensions of manganese-grafted nanodiamonds: Preparation, NMR, and MRI study</article-title><source>Diam. Relat. Mater.</source><year>2023</year><volume>131</volume><fpage>109591</fpage><pub-id pub-id-type="doi">10.1016/j.diamond.2022.109591</pub-id></element-citation></ref><ref id="B28-nanomaterials-15-01340"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Panich</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Salti</surname><given-names>M.</given-names></name><name name-style="western"><surname>Prager</surname><given-names>O.</given-names></name><name name-style="western"><surname>Swissa</surname><given-names>E.</given-names></name><name name-style="western"><surname>Kulvelis</surname><given-names>Y.V.</given-names></name><name name-style="western"><surname>Yudina</surname><given-names>E.B.</given-names></name><name name-style="western"><surname>Aleksenskii</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>Goren</surname><given-names>S.D.</given-names></name><name name-style="western"><surname>Vul</surname><given-names>A.Y.</given-names></name><name name-style="western"><surname>Shames</surname><given-names>A.I.</given-names></name></person-group><article-title>PVP-coated Gd-grafted nanodiamonds as a novel and potentially safer contrast agent for in vivo MRI</article-title><source>Magn. Reson. Med.</source><year>2021</year><volume>86</volume><fpage>935</fpage><lpage>942</lpage><pub-id pub-id-type="doi">10.1002/mrm.28762</pub-id><pub-id pub-id-type="pmid">33724543</pub-id></element-citation></ref><ref id="B29-nanomaterials-15-01340"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jeon</surname><given-names>M.</given-names></name><name name-style="western"><surname>Halbert</surname><given-names>M.V.</given-names></name><name name-style="western"><surname>Stephen</surname><given-names>Z.R.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>M.</given-names></name></person-group><article-title>Iron Oxide Nanoparticles as T<sub>1</sub> Contrast Agents for Magnetic Resonance Imaging: Fundamentals, Challenges, Applications, and Prospectives</article-title><source>Adv. Mater.</source><year>2021</year><volume>33</volume><fpage>1906539</fpage><pub-id pub-id-type="doi">10.1002/adma.201906539</pub-id><pub-id pub-id-type="pmid">32495404</pub-id><pub-id pub-id-type="pmcid">PMC8022883</pub-id></element-citation></ref><ref id="B30-nanomaterials-15-01340"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>T.</given-names></name><name name-style="western"><surname>Spincemaille</surname><given-names>P.</given-names></name><name name-style="western"><surname>de Rochefort</surname><given-names>L.</given-names></name><name name-style="western"><surname>Wong</surname><given-names>R.</given-names></name><name name-style="western"><surname>Prince</surname><given-names>M.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name></person-group><article-title>Unambiguous Identification of Superparamagnetic Iron Oxide Particles through Quantitative Susceptibility Mapping of the Nonlinear Response to Magnetic Fields</article-title><source>Magn. Reson. Imaging</source><year>2010</year><volume>28</volume><fpage>1383</fpage><lpage>1389</lpage><pub-id pub-id-type="doi">10.1016/j.mri.2010.06.011</pub-id><pub-id pub-id-type="pmid">20688448</pub-id><pub-id pub-id-type="pmcid">PMC2963706</pub-id></element-citation></ref><ref id="B31-nanomaterials-15-01340"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van den Bos</surname><given-names>E.J.</given-names></name><name name-style="western"><surname>Baks</surname><given-names>T.</given-names></name><name name-style="western"><surname>Moelker</surname><given-names>A.D.</given-names></name><name name-style="western"><surname>Kerver</surname><given-names>W.</given-names></name><name name-style="western"><surname>van Geuns</surname><given-names>R.-J.</given-names></name><name name-style="western"><surname>van der Giessen</surname><given-names>W.J.</given-names></name><name name-style="western"><surname>Duncker</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Wielopolski</surname><given-names>P.A.</given-names></name></person-group><article-title>Magnetic Resonance Imaging of Haemorrhage within Reperfused Myocardial Infarcts: Possible Interference with Iron Oxide-Labelled Cell Tracking?</article-title><source>Eur. Heart J.</source><year>2006</year><volume>27</volume><fpage>1620</fpage><lpage>1626</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehl059</pub-id><pub-id pub-id-type="pmid">16751204</pub-id></element-citation></ref><ref id="B32-nanomaterials-15-01340"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Girard</surname><given-names>O.M.</given-names></name><name name-style="western"><surname>Du</surname><given-names>J.</given-names></name><name name-style="western"><surname>Agemy</surname><given-names>L.</given-names></name><name name-style="western"><surname>Sugahara</surname><given-names>K.N.</given-names></name><name name-style="western"><surname>Kotamraju</surname><given-names>V.R.</given-names></name><name name-style="western"><surname>Ruoslahti</surname><given-names>E.</given-names></name><name name-style="western"><surname>Bydder</surname><given-names>G.M.</given-names></name><name name-style="western"><surname>Mattrey</surname><given-names>R.F.</given-names></name></person-group><article-title>Optimization of Iron Oxide Nanoparticle Detection Using Ultrashort Echo Time Pulse Sequences: Comparison of T<sub>1</sub>, T<sub>2</sub><sup>*</sup>, and Synergistic T<sub>1</sub>&#8722;T<sub>2</sub><sup>*</sup> Contrast Mechanisms</article-title><source>Magn. Reson. Med.</source><year>2011</year><volume>65</volume><fpage>1649</fpage><lpage>1660</lpage><pub-id pub-id-type="doi">10.1002/mrm.22755</pub-id><pub-id pub-id-type="pmid">21305596</pub-id><pub-id pub-id-type="pmcid">PMC3097261</pub-id></element-citation></ref><ref id="B33-nanomaterials-15-01340"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eibofner</surname><given-names>F.</given-names></name><name name-style="western"><surname>Steidle</surname><given-names>G.</given-names></name><name name-style="western"><surname>Kehlbach</surname><given-names>R.</given-names></name><name name-style="western"><surname>Bantleon</surname><given-names>R.</given-names></name><name name-style="western"><surname>Schick</surname><given-names>F.</given-names></name></person-group><article-title>Positive Contrast Imaging of Iron Oxide Nanoparticles with Susceptibility-Weighted Imaging</article-title><source>Magn. Reson. Med.</source><year>2010</year><volume>64</volume><fpage>1027</fpage><lpage>1038</lpage><pub-id pub-id-type="doi">10.1002/mrm.22498</pub-id><pub-id pub-id-type="pmid">20564596</pub-id></element-citation></ref><ref id="B34-nanomaterials-15-01340"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hedlund</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ahr&#233;n</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gustafsson</surname><given-names>H.</given-names></name><name name-style="western"><surname>Abrikossova</surname><given-names>N.</given-names></name><name name-style="western"><surname>Warntjes</surname><given-names>M.</given-names></name><name name-style="western"><surname>J&#246;nsson</surname><given-names>J.I.</given-names></name><name name-style="western"><surname>Uvdal</surname><given-names>K.</given-names></name><name name-style="western"><surname>Engstr&#246;m</surname><given-names>M.</given-names></name></person-group><article-title>Gd<sub>2</sub>O<sub>3</sub> nanoparticles in hematopoietic cells for MRI contrast enhancement</article-title><source>Int. J. Nanomed.</source><year>2011</year><volume>6</volume><fpage>3233</fpage><lpage>3240</lpage><pub-id pub-id-type="doi">10.2147/ijn.s23940</pub-id><pub-id pub-id-type="pmcid">PMC3252671</pub-id><pub-id pub-id-type="pmid">22228991</pub-id></element-citation></ref><ref id="B35-nanomaterials-15-01340"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blomqvist</surname><given-names>L.</given-names></name><name name-style="western"><surname>Nordberg</surname><given-names>G.F.</given-names></name><name name-style="western"><surname>Nurchi</surname><given-names>V.M.</given-names></name><name name-style="western"><surname>Aaseth</surname><given-names>J.O.</given-names></name></person-group><article-title>Gadolinium in Medical Imaging&#8212;Usefulness, Toxic Reactions and Possible Countermeasures&#8212;A Review</article-title><source>Biomolecules</source><year>2022</year><volume>12</volume><elocation-id>742</elocation-id><pub-id pub-id-type="doi">10.3390/biom12060742</pub-id><pub-id pub-id-type="pmid">35740867</pub-id><pub-id pub-id-type="pmcid">PMC9221011</pub-id></element-citation></ref><ref id="B36-nanomaterials-15-01340"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pichler</surname><given-names>V.</given-names></name><name name-style="western"><surname>Martinho</surname><given-names>R.P.</given-names></name><name name-style="western"><surname>Temming</surname><given-names>L.</given-names></name><name name-style="western"><surname>Segers</surname><given-names>T.</given-names></name><name name-style="western"><surname>Wurm</surname><given-names>F.R.</given-names></name><name name-style="western"><surname>Koshkina</surname><given-names>O.</given-names></name></person-group><article-title>The Environmental Impact of Medical Imaging Agents and the Roadmap to Sustainable Medical Imaging</article-title><source>Adv. Sci.</source><year>2025</year><volume>12</volume><fpage>2404411</fpage><pub-id pub-id-type="doi">10.1002/advs.202404411</pub-id><pub-id pub-id-type="pmid">39905748</pub-id><pub-id pub-id-type="pmcid">PMC11884531</pub-id></element-citation></ref><ref id="B37-nanomaterials-15-01340"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Id&#233;e</surname><given-names>J.-M.</given-names></name><name name-style="western"><surname>Port</surname><given-names>M.</given-names></name><name name-style="western"><surname>Robic</surname><given-names>C.</given-names></name><name name-style="western"><surname>Medina</surname><given-names>C.</given-names></name><name name-style="western"><surname>Sabatou</surname><given-names>M.</given-names></name><name name-style="western"><surname>Corot</surname><given-names>C.</given-names></name></person-group><article-title>Role of Thermodynamic and Kinetic Parameters in Gadolinium Chelate Stability</article-title><source>J. Magn. Reson. Imaging</source><year>2009</year><volume>30</volume><fpage>1249</fpage><lpage>1258</lpage><pub-id pub-id-type="doi">10.1002/jmri.21967</pub-id><pub-id pub-id-type="pmid">19938037</pub-id></element-citation></ref><ref id="B38-nanomaterials-15-01340"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Caravan</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ellison</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>McMurry</surname><given-names>T.J.</given-names></name><name name-style="western"><surname>Lauffer</surname><given-names>R.B.</given-names></name></person-group><article-title>Gadolinium(III) Chelates as MRI Contrast Agents:&#8201; Structure, Dynamics, and Applications</article-title><source>Chem. Rev.</source><year>1999</year><volume>99</volume><fpage>2293</fpage><lpage>2352</lpage><pub-id pub-id-type="doi">10.1021/cr980440x</pub-id><pub-id pub-id-type="pmid">11749483</pub-id></element-citation></ref><ref id="B39-nanomaterials-15-01340"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oliveira</surname><given-names>I.S.</given-names></name><name name-style="western"><surname>Hedgire</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Li</surname><given-names>W.</given-names></name><name name-style="western"><surname>Ganguli</surname><given-names>S.</given-names></name><name name-style="western"><surname>Prabhakar</surname><given-names>A.M.</given-names></name></person-group><article-title>Blood pool contrast agents for venous magnetic resonance imaging</article-title><source>Cardiovasc. Diagn. Ther.</source><year>2016</year><volume>6</volume><fpage>508</fpage><lpage>518</lpage><pub-id pub-id-type="doi">10.21037/cdt.2016.12.05</pub-id><pub-id pub-id-type="pmid">28123972</pub-id><pub-id pub-id-type="pmcid">PMC5220192</pub-id></element-citation></ref><ref id="B40-nanomaterials-15-01340"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomsen</surname><given-names>H.S.</given-names></name><name name-style="western"><surname>Morcos</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Alm&#233;n</surname><given-names>T.</given-names></name><name name-style="western"><surname>Bellin</surname><given-names>M.-F.</given-names></name><name name-style="western"><surname>Bertolotto</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bongartz</surname><given-names>G.</given-names></name><name name-style="western"><surname>Clement</surname><given-names>O.</given-names></name><name name-style="western"><surname>Leander</surname><given-names>P.</given-names></name><name name-style="western"><surname>Heinz-Peer</surname><given-names>G.</given-names></name><name name-style="western"><surname>Reimer</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Nephrogenic systemic fibrosis and gadolinium-based contrast media: Updated ESUR Contrast Medium Safety Committee guidelines</article-title><source>Eur. Radiol.</source><year>2013</year><volume>23</volume><fpage>307</fpage><lpage>318</lpage><pub-id pub-id-type="doi">10.1007/s00330-012-2597-9</pub-id><pub-id pub-id-type="pmid">22865271</pub-id></element-citation></ref><ref id="B41-nanomaterials-15-01340"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomsen</surname><given-names>H.S.</given-names></name></person-group><article-title>Nephrogenic Systemic Fibrosis: History and Epidemiology</article-title><source>Radiol. Clin. N. Am.</source><year>2009</year><volume>47</volume><fpage>827</fpage><lpage>831</lpage><pub-id pub-id-type="doi">10.1016/j.rcl.2009.05.003</pub-id><pub-id pub-id-type="pmid">19744597</pub-id></element-citation></ref><ref id="B42-nanomaterials-15-01340"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bernstein</surname><given-names>E.J.</given-names></name><name name-style="western"><surname>Schmidt-Lauber</surname><given-names>C.</given-names></name><name name-style="western"><surname>Kay</surname><given-names>J.</given-names></name></person-group><article-title>Nephrogenic Systemic Fibrosis: A Systemic Fibrosing Disease Resulting from Gadolinium Exposure</article-title><source>Best Pract. Res. Clin. Rheumatol.</source><year>2012</year><volume>26</volume><fpage>489</fpage><lpage>503</lpage><pub-id pub-id-type="doi">10.1016/j.berh.2012.07.008</pub-id><pub-id pub-id-type="pmid">23040363</pub-id></element-citation></ref><ref id="B43-nanomaterials-15-01340"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murata</surname><given-names>N.</given-names></name><name name-style="western"><surname>Murata</surname><given-names>K.</given-names></name><name name-style="western"><surname>Gonzalez-Cuyar</surname><given-names>L.F.</given-names></name><name name-style="western"><surname>Maravilla</surname><given-names>K.R.</given-names></name></person-group><article-title>Gadolinium tissue deposition in brain and bone</article-title><source>Magn. Reson. Imaging</source><year>2016</year><volume>34</volume><fpage>1359</fpage><lpage>1365</lpage><pub-id pub-id-type="doi">10.1016/j.mri.2016.08.025</pub-id><pub-id pub-id-type="pmid">27720805</pub-id></element-citation></ref><ref id="B44-nanomaterials-15-01340"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khairinisa</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Ariyani</surname><given-names>W.</given-names></name><name name-style="western"><surname>Tsushima</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Koibuchi</surname><given-names>N.</given-names></name></person-group><article-title>Effects of Gadolinium Deposits in the Cerebellum: Reviewing the Literature from In Vitro Laboratory Studies to In Vivo Human Investigations</article-title><source>Int. J. Environ. Res. Public Health</source><year>2021</year><volume>18</volume><elocation-id>7214</elocation-id><pub-id pub-id-type="doi">10.3390/ijerph18147214</pub-id><pub-id pub-id-type="pmid">34299664</pub-id><pub-id pub-id-type="pmcid">PMC8305034</pub-id></element-citation></ref><ref id="B45-nanomaterials-15-01340"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roux</surname><given-names>S.</given-names></name><name name-style="western"><surname>Faure</surname><given-names>A.-C.</given-names></name><name name-style="western"><surname>Mandon</surname><given-names>C.</given-names></name><name name-style="western"><surname>Dufort</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rivi&#232;re</surname><given-names>C.</given-names></name><name name-style="western"><surname>Bridot</surname><given-names>J.-L.</given-names></name><name name-style="western"><surname>Mutelet</surname><given-names>B.</given-names></name><name name-style="western"><surname>Marquette</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Josserand</surname><given-names>V.</given-names></name><name name-style="western"><surname>Le Duc</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Multifunctional Gadolinium Oxide Nanoparticles: Towards Image-Guided Therapy</article-title><source>Imaging Med.</source><year>2010</year><volume>2</volume><fpage>211</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.2217/iim.10.5</pub-id></element-citation></ref><ref id="B46-nanomaterials-15-01340"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Cai</surname><given-names>R.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>T.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>J.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Li</surname><given-names>P.</given-names></name><name name-style="western"><surname>Li</surname><given-names>T.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Hyaluronic Acid-Functionalized Gadolinium Oxide Nanoparticles for Magnetic Resonance Imaging-Guided Radiotherapy of Tumors</article-title><source>Nanoscale Res. Lett.</source><year>2020</year><volume>15</volume><fpage>94</fpage><pub-id pub-id-type="doi">10.1186/s11671-020-03318-9</pub-id><pub-id pub-id-type="pmid">32335719</pub-id><pub-id pub-id-type="pmcid">PMC7183523</pub-id></element-citation></ref><ref id="B47-nanomaterials-15-01340"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahmad</surname><given-names>M.W.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Baeck</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Bae</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Chae</surname><given-names>K.S.</given-names></name><name name-style="western"><surname>Park</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>T.J.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>G.H.</given-names></name></person-group><article-title>Potential dual imaging nanoparticle: Gd<sub>2</sub>O<sub>3</sub> nanoparticle</article-title><source>Sci. Rep.</source><year>2015</year><volume>5</volume><elocation-id>8549</elocation-id><pub-id pub-id-type="doi">10.1038/srep08549</pub-id><pub-id pub-id-type="pmid">25707374</pub-id><pub-id pub-id-type="pmcid">PMC4338476</pub-id></element-citation></ref><ref id="B48-nanomaterials-15-01340"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ho</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Yue</surname><given-names>H.</given-names></name><name name-style="western"><surname>Tegafaw</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>M.Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Nam</surname><given-names>S.-W.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>G.H.</given-names></name></person-group><article-title>Gadolinium Neutron Capture Therapy (GdNCT) Agents from Molecular to Nano: Current Status and Perspectives</article-title><source>ACS Omega</source><year>2022</year><volume>7</volume><fpage>2533</fpage><lpage>2553</lpage><pub-id pub-id-type="doi">10.1021/acsomega.1c06603</pub-id><pub-id pub-id-type="pmid">35097254</pub-id><pub-id pub-id-type="pmcid">PMC8793081</pub-id></element-citation></ref><ref id="B49-nanomaterials-15-01340"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>N.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Y.</given-names></name></person-group><article-title>Surface engineered multifunctional nano-systems for localised drug delivery against thyroid cancer: A review of current practices</article-title><source>Biomed. Pharmacother.</source><year>2024</year><volume>176</volume><elocation-id>116840</elocation-id><pub-id pub-id-type="doi">10.1016/j.biopha.2024.116840</pub-id><pub-id pub-id-type="pmid">38820975</pub-id></element-citation></ref><ref id="B50-nanomaterials-15-01340"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Al-Thani</surname><given-names>A.N.</given-names></name><name name-style="western"><surname>Jan</surname><given-names>A.G.</given-names></name><name name-style="western"><surname>Abbas</surname><given-names>M.</given-names></name><name name-style="western"><surname>Geetha</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sadasivuni</surname><given-names>K.K.</given-names></name></person-group><article-title>Nanoparticles in cancer theragnostic and drug delivery: A comprehensive review</article-title><source>Life Sci.</source><year>2024</year><volume>352</volume><fpage>122899</fpage><pub-id pub-id-type="doi">10.1016/j.lfs.2024.122899</pub-id><pub-id pub-id-type="pmid">38992574</pub-id></element-citation></ref><ref id="B51-nanomaterials-15-01340"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miao</surname><given-names>X.</given-names></name><name name-style="western"><surname>Ho</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Tegafaw</surname><given-names>T.</given-names></name><name name-style="western"><surname>Cha</surname><given-names>H.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Oh</surname><given-names>I.T.</given-names></name><name name-style="western"><surname>Yaseen</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Marasini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ghazanfari</surname><given-names>A.</given-names></name><name name-style="western"><surname>Yue</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Stable and Non-Toxic Ultrasmall Gadolinium Oxide Nanoparticle Colloids (Coating Material = Polyacrylic Acid) as High-Performance T<sub>1</sub> Magnetic Resonance Imaging Contrast Agents</article-title><source>RSC Adv.</source><year>2018</year><volume>8</volume><fpage>3189</fpage><lpage>3197</lpage><pub-id pub-id-type="doi">10.1039/C7RA11830A</pub-id><pub-id pub-id-type="pmid">35541201</pub-id><pub-id pub-id-type="pmcid">PMC9077528</pub-id></element-citation></ref><ref id="B52-nanomaterials-15-01340"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yue</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ho</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S.</given-names></name><name name-style="western"><surname>Park</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Tegafaw</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>M.Y.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S.</given-names></name><name name-style="western"><surname>Saidi</surname><given-names>A.K.A.A.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Enhanced Tumor Imaging Using Glucosamine-Conjugated Polyacrylic Acid-Coated Ultrasmall Gadolinium Oxide Nanoparticles in Magnetic Resonance Imaging</article-title><source>Int. J. Mol. Sci.</source><year>2022</year><volume>23</volume><elocation-id>1792</elocation-id><pub-id pub-id-type="doi">10.3390/ijms23031792</pub-id><pub-id pub-id-type="pmid">35163714</pub-id><pub-id pub-id-type="pmcid">PMC8836488</pub-id></element-citation></ref><ref id="B53-nanomaterials-15-01340"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahr&#233;n</surname><given-names>M.</given-names></name><name name-style="western"><surname>Seleg&#229;rd</surname><given-names>L.</given-names></name><name name-style="western"><surname>S&#246;derlind</surname><given-names>F.</given-names></name><name name-style="western"><surname>Linares</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kauczor</surname><given-names>J.</given-names></name><name name-style="western"><surname>Norman</surname><given-names>P.</given-names></name><name name-style="western"><surname>K&#228;ll</surname><given-names>P.-O.</given-names></name><name name-style="western"><surname>Uvdal</surname><given-names>K.</given-names></name></person-group><article-title>A Simple Polyol-Free Synthesis Route to Gd<sub>2</sub>O<sub>3</sub> Nanoparticles for MRI Applications: An Experimental and Theoretical Study</article-title><source>J. Nanopart. Res.</source><year>2012</year><volume>14</volume><fpage>1006</fpage><pub-id pub-id-type="doi">10.1007/s11051-012-1006-2</pub-id></element-citation></ref><ref id="B54-nanomaterials-15-01340"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>D.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ho</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Tegafaw</surname><given-names>T.</given-names></name><name name-style="western"><surname>Saidi</surname><given-names>A.K.A.A.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ahn</surname><given-names>D.</given-names></name><name name-style="western"><surname>Nam</surname><given-names>H.</given-names></name><name name-style="western"><surname>Park</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J.-U.</given-names></name><etal/></person-group><article-title>Multi-functional GdEu<sub>x</sub>Tb<sub>1&#8722;x</sub>O<sub>3</sub> (x = 0 to 1) nanoparticles: Colour tuning optical properties, water proton spin relaxivities, and X-ray attenuation properties</article-title><source>Nanoscale</source><year>2024</year><volume>16</volume><fpage>16998</fpage><lpage>17008</lpage><pub-id pub-id-type="doi">10.1039/D4NR02195A</pub-id><pub-id pub-id-type="pmid">39188197</pub-id></element-citation></ref><ref id="B55-nanomaterials-15-01340"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cai</surname><given-names>W.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Tian</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Pan</surname><given-names>H.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>W.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Engineering the Surface of Gd<sub>2</sub>O<sub>3</sub> Nanoplates for Improved T<sub>1</sub>-Weighted Magnetic Resonance Imaging</article-title><source>Chem. Eng. J.</source><year>2020</year><volume>380</volume><fpage>122473</fpage><pub-id pub-id-type="doi">10.1016/j.cej.2019.122473</pub-id></element-citation></ref><ref id="B56-nanomaterials-15-01340"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Feng</surname><given-names>W.</given-names></name><name name-style="western"><surname>Li</surname><given-names>F.</given-names></name></person-group><article-title>Long-term in vivo biodistribution and toxicity of Gd(OH)<sub>3</sub> nanorods</article-title><source>Biomaterials</source><year>2013</year><volume>34</volume><fpage>508</fpage><lpage>515</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2012.09.075</pub-id><pub-id pub-id-type="pmid">23099061</pub-id></element-citation></ref><ref id="B57-nanomaterials-15-01340"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tegafaw</surname><given-names>T.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ho</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>M.Y.</given-names></name><name name-style="western"><surname>Saidi</surname><given-names>A.K.A.A.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>D.</given-names></name><name name-style="western"><surname>Ahn</surname><given-names>D.</given-names></name><name name-style="western"><surname>Nam</surname><given-names>H.</given-names></name><name name-style="western"><surname>Chae</surname><given-names>W.-S.</given-names></name><etal/></person-group><article-title>High-Quantum-Yield Ultrasmall Ln<sub>2</sub>O<sub>3</sub> (Ln = Eu, Tb, or Dy) Nanoparticle Colloids in Aqueous Media Obtained via Photosensitization</article-title><source>Langmuir</source><year>2023</year><volume>39</volume><fpage>15338</fpage><lpage>15342</lpage><pub-id pub-id-type="doi">10.1021/acs.langmuir.3c02229</pub-id><pub-id pub-id-type="pmid">37856331</pub-id></element-citation></ref><ref id="B58-nanomaterials-15-01340"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahmad</surname><given-names>M.Y.</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>M.W.</given-names></name><name name-style="western"><surname>Yue</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ho</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Park</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Jung</surname><given-names>K.-H.</given-names></name><name name-style="western"><surname>Cha</surname><given-names>H.</given-names></name><name name-style="western"><surname>Marasini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ghazanfari</surname><given-names>A.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S.</given-names></name><etal/></person-group><article-title>In Vivo Positive Magnetic Resonance Imaging Applications of Poly(Methyl Vinyl Ether-Alt-Maleic Acid)-Coated Ultra-Small Paramagnetic Gadolinium Oxide Nanoparticles</article-title><source>Molecules</source><year>2020</year><volume>25</volume><elocation-id>1159</elocation-id><pub-id pub-id-type="doi">10.3390/molecules25051159</pub-id><pub-id pub-id-type="pmid">32150823</pub-id><pub-id pub-id-type="pmcid">PMC7179159</pub-id></element-citation></ref><ref id="B59-nanomaterials-15-01340"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saidi</surname><given-names>A.K.A.A.</given-names></name><name name-style="western"><surname>Baek</surname><given-names>A.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mengesha</surname><given-names>T.T.</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>M.Y.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>D.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J.U.</given-names></name><name name-style="western"><surname>Park</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Hwang</surname><given-names>D.W.</given-names></name><etal/></person-group><article-title>Lead Oxide Nanoparticles as X-Ray Contrast Agents for In Vitro and In Vivo Imaging</article-title><source>ACS Appl. Nano Mater.</source><year>2023</year><volume>6</volume><fpage>20129</fpage><lpage>20138</lpage><pub-id pub-id-type="doi">10.1021/acsanm.3c03928</pub-id></element-citation></ref><ref id="B60-nanomaterials-15-01340"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saidi</surname><given-names>A.K.A.A.</given-names></name><name name-style="western"><surname>Ghazanfari</surname><given-names>A.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tegafaw</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>M.Y.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>D.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Hwang</surname><given-names>D.W.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J.-U.</given-names></name><etal/></person-group><article-title>Facile Synthesis and X-ray Attenuation Properties of Ultrasmall Platinum Nanoparticles Grafted with Three Types of Hydrophilic Polymers</article-title><source>Nanomaterials</source><year>2023</year><volume>13</volume><elocation-id>806</elocation-id><pub-id pub-id-type="doi">10.3390/nano13050806</pub-id><pub-id pub-id-type="pmid">36903686</pub-id><pub-id pub-id-type="pmcid">PMC10004834</pub-id></element-citation></ref><ref id="B61-nanomaterials-15-01340"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jang</surname><given-names>Y.-J.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yue</surname><given-names>H.</given-names></name><name name-style="western"><surname>Park</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Cha</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ho</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Marasini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ghazanfari</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>M.Y.</given-names></name><name name-style="western"><surname>Miao</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Hydrophilic Biocompatible Poly(Acrylic Acid-Co-Maleic Acid) Polymer as a Surface-Coating Ligand of Ultrasmall Gd<sub>2</sub>O<sub>3</sub> Nanoparticles to Obtain a High r<sub>1</sub> Value and T<sub>1</sub> MR Images</article-title><source>Diagnostics</source><year>2021</year><volume>11</volume><elocation-id>2</elocation-id><pub-id pub-id-type="doi">10.3390/diagnostics11010002</pub-id><pub-id pub-id-type="pmid">33375089</pub-id><pub-id pub-id-type="pmcid">PMC7822180</pub-id></element-citation></ref><ref id="B62-nanomaterials-15-01340"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saidi</surname><given-names>A.K.A.A.</given-names></name><name name-style="western"><surname>Ghazanfari</surname><given-names>A.</given-names></name><name name-style="western"><surname>Baek</surname><given-names>A.</given-names></name><name name-style="western"><surname>Tegafaw</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>M.Y.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>D.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J.-u.</given-names></name><name name-style="western"><surname>Park</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>B.W.</given-names></name><etal/></person-group><article-title>Ultrasmall Cerium Oxide Nanoparticles as Highly Sensitive X-Ray Contrast Agents and Their Antioxidant Effect</article-title><source>RSC Adv.</source><year>2024</year><volume>14</volume><fpage>3647</fpage><lpage>3658</lpage><pub-id pub-id-type="doi">10.1039/D3RA08372A</pub-id><pub-id pub-id-type="pmid">38268539</pub-id><pub-id pub-id-type="pmcid">PMC10805080</pub-id></element-citation></ref><ref id="B63-nanomaterials-15-01340"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marasini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yue</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ghazanfari</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ho</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Park</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S.</given-names></name><name name-style="western"><surname>Cha</surname><given-names>H.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tegafaw</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>M.Y.</given-names></name><etal/></person-group><article-title>Polyaspartic Acid-Coated Paramagnetic Gadolinium Oxide Nanoparticles as a Dual-Modal T<sub>1</sub> and T<sub>2</sub> Magnetic Resonance Imaging Contrast Agent</article-title><source>Appl. Sci.</source><year>2021</year><volume>11</volume><elocation-id>8222</elocation-id><pub-id pub-id-type="doi">10.3390/app11178222</pub-id></element-citation></ref><ref id="B64-nanomaterials-15-01340"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Baek</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Choi</surname><given-names>E.S.</given-names></name><name name-style="western"><surname>Woo</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>T.J.</given-names></name><name name-style="western"><surname>Jung</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Chae</surname><given-names>K.S.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>G.H.</given-names></name></person-group><article-title>Paramagnetic Ultrasmall Gadolinium Oxide Nanoparticles as Advanced T<sub>1</sub> MRI Contrast Agent: Account for Large Longitudinal Relaxivity, Optimal Particle Diameter, and In Vivo T<sub>1</sub> MR Images</article-title><source>ACS Nano</source><year>2009</year><volume>3</volume><fpage>3663</fpage><lpage>3669</lpage><pub-id pub-id-type="doi">10.1021/nn900761s</pub-id><pub-id pub-id-type="pmid">19835389</pub-id></element-citation></ref><ref id="B65-nanomaterials-15-01340"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tegafaw</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ho</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Yue</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>D.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Mulugeta</surname><given-names>E.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ahn</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Magnetic Resonance Imaging and X-Ray Imaging Properties of Ultrasmall Lanthanide Oxide (Ln = Eu, Gd, and Tb) Nanoparticles Synthesized via Thermal Decomposition</article-title><source>Molecules</source><year>2025</year><volume>30</volume><elocation-id>2519</elocation-id><pub-id pub-id-type="doi">10.3390/molecules30122519</pub-id><pub-id pub-id-type="pmid">40572485</pub-id><pub-id pub-id-type="pmcid">PMC12196006</pub-id></element-citation></ref><ref id="B66-nanomaterials-15-01340"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Miao</surname><given-names>X.</given-names></name><name name-style="western"><surname>Oh</surname><given-names>I.</given-names></name><name name-style="western"><surname>Chae</surname><given-names>K.S.</given-names></name><name name-style="western"><surname>Cha</surname><given-names>H.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>G.H.</given-names></name></person-group><article-title>Dextran-Coated Ultrasmall Gd<sub>2</sub>O<sub>3</sub> Nanoparticles as Potential T<sub>1</sub> MRI Contrast Agent</article-title><source>ChemistrySelect</source><year>2016</year><volume>1</volume><fpage>6086</fpage><lpage>6091</lpage><pub-id pub-id-type="doi">10.1002/slct.201600832</pub-id></element-citation></ref><ref id="B67-nanomaterials-15-01340"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahab</surname><given-names>A.</given-names></name><name name-style="western"><surname>Rohman</surname><given-names>F.</given-names></name><name name-style="western"><surname>Iskandar</surname><given-names>F.</given-names></name><name name-style="western"><surname>Haryanto</surname><given-names>F.</given-names></name><name name-style="western"><surname>Arif</surname><given-names>I.</given-names></name></person-group><article-title>A simple straightforward thermal decomposition synthesis of PEG-covered Gd<sub>2</sub>O<sub>3</sub> (Gd<sub>2</sub>O<sub>3</sub>@PEG) nanoparticles</article-title><source>Adv. Powder Technol.</source><year>2016</year><volume>27</volume><fpage>1800</fpage><lpage>1805</lpage><pub-id pub-id-type="doi">10.1016/j.apt.2016.06.012</pub-id></element-citation></ref><ref id="B68-nanomaterials-15-01340"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vahdatkhah</surname><given-names>P.</given-names></name><name name-style="western"><surname>Madaah Hosseini</surname><given-names>H.R.</given-names></name><name name-style="western"><surname>Khodaei</surname><given-names>A.</given-names></name><name name-style="western"><surname>Montazerabadi</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>Irajirad</surname><given-names>R.</given-names></name><name name-style="western"><surname>Oghabian</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Delavari</surname><given-names>H.H.</given-names></name></person-group><article-title>Rapid Microwave-Assisted Synthesis of PVP-Coated Ultrasmall Gadolinium Oxide Nanoparticles for Magnetic Resonance Imaging</article-title><source>Chem. Phys.</source><year>2015</year><volume>453&#8211;454</volume><fpage>35</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1016/j.chemphys.2015.03.007</pub-id></element-citation></ref><ref id="B69-nanomaterials-15-01340"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yue</surname><given-names>H.</given-names></name><name name-style="western"><surname>Marasini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>M.Y.</given-names></name><name name-style="western"><surname>Ho</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Cha</surname><given-names>H.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Jang</surname><given-names>Y.J.</given-names></name><name name-style="western"><surname>Tegafaw</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ghazanfari</surname><given-names>A.</given-names></name><name name-style="western"><surname>Miao</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Carbon-coated ultrasmall gadolinium oxide (Gd<sub>2</sub>O<sub>3</sub>@C) nanoparticles: Application to magnetic resonance imaging and fluorescence properties</article-title><source>Colloids Surf. A Physicochem. Eng. Asp.</source><year>2020</year><volume>586</volume><fpage>124261</fpage><pub-id pub-id-type="doi">10.1016/j.colsurfa.2019.124261</pub-id></element-citation></ref><ref id="B70-nanomaterials-15-01340"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guleria</surname><given-names>A.</given-names></name><name name-style="western"><surname>Pranjali</surname><given-names>P.</given-names></name><name name-style="western"><surname>Meher</surname><given-names>M.K.</given-names></name><name name-style="western"><surname>Chaturvedi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Chakraborti</surname><given-names>S.</given-names></name><name name-style="western"><surname>Raj</surname><given-names>R.</given-names></name><name name-style="western"><surname>Poluri</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>D.</given-names></name></person-group><article-title>Effect of Polyol Chain Length on Proton Relaxivity of Gadolinium Oxide Nanoparticles for Enhanced Magnetic Resonance Imaging Contrast</article-title><source>J. Phys. Chem. C</source><year>2019</year><volume>123</volume><fpage>18061</fpage><lpage>18070</lpage><pub-id pub-id-type="doi">10.1021/acs.jpcc.9b04089</pub-id></element-citation></ref><ref id="B71-nanomaterials-15-01340"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tegafaw</surname><given-names>T.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Chae</surname><given-names>K.S.</given-names></name><name name-style="western"><surname>Cha</surname><given-names>H.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>G.H.</given-names></name></person-group><article-title>Ligand-size and ligand-chain hydrophilicity effects on the relaxometric properties of ultrasmall Gd<sub>2</sub>O<sub>3</sub> nanoparticles</article-title><source>AIP Adv.</source><year>2016</year><volume>6</volume><fpage>065114</fpage><pub-id pub-id-type="doi">10.1063/1.4954182</pub-id></element-citation></ref><ref id="B72-nanomaterials-15-01340"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fortin</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Petoral</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>S&#246;derlind</surname><given-names>F.</given-names></name><name name-style="western"><surname>Klasson</surname><given-names>A.</given-names></name><name name-style="western"><surname>Engstr&#246;m</surname><given-names>M.</given-names></name><name name-style="western"><surname>Veres</surname><given-names>T.</given-names></name><name name-style="western"><surname>K&#228;ll</surname><given-names>P.O.</given-names></name><name name-style="western"><surname>Uvdal</surname><given-names>K.</given-names></name></person-group><article-title>Polyethylene glycol-covered ultra-small Gd<sub>2</sub>O<sub>3</sub> nanoparticles for positive contrast at 1.5 T magnetic resonance clinical scanning</article-title><source>Nanotechnology</source><year>2007</year><volume>18</volume><fpage>395501</fpage><pub-id pub-id-type="doi">10.1088/0957-4484/18/39/395501</pub-id></element-citation></ref><ref id="B73-nanomaterials-15-01340"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Faucher</surname><given-names>L.</given-names></name><name name-style="western"><surname>Tremblay</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lagueux</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gossuin</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Fortin</surname><given-names>M.-A.</given-names></name></person-group><article-title>Rapid Synthesis of PEGylated Ultrasmall Gadolinium Oxide Nanoparticles for Cell Labeling and Tracking with MRI</article-title><source>ACS Appl. Mater. Interfaces</source><year>2012</year><volume>4</volume><fpage>4506</fpage><lpage>4515</lpage><pub-id pub-id-type="doi">10.1021/am3006466</pub-id><pub-id pub-id-type="pmid">22834680</pub-id></element-citation></ref><ref id="B74-nanomaterials-15-01340"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rahman</surname><given-names>A.T.M.A.</given-names></name><name name-style="western"><surname>Vasilev</surname><given-names>K.</given-names></name><name name-style="western"><surname>Majewski</surname><given-names>P.</given-names></name></person-group><article-title>Ultra small Gd<sub>2</sub>O<sub>3</sub> nanoparticles: Absorption and emission properties</article-title><source>J. Colloid. Interface Sci.</source><year>2011</year><volume>354</volume><fpage>592</fpage><lpage>596</lpage><pub-id pub-id-type="doi">10.1016/j.jcis.2010.11.012</pub-id><pub-id pub-id-type="pmid">21147481</pub-id></element-citation></ref><ref id="B75-nanomaterials-15-01340"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miao</surname><given-names>X.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Cha</surname><given-names>H.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Oh</surname><given-names>I.T.</given-names></name><name name-style="western"><surname>Chae</surname><given-names>K.S.</given-names></name><name name-style="western"><surname>Tegafaw</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ho</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>G.H.</given-names></name></person-group><article-title>Ultrasmall Gd<sub>2</sub>O<sub>3</sub> nano-particles surface-coated by polyacrylic acid (PAA) and their PAA-size dependent relaxometric properties</article-title><source>Appl. Surf. Sci.</source><year>2019</year><volume>477</volume><fpage>111</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.1016/j.apsusc.2017.11.225</pub-id></element-citation></ref><ref id="B76-nanomaterials-15-01340"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Ahr&#233;n</surname><given-names>M.</given-names></name><name name-style="western"><surname>Seleg&#229;rd</surname><given-names>L.</given-names></name><name name-style="western"><surname>Skoglund</surname><given-names>C.</given-names></name><name name-style="western"><surname>S&#246;derlind</surname><given-names>F.</given-names></name><name name-style="western"><surname>Engstr&#246;m</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Uvdal</surname><given-names>K.</given-names></name></person-group><article-title>Highly Water-Dispersible Surface-Modified Gd<sub>2</sub>O<sub>3</sub> Nanoparticles for Potential Dual-Modal Bioimaging</article-title><source>Chem. Eur. J.</source><year>2013</year><volume>19</volume><fpage>12658</fpage><lpage>12667</lpage><pub-id pub-id-type="doi">10.1002/chem.201301687</pub-id><pub-id pub-id-type="pmid">24175343</pub-id></element-citation></ref><ref id="B77-nanomaterials-15-01340"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cui</surname><given-names>D.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Yan</surname><given-names>C.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Hou</surname><given-names>M.</given-names></name><name name-style="western"><surname>Xia</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>R.</given-names></name></person-group><article-title>Gastrin-releasing peptide receptor-targeted gadolinium oxide-based multifunctional nanoparticles for dual magnetic resonance/fluorescent molecular imaging of prostate cancer</article-title><source>Int. J. Nanomed.</source><year>2017</year><volume>12</volume><fpage>6787</fpage><lpage>6797</lpage><pub-id pub-id-type="doi">10.2147/IJN.S139246</pub-id><pub-id pub-id-type="pmid">28979118</pub-id><pub-id pub-id-type="pmcid">PMC5602459</pub-id></element-citation></ref><ref id="B78-nanomaterials-15-01340"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Chandrasekharan</surname><given-names>P.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X.-L.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Lv</surname><given-names>Y.-B.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>C.-T.</given-names></name><name name-style="western"><surname>Ding</surname><given-names>J.</given-names></name></person-group><article-title>Manipulating the surface coating of ultra-small Gd<sub>2</sub>O<sub>3</sub> nanoparticles for improved T<sub>1</sub>-weighted MR imaging</article-title><source>Biomaterials</source><year>2014</year><volume>35</volume><fpage>1636</fpage><lpage>1642</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2013.11.032</pub-id><pub-id pub-id-type="pmid">24290697</pub-id></element-citation></ref><ref id="B79-nanomaterials-15-01340"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Song</surname><given-names>G.</given-names></name><name name-style="western"><surname>Li</surname><given-names>S.</given-names></name><name name-style="western"><surname>Shao</surname><given-names>C.</given-names></name><name name-style="western"><surname>Yan</surname><given-names>C.</given-names></name><name name-style="western"><surname>Ye</surname><given-names>L.</given-names></name></person-group><article-title>Chlorotoxin-conjugated, PEGylated Gd<sub>2</sub>O<sub>3</sub> nanoparticles as a glioma-specific magnetic resonance imaging contrast agent</article-title><source>RSC Adv.</source><year>2014</year><volume>4</volume><fpage>50254</fpage><lpage>50260</lpage><pub-id pub-id-type="doi">10.1039/C4RA10934A</pub-id></element-citation></ref><ref id="B80-nanomaterials-15-01340"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cho</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sethi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Narayanan</surname><given-names>J.S.A.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Benoit</surname><given-names>D.N.</given-names></name><name name-style="western"><surname>Taheri</surname><given-names>N.</given-names></name><name name-style="western"><surname>Decuzzi</surname><given-names>P.</given-names></name><name name-style="western"><surname>Colvin</surname><given-names>V.L.</given-names></name></person-group><article-title>Gadolinium oxide nanoplates with high longitudinal relaxivity for magnetic resonance imaging</article-title><source>Nanoscale</source><year>2014</year><volume>6</volume><fpage>13637</fpage><lpage>13645</lpage><pub-id pub-id-type="doi">10.1039/C4NR03505D</pub-id><pub-id pub-id-type="pmid">25273814</pub-id></element-citation></ref><ref id="B81-nanomaterials-15-01340"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khue</surname><given-names>N.T.T.</given-names></name><name name-style="western"><surname>Tam</surname><given-names>L.T.T.</given-names></name><name name-style="western"><surname>Dung</surname><given-names>N.T.</given-names></name><name name-style="western"><surname>Tam</surname><given-names>L.T.</given-names></name><name name-style="western"><surname>Chung</surname><given-names>N.X.</given-names></name><name name-style="western"><surname>Linh</surname><given-names>N.T.N.</given-names></name><name name-style="western"><surname>Vinh</surname><given-names>N.D.</given-names></name><name name-style="western"><surname>Quy</surname><given-names>B.M.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>L.</given-names></name></person-group><article-title>Water-dispersible Gadolinium Oxide Nanoplates as an Effective Positive Magnetic Resonance Imaging Contrast Agent</article-title><source>ChemistrySelect</source><year>2022</year><volume>7</volume><fpage>e202202062</fpage><pub-id pub-id-type="doi">10.1002/slct.202202062</pub-id></element-citation></ref><ref id="B82-nanomaterials-15-01340"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cao</surname><given-names>Y.C.</given-names></name></person-group><article-title>Synthesis of Square Gadolinium-Oxide Nanoplates</article-title><source>J. Am. Chem. Soc.</source><year>2004</year><volume>126</volume><fpage>7456</fpage><lpage>7457</lpage><pub-id pub-id-type="doi">10.1021/ja0481676</pub-id><pub-id pub-id-type="pmid">15198589</pub-id></element-citation></ref><ref id="B83-nanomaterials-15-01340"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Dong</surname><given-names>K.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Ren</surname><given-names>J.</given-names></name><name name-style="western"><surname>Qu</surname><given-names>X.</given-names></name></person-group><article-title>Hybrid mesoporous gadolinium oxide nanorods: A platform for multimodal Imaging and Enhanced Insoluble Anticancer Drug Delivery with Low Systemic toxicity</article-title><source>J. Mater. Chem.</source><year>2012</year><volume>22</volume><fpage>14982</fpage><lpage>14990</lpage><pub-id pub-id-type="doi">10.1039/c2jm31100c</pub-id></element-citation></ref><ref id="B84-nanomaterials-15-01340"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jegadeesan</surname><given-names>P.</given-names></name><name name-style="western"><surname>Sen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Padmaprabu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Srivastava</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Das</surname><given-names>A.</given-names></name><name name-style="western"><surname>Amirthapandian</surname><given-names>S.</given-names></name></person-group><article-title>Morphological and optical investigations on Gd<sub>2</sub>O<sub>3</sub> nanostructures</article-title><source>Inorg. Chem. Commun.</source><year>2023</year><volume>150</volume><fpage>110493</fpage><pub-id pub-id-type="doi">10.1016/j.inoche.2023.110493</pub-id></element-citation></ref><ref id="B85-nanomaterials-15-01340"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wyantuti</surname><given-names>S.</given-names></name><name name-style="western"><surname>Fadhilatunnisa</surname><given-names>B.</given-names></name><name name-style="western"><surname>Fauzia</surname><given-names>R.P.</given-names></name><name name-style="western"><surname>Jia</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Rahmani</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Irkham</surname></name><name name-style="western"><surname>Bahti</surname><given-names>H.H.</given-names></name></person-group><article-title>Response surface methodology box-behnken design to optimise the hydrothermal synthesis of gadolinium nanoparticles</article-title><source>Chin. J. Anal. Chem.</source><year>2023</year><volume>51</volume><fpage>100316</fpage><pub-id pub-id-type="doi">10.1016/j.cjac.2023.100316</pub-id></element-citation></ref><ref id="B86-nanomaterials-15-01340"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kang</surname><given-names>J.-G.</given-names></name><name name-style="western"><surname>Min</surname><given-names>B.-K.</given-names></name><name name-style="western"><surname>Sohn</surname><given-names>Y.</given-names></name></person-group><article-title>Synthesis and characterization of Gd(OH)<sub>3</sub> and Gd<sub>2</sub>O<sub>3</sub> nanorods</article-title><source>Ceram. Int.</source><year>2015</year><volume>41</volume><fpage>1243</fpage><lpage>1248</lpage><pub-id pub-id-type="doi">10.1016/j.ceramint.2014.09.053</pub-id></element-citation></ref><ref id="B87-nanomaterials-15-01340"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mulugeta</surname><given-names>E.</given-names></name><name name-style="western"><surname>Tegafaw</surname><given-names>T.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>D.</given-names></name><name name-style="western"><surname>Baek</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>G.H.</given-names></name></person-group><article-title>Synthesis, Characterization, Magnetic Properties, and Applications of Carbon Dots as Diamagnetic Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Contrast Agents: A Review</article-title><source>Nanomaterials</source><year>2025</year><volume>15</volume><elocation-id>542</elocation-id><pub-id pub-id-type="doi">10.3390/nano15070542</pub-id><pub-id pub-id-type="pmid">40214587</pub-id><pub-id pub-id-type="pmcid">PMC11990683</pub-id></element-citation></ref><ref id="B88-nanomaterials-15-01340"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Uvarov</surname><given-names>V.</given-names></name><name name-style="western"><surname>Popov</surname><given-names>I.</given-names></name></person-group><article-title>Metrological characterization of X-ray diffraction methods at different acquisition geometries for determination of crystallite size in nano-scale materials</article-title><source>Mater. Charact.</source><year>2013</year><volume>85</volume><fpage>111</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1016/j.matchar.2013.09.002</pub-id></element-citation></ref><ref id="B89-nanomaterials-15-01340"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Billinge</surname><given-names>S.J.L.</given-names></name></person-group><article-title>The rise of the X-ray atomic pair distribution function method: A series of fortunate events</article-title><source>Philos. Trans. R. Soc. A</source><year>2019</year><volume>377</volume><fpage>20180413</fpage><pub-id pub-id-type="doi">10.1098/rsta.2018.0413</pub-id><pub-id pub-id-type="pmid">31030657</pub-id><pub-id pub-id-type="pmcid">PMC6501893</pub-id></element-citation></ref><ref id="B90-nanomaterials-15-01340"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Whba</surname><given-names>F.</given-names></name><name name-style="western"><surname>Mohamed</surname><given-names>F.</given-names></name><name name-style="western"><surname>Rosli</surname><given-names>N.R.A.M.</given-names></name><name name-style="western"><surname>Rahman</surname><given-names>I.A.</given-names></name><name name-style="western"><surname>Idris</surname><given-names>M.I.</given-names></name></person-group><article-title>The crystalline structure of gadolinium oxide nanoparticles (Gd<sub>2</sub>O<sub>3</sub>-NPs) synthesized at different temperatures via X-ray diffraction (XRD) technique</article-title><source>Radiat. Phys. Chem.</source><year>2021</year><volume>179</volume><fpage>109212</fpage><pub-id pub-id-type="doi">10.1016/j.radphyschem.2020.109212</pub-id></element-citation></ref><ref id="B91-nanomaterials-15-01340"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mahajan</surname><given-names>S.V.</given-names></name><name name-style="western"><surname>Dickerson</surname><given-names>J.H.</given-names></name></person-group><article-title>Synthesis of monodisperse Sub-3 nm RE<sub>2</sub>O<sub>3</sub> and Gd<sub>2</sub>O<sub>3</sub>:RE<sup>3+</sup> nanocrystals</article-title><source>Nanotechnology</source><year>2007</year><volume>18</volume><fpage>325605</fpage><pub-id pub-id-type="doi">10.1088/0957-4484/18/32/325605</pub-id></element-citation></ref><ref id="B92-nanomaterials-15-01340"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rahmani</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Jia</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Bahti</surname><given-names>H.H.</given-names></name><name name-style="western"><surname>Fauzia</surname><given-names>R.P.</given-names></name><name name-style="western"><surname>Wyantuti</surname><given-names>S.</given-names></name></person-group><article-title>Recent advances in lanthanide-based nanoparticle contrast agents for magnetic resonance imaging: Synthesis, characterization, and applications</article-title><source>OpenNano</source><year>2025</year><volume>21</volume><fpage>100226</fpage><pub-id pub-id-type="doi">10.1016/j.onano.2024.100226</pub-id></element-citation></ref><ref id="B93-nanomaterials-15-01340"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Siribbal</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Jurewicz</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hassan</surname><given-names>M.</given-names></name><name name-style="western"><surname>Iqbal</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Uvdal</surname><given-names>K.</given-names></name><name name-style="western"><surname>Hussain</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Mathur</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ilyas</surname><given-names>S.</given-names></name></person-group><article-title>Biocompatible Hollow Gadolinium Oxide Nanocarriers for the Transport of Bioactive Molecules to Cells</article-title><source>ACS Appl. Nano Mater.</source><year>2024</year><volume>7</volume><fpage>12408</fpage><lpage>12419</lpage><pub-id pub-id-type="doi">10.1021/acsanm.4c00404</pub-id></element-citation></ref><ref id="B94-nanomaterials-15-01340"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahmad</surname><given-names>M.Y.</given-names></name><name name-style="western"><surname>Yue</surname><given-names>H.</given-names></name><name name-style="western"><surname>Tegafaw</surname><given-names>T.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S.W.</given-names></name><name name-style="western"><surname>Ho</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>G.H.</given-names></name><name name-style="western"><surname>Nam</surname><given-names>S.W.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>Y.M.</given-names></name></person-group><article-title>Functionalized Lanthanide Oxide Nanoparticles for Tumor Targeting, Medical Imaging, and Therapy</article-title><source>Pharmaceutics</source><year>2021</year><volume>13</volume><elocation-id>1890</elocation-id><pub-id pub-id-type="doi">10.3390/pharmaceutics13111890</pub-id><pub-id pub-id-type="pmid">34834305</pub-id><pub-id pub-id-type="pmcid">PMC8624040</pub-id></element-citation></ref><ref id="B95-nanomaterials-15-01340"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ho</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Choi</surname><given-names>G.</given-names></name><name name-style="western"><surname>Yue</surname><given-names>H.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>H.-K.</given-names></name><name name-style="western"><surname>Jung</surname><given-names>K.-H.</given-names></name><name name-style="western"><surname>Park</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>Y.J.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Miao</surname><given-names>X.</given-names></name><etal/></person-group><article-title>In Vivo neutron capture therapy of cancer using ultrasmall gadolinium oxide nanoparticles with cancer-targeting ability</article-title><source>RSC Adv.</source><year>2020</year><volume>10</volume><fpage>865</fpage><lpage>874</lpage><pub-id pub-id-type="doi">10.1039/C9RA08961F</pub-id><pub-id pub-id-type="pmid">35494457</pub-id><pub-id pub-id-type="pmcid">PMC9047061</pub-id></element-citation></ref><ref id="B96-nanomaterials-15-01340"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kunc</surname><given-names>F.</given-names></name><name name-style="western"><surname>Gallerneault</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kodra</surname><given-names>O.</given-names></name><name name-style="western"><surname>Brinkmann</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lopinski</surname><given-names>G.P.</given-names></name><name name-style="western"><surname>Johnston</surname><given-names>L.J.</given-names></name></person-group><article-title>Surface chemistry of metal oxide nanoparticles: NMR and TGA quantification</article-title><source>Anal. Bioanal. Chem.</source><year>2022</year><volume>414</volume><fpage>4409</fpage><lpage>4425</lpage><pub-id pub-id-type="doi">10.1007/s00216-022-03906-x</pub-id><pub-id pub-id-type="pmid">35234982</pub-id><pub-id pub-id-type="pmcid">PMC9142474</pub-id></element-citation></ref><ref id="B97-nanomaterials-15-01340"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>C.R.</given-names></name><name name-style="western"><surname>Baeck</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Bae</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Chae</surname><given-names>K.S.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>G.H.</given-names></name></person-group><article-title>Ligand-size dependent water proton relaxivities in ultrasmall gadolinium oxide nanoparticles and in vivo T<sub>1</sub> MR images in a 1.5 T MR field</article-title><source>Phys. Chem. Chem. Phys.</source><year>2014</year><volume>16</volume><fpage>19866</fpage><lpage>19873</lpage><pub-id pub-id-type="doi">10.1039/C4CP01946F</pub-id><pub-id pub-id-type="pmid">25123195</pub-id></element-citation></ref><ref id="B98-nanomaterials-15-01340"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kattel</surname><given-names>K.</given-names></name><name name-style="western"><surname>Park</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>H.G.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>E.J.</given-names></name><name name-style="western"><surname>Bony</surname><given-names>B.A.</given-names></name><name name-style="western"><surname>Heo</surname><given-names>W.C.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>S.</given-names></name><name name-style="western"><surname>Baeck</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Paramagnetic dysprosium oxide nanoparticles and dysprosium hydroxide nanorods as <italic toggle="yes">T<sub>2</sub></italic> MRI contrast agents</article-title><source>Biomaterials</source><year>2012</year><volume>33</volume><fpage>3254</fpage><lpage>3261</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2012.01.008</pub-id><pub-id pub-id-type="pmid">22277624</pub-id></element-citation></ref><ref id="B99-nanomaterials-15-01340"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>G.H.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>S.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Bae</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Chae</surname><given-names>K.S.</given-names></name></person-group><article-title>Various ligand-coated ultrasmall gadolinium-oxide nanoparticles: Water proton relaxivity and in-vivo T<sub>1</sub> MR image</article-title><source>J. Korean Phys. Soc.</source><year>2015</year><volume>66</volume><fpage>1295</fpage><lpage>1302</lpage><pub-id pub-id-type="doi">10.3938/jkps.66.1295</pub-id></element-citation></ref><ref id="B100-nanomaterials-15-01340"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schlenoff</surname><given-names>J.B.</given-names></name></person-group><article-title>Zwitteration: Coating surfaces with zwitterionic functionality to reduce nonspecific adsorption</article-title><source>Langmuir</source><year>2014</year><volume>30</volume><fpage>9625</fpage><lpage>9636</lpage><pub-id pub-id-type="doi">10.1021/la500057j</pub-id><pub-id pub-id-type="pmid">24754399</pub-id><pub-id pub-id-type="pmcid">PMC4140545</pub-id></element-citation></ref><ref id="B101-nanomaterials-15-01340"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Honary</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zahir</surname><given-names>F.</given-names></name></person-group><article-title>Effect of Zeta Potential on the Properties of Nano-Drug Delivery Systems&#8212;A Review (Part 2)</article-title><source>Trop. J. Pharm. Res.</source><year>2013</year><volume>12</volume><fpage>265</fpage><lpage>273</lpage></element-citation></ref><ref id="B102-nanomaterials-15-01340"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>X.</given-names></name><name name-style="western"><surname>Kou</surname><given-names>B.</given-names></name></person-group><article-title>Biocompatibility and potential anticancer activity of gadolinium oxide (Gd<sub>2</sub>O<sub>3</sub>) nanoparticles against nasal squamous cell carcinoma</article-title><source>BMC Biotechnol.</source><year>2024</year><volume>24</volume><elocation-id>53</elocation-id><pub-id pub-id-type="doi">10.1186/s12896-024-00877-y</pub-id><pub-id pub-id-type="pmid">39107760</pub-id><pub-id pub-id-type="pmcid">PMC11304937</pub-id></element-citation></ref><ref id="B103-nanomaterials-15-01340"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frencken</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Blasiak</surname><given-names>B.</given-names></name><name name-style="western"><surname>Tomanek</surname><given-names>B.</given-names></name><name name-style="western"><surname>Kruk</surname><given-names>D.</given-names></name><name name-style="western"><surname>van Veggel</surname><given-names>F.C.J.M.</given-names></name></person-group><article-title>Utilizing T<sub>1</sub>- and T<sub>2</sub>-Specific Contrast Agents as &#8220;Two Colors&#8221; MRI Correlation</article-title><source>Materials</source><year>2025</year><volume>18</volume><elocation-id>2290</elocation-id><pub-id pub-id-type="doi">10.3390/ma18102290</pub-id><pub-id pub-id-type="pmid">40429026</pub-id><pub-id pub-id-type="pmcid">PMC12113452</pub-id></element-citation></ref><ref id="B104-nanomaterials-15-01340"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dash</surname><given-names>A.</given-names></name><name name-style="western"><surname>Blasiak</surname><given-names>B.</given-names></name><name name-style="western"><surname>Tomanek</surname><given-names>B.</given-names></name><name name-style="western"><surname>van Veggel</surname><given-names>F.C.J.M.</given-names></name></person-group><article-title>Validation of Inner, Second, and Outer Sphere Contributions to T<sub>1</sub> and T<sub>2</sub> Relaxation in Gd<sup>3+</sup>-Based Nanoparticles Using Eu<sup>3+</sup> Lifetime Decay as a Probe</article-title><source>J. Phys. Chem. C</source><year>2018</year><volume>122</volume><fpage>11557</fpage><lpage>11569</lpage><pub-id pub-id-type="doi">10.1021/acs.jpcc.8b02807</pub-id></element-citation></ref><ref id="B105-nanomaterials-15-01340"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Faucher</surname><given-names>L.</given-names></name><name name-style="western"><surname>Guay-B&#233;gin</surname><given-names>A.-A.</given-names></name><name name-style="western"><surname>Lagueux</surname><given-names>J.</given-names></name><name name-style="western"><surname>C&#244;t&#233;</surname><given-names>M.-F.</given-names></name><name name-style="western"><surname>Petitclerc</surname><given-names>&#201;.</given-names></name><name name-style="western"><surname>Fortin</surname><given-names>M.-A.</given-names></name></person-group><article-title>Ultra-small gadolinium oxide nanoparticles to image brain cancer cells in vivo with MRI</article-title><source>Contrast Media Mol. Imaging</source><year>2011</year><volume>6</volume><fpage>209</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1002/cmmi.420</pub-id><pub-id pub-id-type="pmid">21861281</pub-id></element-citation></ref><ref id="B106-nanomaterials-15-01340"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yin</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Qu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Tian</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>F.</given-names></name><name name-style="western"><surname>Shao</surname><given-names>Y.</given-names></name></person-group><article-title>Silica Nanoparticles Decorated with Gadolinium Oxide Nanoparticles for Magnetic Resonance and Optical Imaging of Tumors</article-title><source>ACS Appl. Nano Mater.</source><year>2021</year><volume>4</volume><fpage>3767</fpage><lpage>3779</lpage><pub-id pub-id-type="doi">10.1021/acsanm.1c00224</pub-id></element-citation></ref><ref id="B107-nanomaterials-15-01340"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shen</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Fan</surname><given-names>W.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Bregadze</surname><given-names>V.I.</given-names></name><name name-style="western"><surname>Mandal</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Yung</surname><given-names>B.C.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>L.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>T.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>W.</given-names></name><etal/></person-group><article-title>Exceedingly Small Gadolinium Oxide Nanoparticles with Remarkable Relaxivities for Magnetic Resonance Imaging of Tumors</article-title><source>Small</source><year>2019</year><volume>15</volume><fpage>1903422</fpage><pub-id pub-id-type="doi">10.1002/smll.201903422</pub-id><pub-id pub-id-type="pmid">31448577</pub-id></element-citation></ref><ref id="B108-nanomaterials-15-01340"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mekuria</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Debele</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>H.-C.</given-names></name></person-group><article-title>Encapsulation of Gadolinium Oxide Nanoparticle (Gd<sub>2</sub>O<sub>3</sub>) Contrasting Agents in PAMAM Dendrimer Templates for Enhanced Magnetic Resonance Imaging in Vivo</article-title><source>ACS Appl. Mater. Interfaces</source><year>2017</year><volume>9</volume><fpage>6782</fpage><lpage>6795</lpage><pub-id pub-id-type="doi">10.1021/acsami.6b14075</pub-id><pub-id pub-id-type="pmid">28164704</pub-id></element-citation></ref><ref id="B109-nanomaterials-15-01340"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bridot</surname><given-names>J.-L.</given-names></name><name name-style="western"><surname>Faure</surname><given-names>A.-C.</given-names></name><name name-style="western"><surname>Laurent</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rivi&#232;re</surname><given-names>C.</given-names></name><name name-style="western"><surname>Billotey</surname><given-names>C.</given-names></name><name name-style="western"><surname>Hiba</surname><given-names>B.</given-names></name><name name-style="western"><surname>Janier</surname><given-names>M.</given-names></name><name name-style="western"><surname>Josserand</surname><given-names>V.</given-names></name><name name-style="western"><surname>Coll</surname><given-names>J.-L.</given-names></name><name name-style="western"><surname>Vander Elst</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Hybrid Gadolinium Oxide Nanoparticles:&#8201; Multimodal Contrast Agents for in Vivo Imaging</article-title><source>J. Am. Chem. Soc.</source><year>2007</year><volume>129</volume><fpage>5076</fpage><lpage>5084</lpage><pub-id pub-id-type="doi">10.1021/ja068356j</pub-id><pub-id pub-id-type="pmid">17397154</pub-id></element-citation></ref><ref id="B110-nanomaterials-15-01340"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>E.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>B.</given-names></name><name name-style="western"><surname>Li</surname><given-names>S.F.Y.</given-names></name><name name-style="western"><surname>Xue</surname><given-names>J.M.</given-names></name></person-group><article-title>Synthesis of Water-Dispersible Gd<sub>2</sub>O<sub>3</sub>/GO Nanocomposites with Enhanced MRI T<sub>1</sub> Relaxivity</article-title><source>J. Phys. Chem. C</source><year>2015</year><volume>119</volume><fpage>23735</fpage><lpage>23742</lpage><pub-id pub-id-type="doi">10.1021/acs.jpcc.5b06037</pub-id></element-citation></ref><ref id="B111-nanomaterials-15-01340"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kryza</surname><given-names>D.</given-names></name><name name-style="western"><surname>Taleb</surname><given-names>J.</given-names></name><name name-style="western"><surname>Janier</surname><given-names>M.</given-names></name><name name-style="western"><surname>Marmuse</surname><given-names>L.</given-names></name><name name-style="western"><surname>Miladi</surname><given-names>I.</given-names></name><name name-style="western"><surname>Bonazza</surname><given-names>P.</given-names></name><name name-style="western"><surname>Louis</surname><given-names>C.</given-names></name><name name-style="western"><surname>Perriat</surname><given-names>P.</given-names></name><name name-style="western"><surname>Roux</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tillement</surname><given-names>O.</given-names></name><etal/></person-group><article-title>Biodistribution Study of Nanometric Hybrid Gadolinium Oxide Particles as a Multimodal SPECT/MR/Optical Imaging and Theragnostic Agent</article-title><source>Bioconjug. Chem.</source><year>2011</year><volume>22</volume><fpage>1145</fpage><lpage>1152</lpage><pub-id pub-id-type="doi">10.1021/bc1005976</pub-id><pub-id pub-id-type="pmid">21545181</pub-id></element-citation></ref><ref id="B112-nanomaterials-15-01340"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahr&#233;n</surname><given-names>M.</given-names></name><name name-style="western"><surname>Seleg&#229;rd</surname><given-names>L.</given-names></name><name name-style="western"><surname>Klasson</surname><given-names>A.</given-names></name><name name-style="western"><surname>S&#246;derlind</surname><given-names>F.</given-names></name><name name-style="western"><surname>Abrikossova</surname><given-names>N.</given-names></name><name name-style="western"><surname>Skoglund</surname><given-names>C.</given-names></name><name name-style="western"><surname>Bengtsson</surname><given-names>T.</given-names></name><name name-style="western"><surname>Engstr&#246;m</surname><given-names>M.</given-names></name><name name-style="western"><surname>K&#228;ll</surname><given-names>P.-O.</given-names></name><name name-style="western"><surname>Uvdal</surname><given-names>K.</given-names></name></person-group><article-title>Synthesis and Characterization of PEGylated Gd<sub>2</sub>O<sub>3</sub> Nanoparticles for MRI Contrast Enhancement</article-title><source>Langmuir</source><year>2010</year><volume>26</volume><fpage>5753</fpage><lpage>5762</lpage><pub-id pub-id-type="doi">10.1021/la903566y</pub-id><pub-id pub-id-type="pmid">20334417</pub-id></element-citation></ref><ref id="B113-nanomaterials-15-01340"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramalho</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ramalho</surname><given-names>M.</given-names></name><name name-style="western"><surname>Jay</surname><given-names>M.</given-names></name><name name-style="western"><surname>Burke</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>Semelka</surname><given-names>R.C.</given-names></name></person-group><article-title>Gadolinium toxicity and treatment</article-title><source>Magn. Reson. Imaging</source><year>2016</year><volume>34</volume><fpage>1394</fpage><lpage>1398</lpage><pub-id pub-id-type="doi">10.1016/j.mri.2016.09.005</pub-id><pub-id pub-id-type="pmid">27693607</pub-id></element-citation></ref><ref id="B114-nanomaterials-15-01340"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grobner</surname><given-names>T.</given-names></name><name name-style="western"><surname>Prischl</surname><given-names>F.C.</given-names></name></person-group><article-title>Gadolinium and nephrogenic systemic fibrosis</article-title><source>Kidney Int.</source><year>2007</year><volume>72</volume><fpage>260</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.1038/sj.ki.5002338</pub-id><pub-id pub-id-type="pmid">17507905</pub-id></element-citation></ref><ref id="B115-nanomaterials-15-01340"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garcia</surname><given-names>J.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S.Z.</given-names></name><name name-style="western"><surname>Louie</surname><given-names>A.Y.</given-names></name></person-group><article-title>Biological effects of MRI contrast agents: Gadolinium retention, potential mechanisms and a role for phosphorus</article-title><source>Philos. Trans. R. Soc. A Math. Phys. Eng. Sci.</source><year>2017</year><volume>375</volume><fpage>20170180</fpage><pub-id pub-id-type="doi">10.1098/rsta.2017.0180</pub-id><pub-id pub-id-type="pmid">29038383</pub-id><pub-id pub-id-type="pmcid">PMC5647271</pub-id></element-citation></ref><ref id="B116-nanomaterials-15-01340"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kloc</surname><given-names>M.</given-names></name><name name-style="western"><surname>Halasa</surname><given-names>M.</given-names></name><name name-style="western"><surname>Wosik</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ghobrial</surname><given-names>R.M.</given-names></name></person-group><article-title>Gadolinium-based MRI contrast agent effects on calcium signaling and actin-dependent cell functions</article-title><source>Magn. Med.</source><year>2025</year><volume>1</volume><fpage>100004</fpage><pub-id pub-id-type="doi">10.1016/j.magmed.2025.100004</pub-id></element-citation></ref><ref id="B117-nanomaterials-15-01340"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saadh</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Haddad</surname><given-names>M.</given-names></name><name name-style="western"><surname>Dababneh</surname><given-names>M.F.</given-names></name><name name-style="western"><surname>Bayan</surname><given-names>M.F.</given-names></name><name name-style="western"><surname>Al-Jaidi</surname><given-names>B.A.</given-names></name></person-group><article-title>A Guide for Estimating the Maximum Safe Starting Dose and Conversion it between Animals and Humans</article-title><source>Syst. Rev. Pharm.</source><year>2020</year><volume>11</volume><fpage>98</fpage><lpage>101</lpage></element-citation></ref><ref id="B118-nanomaterials-15-01340"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheong</surname><given-names>B.Y.C.</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Preventza</surname><given-names>O.A.</given-names></name><name name-style="western"><surname>Muthupillai</surname><given-names>R.</given-names></name></person-group><article-title>Gadolinium-Based Contrast Agents: Updates and Answers to Typical Questions Regarding Gadolinium Use</article-title><source>Tex. Heart Inst. J.</source><year>2022</year><volume>49</volume><fpage>e217680</fpage><pub-id pub-id-type="doi">10.14503/THIJ-21-7680</pub-id><pub-id pub-id-type="pmid">35612906</pub-id><pub-id pub-id-type="pmcid">PMC9242635</pub-id></element-citation></ref><ref id="B119-nanomaterials-15-01340"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ho</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Cha</surname><given-names>H.</given-names></name><name name-style="western"><surname>Oh</surname><given-names>I.T.</given-names></name><name name-style="western"><surname>Jung</surname><given-names>K.-H.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>Y.J.</given-names></name><name name-style="western"><surname>Miao</surname><given-names>X.</given-names></name><name name-style="western"><surname>Tegafaw</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>M.Y.</given-names></name><name name-style="western"><surname>Chae</surname><given-names>K.S.</given-names></name><etal/></person-group><article-title>Magnetic resonance imaging, gadolinium neutron capture therapy, and tumor cell detection using ultrasmall Gd<sub>2</sub>O<sub>3</sub> nanoparticles coated with polyacrylic acid-rhodamine B as a multifunctional tumor theragnostic agent</article-title><source>RSC Adv.</source><year>2018</year><volume>8</volume><fpage>12653</fpage><lpage>12665</lpage><pub-id pub-id-type="doi">10.1039/C8RA00553B</pub-id><pub-id pub-id-type="pmid">35541232</pub-id><pub-id pub-id-type="pmcid">PMC9079332</pub-id></element-citation></ref><ref id="B120-nanomaterials-15-01340"><label>120.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Stoddart</surname><given-names>M.J.</given-names></name></person-group><source>Mammalian Cell Viability: Methods and Protocols</source><publisher-name>Humana Press</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>2011</year></element-citation></ref><ref id="B121-nanomaterials-15-01340"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kamiloglu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sari</surname><given-names>G.</given-names></name><name name-style="western"><surname>Ozdal</surname><given-names>T.</given-names></name><name name-style="western"><surname>Capanoglu</surname><given-names>E.</given-names></name></person-group><article-title>Guidelines for cell viability assays</article-title><source>Food Front.</source><year>2020</year><volume>1</volume><fpage>332</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.1002/fft2.44</pub-id></element-citation></ref><ref id="B122-nanomaterials-15-01340"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahmad</surname><given-names>M.Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tegafaw</surname><given-names>T.</given-names></name><name name-style="western"><surname>Saidi</surname><given-names>A.K.A.A.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>D.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Hwang</surname><given-names>D.W.</given-names></name><etal/></person-group><article-title>Biotin-Conjugated Poly(Acrylic Acid)-Grafted Ultrasmall Gadolinium Oxide Nanoparticles for Enhanced Tumor Imaging</article-title><source>Eur. J. Inorg. Chem.</source><year>2023</year><volume>26</volume><fpage>e202300430</fpage><pub-id pub-id-type="doi">10.1002/ejic.202300430</pub-id></element-citation></ref><ref id="B123-nanomaterials-15-01340"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>X.D.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>Y.H.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>L.N.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>G.F.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z.X.</given-names></name></person-group><article-title>The Renal Clearable Magnetic Resonance Imaging Contrast Agents: State of the Art and Recent Advances</article-title><source>Molecules</source><year>2020</year><volume>25</volume><elocation-id>5072</elocation-id><pub-id pub-id-type="doi">10.3390/molecules25215072</pub-id><pub-id pub-id-type="pmid">33139643</pub-id><pub-id pub-id-type="pmcid">PMC7662352</pub-id></element-citation></ref><ref id="B124-nanomaterials-15-01340"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dai</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>M.</given-names></name><name name-style="western"><surname>Li</surname><given-names>J.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>K.</given-names></name></person-group><article-title>Comparative study on in vivo behavior of PEGylated gadolinium oxide nanoparticles and Magnevist as MRI contrast agent</article-title><source>Nanomed. Nanotechnol. Biol. Med.</source><year>2018</year><volume>14</volume><fpage>547</fpage><lpage>555</lpage><pub-id pub-id-type="doi">10.1016/j.nano.2017.12.005</pub-id><pub-id pub-id-type="pmid">29253637</pub-id></element-citation></ref><ref id="B125-nanomaterials-15-01340"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ashouri</surname><given-names>H.</given-names></name><name name-style="western"><surname>Riyahi Alam</surname><given-names>N.</given-names></name><name name-style="western"><surname>Khoobi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Haghgoo</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rasouli</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Gholami</surname><given-names>M.</given-names></name></person-group><article-title>NSF evaluation of gadolinium biodistribution in renally impaired rats: Using novel metabolic Gd<sub>2</sub>O<sub>3</sub> nanoparticles coated with &#946;-cyclodextrin (Gd<sub>2</sub>O<sub>3</sub>@PCD) in MR molecular Imaging</article-title><source>Magn. Reson. Imaging</source><year>2024</year><volume>107</volume><fpage>120</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1016/j.mri.2024.01.003</pub-id><pub-id pub-id-type="pmid">38215955</pub-id></element-citation></ref><ref id="B126-nanomaterials-15-01340"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sarikhani</surname><given-names>A.</given-names></name><name name-style="western"><surname>Alamzadeh</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Beik</surname><given-names>J.</given-names></name><name name-style="western"><surname>Irajirad</surname><given-names>R.</given-names></name><name name-style="western"><surname>Mirrahimi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mahabadi</surname><given-names>V.P.</given-names></name><name name-style="western"><surname>Kamrava</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Ghaznavi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Khoei</surname><given-names>S.</given-names></name></person-group><article-title>Ultrasmall Fe<sub>3</sub>O<sub>4</sub> and Gd<sub>2</sub>O<sub>3</sub> hybrid nanoparticles for T<sub>1</sub>-weighted MR imaging of cancer</article-title><source>Cancer Nanotechnol.</source><year>2022</year><volume>13</volume><fpage>43</fpage><pub-id pub-id-type="doi">10.1186/s12645-022-00148-5</pub-id></element-citation></ref><ref id="B127-nanomaterials-15-01340"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xie</surname><given-names>M.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Mao</surname><given-names>H.</given-names></name></person-group><article-title>Going Even Smaller: Engineering Sub-5 nm Nanoparticles for Improved Delivery, Biocompatibility and Functionality</article-title><source>Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol.</source><year>2020</year><volume>12</volume><elocation-id>e1644</elocation-id><pub-id pub-id-type="doi">10.1002/wnan.1644</pub-id><pub-id pub-id-type="pmid">32432393</pub-id><pub-id pub-id-type="pmcid">PMC8654183</pub-id></element-citation></ref><ref id="B128-nanomaterials-15-01340"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>S.</given-names></name><name name-style="western"><surname>Feng</surname><given-names>J.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>W.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yan</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Kilogram-Scale Synthesis of Extremely Small Gadolinium Oxide Nanoparticles as a T<sub>1</sub>-Weighted Contrast Agent for Magnetic Resonance Imaging</article-title><source>Small</source><year>2024</year><volume>20</volume><fpage>2308547</fpage><pub-id pub-id-type="doi">10.1002/smll.202308547</pub-id><pub-id pub-id-type="pmid">37988646</pub-id></element-citation></ref><ref id="B129-nanomaterials-15-01340"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tian</surname><given-names>X.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>D.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>J.</given-names></name><name name-style="western"><surname>He</surname><given-names>F.</given-names></name><name name-style="western"><surname>Li</surname><given-names>L.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name></person-group><article-title>Toxicity evaluation of Gd<sub>2</sub>O<sub>3</sub>@SiO<sub>2</sub> nanoparticles prepared by laser ablation in liquid as MRI contrast agents in vivo</article-title><source>Int. J. Nanomed.</source><year>2014</year><volume>9</volume><fpage>4043</fpage><lpage>4053</lpage><pub-id pub-id-type="doi">10.2147/IJN.S66164</pub-id><pub-id pub-id-type="pmcid">PMC4149443</pub-id><pub-id pub-id-type="pmid">25187708</pub-id></element-citation></ref><ref id="B130-nanomaterials-15-01340"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Longmire</surname><given-names>M.</given-names></name><name name-style="western"><surname>Choyke</surname><given-names>P.L.</given-names></name><name name-style="western"><surname>and Kobayashi</surname><given-names>H.</given-names></name></person-group><article-title>Clearance Properties of Nano-Sized Particles and Molecules as Imaging Agents: Considerations and Caveats</article-title><source>Nanomedicine</source><year>2008</year><volume>3</volume><fpage>703</fpage><lpage>717</lpage><pub-id pub-id-type="doi">10.2217/17435889.3.5.703</pub-id><pub-id pub-id-type="pmid">18817471</pub-id><pub-id pub-id-type="pmcid">PMC3407669</pub-id></element-citation></ref><ref id="B131-nanomaterials-15-01340"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>C.</given-names></name><name name-style="western"><surname>Tian</surname><given-names>X.</given-names></name><name name-style="western"><surname>Cai</surname><given-names>J.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>F.</given-names></name><name name-style="western"><surname>Li</surname><given-names>L.</given-names></name></person-group><article-title>In vivo immunotoxicity of Gd<sub>2</sub>O<sub>3</sub>: Eu<sup>3+</sup> nanoparticles and the associated molecular mechanism</article-title><source>J. Biochem. Mol. Toxicol.</source><year>2020</year><volume>34</volume><elocation-id>e22562</elocation-id><pub-id pub-id-type="doi">10.1002/jbt.22562</pub-id><pub-id pub-id-type="pmid">32659858</pub-id></element-citation></ref><ref id="B132-nanomaterials-15-01340"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roch</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gossuin</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Muller</surname><given-names>R.N.</given-names></name><name name-style="western"><surname>Gillis</surname><given-names>P.</given-names></name></person-group><article-title>Superparamagnetic colloid suspensions: Water magnetic relaxation and clustering</article-title><source>J. Magn. Magn. Mater.</source><year>2005</year><volume>293</volume><fpage>532</fpage><lpage>539</lpage><pub-id pub-id-type="doi">10.1016/j.jmmm.2005.01.070</pub-id></element-citation></ref><ref id="B133-nanomaterials-15-01340"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roch</surname><given-names>A.</given-names></name><name name-style="western"><surname>Muller</surname><given-names>R.N.</given-names></name><name name-style="western"><surname>Gillis</surname><given-names>P.</given-names></name></person-group><article-title>Theory of proton relaxation induced by superparamagnetic particles</article-title><source>J. Chem. Phys.</source><year>1999</year><volume>110</volume><fpage>5403</fpage><lpage>5411</lpage><pub-id pub-id-type="doi">10.1063/1.478435</pub-id></element-citation></ref><ref id="B134-nanomaterials-15-01340"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lauffer</surname><given-names>R.B.</given-names></name></person-group><article-title>Paramagnetic Metal Complexes as Water Proton Relaxation Agents for NMR Imaging: Theory and Design</article-title><source>Chem. Rev.</source><year>1987</year><volume>87</volume><fpage>901</fpage><lpage>927</lpage><pub-id pub-id-type="doi">10.1021/cr00081a003</pub-id></element-citation></ref><ref id="B135-nanomaterials-15-01340"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carniato</surname><given-names>F.</given-names></name><name name-style="western"><surname>Thangavel</surname><given-names>K.</given-names></name><name name-style="western"><surname>Tei</surname><given-names>L.</given-names></name><name name-style="western"><surname>Botta</surname><given-names>M.</given-names></name></person-group><article-title>Structure and dynamics of the hydration shells of citrate-coated GdF<sub>3</sub> nanoparticles</article-title><source>J. Mater. Chem. B</source><year>2013</year><volume>1</volume><fpage>2442</fpage><lpage>2446</lpage><pub-id pub-id-type="doi">10.1039/c3tb20174k</pub-id><pub-id pub-id-type="pmid">32261042</pub-id></element-citation></ref><ref id="B136-nanomaterials-15-01340"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Choi</surname><given-names>E.S.</given-names></name><name name-style="western"><surname>Baek</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>G.H.</given-names></name><name name-style="western"><surname>Woo</surname><given-names>S.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>Y.</given-names></name></person-group><article-title>Water-Soluble Ultra Small Paramagnetic or Superparamagnetic Metal Oxide Nanoparticles for Molecular MR Imaging</article-title><source>Eur. J. Inorg. Chem.</source><year>2009</year><volume>2009</volume><fpage>2477</fpage><lpage>2481</lpage><pub-id pub-id-type="doi">10.1002/ejic.200900173</pub-id></element-citation></ref><ref id="B137-nanomaterials-15-01340"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guay-B&#233;gin</surname><given-names>A.-A.</given-names></name><name name-style="western"><surname>Chevallier</surname><given-names>P.</given-names></name><name name-style="western"><surname>Faucher</surname><given-names>L.</given-names></name><name name-style="western"><surname>Turgeon</surname><given-names>S.</given-names></name><name name-style="western"><surname>Fortin</surname><given-names>M.-A.</given-names></name></person-group><article-title>Surface Modification of Gadolinium Oxide Thin Films and Nanoparticles Using Poly(ethylene glycol)-Phosphate</article-title><source>Langmuir</source><year>2012</year><volume>28</volume><fpage>774</fpage><lpage>782</lpage><pub-id pub-id-type="doi">10.1021/la202780x</pub-id><pub-id pub-id-type="pmid">21970413</pub-id></element-citation></ref><ref id="B138-nanomaterials-15-01340"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kattel</surname><given-names>K.</given-names></name><name name-style="western"><surname>Park</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>H.G.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>E.J.</given-names></name><name name-style="western"><surname>Bony</surname><given-names>B.A.</given-names></name><name name-style="western"><surname>Heo</surname><given-names>W.C.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>S.</given-names></name><name name-style="western"><surname>Baeck</surname><given-names>J.S.</given-names></name><etal/></person-group><article-title>A Facile Synthesis, In Vitro and In Vivo MR Studies of d-Glucuronic Acid-Coated Ultrasmall Ln<sub>2</sub>O<sub>3</sub> (Ln = Eu, Gd, Dy, Ho, and Er) Nanoparticles as a New Potential MRI Contrast Agent</article-title><source>ACS Appl. Mater. Interfaces</source><year>2011</year><volume>3</volume><fpage>3325</fpage><lpage>3334</lpage><pub-id pub-id-type="doi">10.1021/am200437r</pub-id><pub-id pub-id-type="pmid">21853997</pub-id></element-citation></ref><ref id="B139-nanomaterials-15-01340"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Park</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Kattel</surname><given-names>K.</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>M.W.</given-names></name><name name-style="western"><surname>Bony</surname><given-names>B.A.</given-names></name><name name-style="western"><surname>Heo</surname><given-names>W.C.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>S.</given-names></name><name name-style="western"><surname>Park</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>T.J.</given-names></name><etal/></person-group><article-title>Fluorescein-polyethyleneimine coated gadolinium oxide nanoparticles as T<sub>1</sub> magnetic resonance imaging (MRI)&#8211;cell labeling (CL) dual agents</article-title><source>RSC Adv.</source><year>2012</year><volume>2</volume><fpage>10907</fpage><lpage>10915</lpage><pub-id pub-id-type="doi">10.1039/c2ra21052e</pub-id></element-citation></ref><ref id="B140-nanomaterials-15-01340"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ni</surname><given-names>K.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ai</surname><given-names>H.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>J.</given-names></name></person-group><article-title>Geometrically Confined Ultrasmall Gadolinium Oxide Nanoparticles Boost the T<sub>1</sub> Contrast Ability</article-title><source>Nanoscale</source><year>2016</year><volume>8</volume><fpage>3768</fpage><lpage>3774</lpage><pub-id pub-id-type="doi">10.1039/C5NR08402D</pub-id><pub-id pub-id-type="pmid">26814592</pub-id></element-citation></ref><ref id="B141-nanomaterials-15-01340"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahmad</surname><given-names>M.W.</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>M.Y.</given-names></name><name name-style="western"><surname>Ul-Islam</surname><given-names>M.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Tegafaw</surname><given-names>T.</given-names></name><name name-style="western"><surname>Wazwaz</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Ibrehem</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Khan</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Oh</surname><given-names>I.-T.</given-names></name><name name-style="western"><surname>Chae</surname><given-names>K.S.</given-names></name><etal/></person-group><article-title>Synthesis, MR Relaxivities, and In Vitro Cytotoxicity of 3,5-Diiodo-L-Tyrosine-Coated Gd<sub>2</sub>O<sub>3</sub> Nanoparticles</article-title><source>Bionanoscience</source><year>2019</year><volume>9</volume><fpage>179</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1007/s12668-018-0582-8</pub-id></element-citation></ref><ref id="B142-nanomaterials-15-01340"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miao</surname><given-names>X.</given-names></name><name name-style="western"><surname>Yue</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ho</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Cha</surname><given-names>H.</given-names></name><name name-style="western"><surname>Marasini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ghazanfari</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>M.Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tegafaw</surname><given-names>T.</given-names></name><name name-style="western"><surname>Chae</surname><given-names>K.-S.</given-names></name><etal/></person-group><article-title>Synthesis, Biocompatibility, and Relaxometric Properties of Heavily Loaded Apoferritin with D-Glucuronic Acid-Coated Ultrasmall Gd<sub>2</sub>O<sub>3</sub> Nanoparticles</article-title><source>Bionanoscience</source><year>2021</year><volume>11</volume><fpage>380</fpage><lpage>389</lpage><pub-id pub-id-type="doi">10.1007/s12668-021-00848-z</pub-id></element-citation></ref><ref id="B143-nanomaterials-15-01340"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rahman</surname><given-names>A.T.M.A.</given-names></name><name name-style="western"><surname>Majewski</surname><given-names>P.</given-names></name><name name-style="western"><surname>Vasilev</surname><given-names>K.</given-names></name></person-group><article-title>Gd<sub>2</sub>O<sub>3</sub> nanoparticles: Size-dependent nuclear magnetic resonance</article-title><source>Contrast Media Mol. Imaging</source><year>2013</year><volume>8</volume><fpage>92</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1002/cmmi.1481</pub-id><pub-id pub-id-type="pmid">23109397</pub-id></element-citation></ref><ref id="B144-nanomaterials-15-01340"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gossuin</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Hocq</surname><given-names>A.</given-names></name><name name-style="western"><surname>Vuong</surname><given-names>Q.L.</given-names></name><name name-style="western"><surname>Disch</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hermann</surname><given-names>R.P.</given-names></name><name name-style="western"><surname>Gillis</surname><given-names>P.</given-names></name></person-group><article-title>Physico-chemical and NMR relaxometric characterization of gadolinium hydroxide and dysprosium oxide nanoparticles</article-title><source>Nanotechnology</source><year>2008</year><volume>19</volume><fpage>475102</fpage><pub-id pub-id-type="doi">10.1088/0957-4484/19/47/475102</pub-id><pub-id pub-id-type="pmid">21836265</pub-id></element-citation></ref><ref id="B145-nanomaterials-15-01340"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marangoni</surname><given-names>V.S.</given-names></name><name name-style="western"><surname>Neumann</surname><given-names>O.</given-names></name><name name-style="western"><surname>Henderson</surname><given-names>L.</given-names></name><name name-style="western"><surname>Kaffes</surname><given-names>C.C.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>R.</given-names></name><name name-style="western"><surname>Bishnoi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ayala-Orozco</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zucolotto</surname><given-names>V.</given-names></name><name name-style="western"><surname>Bankson</surname><given-names>J.A.</given-names></name><etal/></person-group><article-title>Enhancing T<sub>1</sub> magnetic resonance imaging contrast with internalized gadolinium(III) in a multilayer nanoparticle</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2017</year><volume>114</volume><fpage>6960</fpage><lpage>6965</lpage><pub-id pub-id-type="doi">10.1073/pnas.1701944114</pub-id><pub-id pub-id-type="pmid">28630340</pub-id><pub-id pub-id-type="pmcid">PMC5502613</pub-id></element-citation></ref><ref id="B146-nanomaterials-15-01340"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rinck</surname><given-names>P.A.</given-names></name><name name-style="western"><surname>Muller</surname><given-names>R.N.</given-names></name></person-group><article-title>Field strength and dose dependence of contrast enhancement by gadolinium-based MR contrast agents</article-title><source>Eur. Radiol.</source><year>1999</year><volume>9</volume><fpage>998</fpage><lpage>1004</lpage><pub-id pub-id-type="doi">10.1007/s003300050781</pub-id><pub-id pub-id-type="pmid">10370005</pub-id></element-citation></ref><ref id="B147-nanomaterials-15-01340"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>J.</given-names></name></person-group><article-title>The enhanced permeability and retention (EPR) effect: The significance of the concept and methods to enhance its application</article-title><source>J. Pers. Med.</source><year>2021</year><volume>11</volume><elocation-id>771</elocation-id><pub-id pub-id-type="doi">10.3390/jpm11080771</pub-id><pub-id pub-id-type="pmid">34442415</pub-id><pub-id pub-id-type="pmcid">PMC8402171</pub-id></element-citation></ref><ref id="B148-nanomaterials-15-01340"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hua</surname><given-names>S.</given-names></name><name name-style="western"><surname>de Matos</surname><given-names>M.B.C.</given-names></name><name name-style="western"><surname>Metselaar</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Storm</surname><given-names>G.</given-names></name></person-group><article-title>Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization</article-title><source>Front. Pharmacol.</source><year>2018</year><volume>9</volume><elocation-id>790</elocation-id><pub-id pub-id-type="doi">10.3389/fphar.2018.00790</pub-id><pub-id pub-id-type="pmid">30065653</pub-id><pub-id pub-id-type="pmcid">PMC6056679</pub-id></element-citation></ref><ref id="B149-nanomaterials-15-01340"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>&#272;or&#273;evi&#263;</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gonzalez</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Conejos-S&#225;nchez</surname><given-names>I.</given-names></name><name name-style="western"><surname>Carreira</surname><given-names>B.</given-names></name><name name-style="western"><surname>Pozzi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ac&#250;rcio</surname><given-names>R.C.</given-names></name><name name-style="western"><surname>Satchi-Fainaro</surname><given-names>R.</given-names></name><name name-style="western"><surname>Florindo</surname><given-names>H.F.</given-names></name><name name-style="western"><surname>Vicent</surname><given-names>M.J.</given-names></name></person-group><article-title>Current hurdles to the translation of nanomedicines from bench to the clinic</article-title><source>Drug Deliv. Transl. Res.</source><year>2021</year><volume>12</volume><fpage>500</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.1007/s13346-021-01024-2</pub-id><pub-id pub-id-type="pmid">34302274</pub-id><pub-id pub-id-type="pmcid">PMC8300981</pub-id></element-citation></ref><ref id="B150-nanomaterials-15-01340"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marasini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yue</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ho</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Park</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S.</given-names></name><name name-style="western"><surname>Jung</surname><given-names>K.-H.</given-names></name><name name-style="western"><surname>Cha</surname><given-names>H.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tegafaw</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>M.Y.</given-names></name><etal/></person-group><article-title>Synthesis, Characterizations, and 9.4 Tesla T2 MR Images of Polyacrylic Acid-Coated Terbium(III) and Holmium(III) Oxide Nanoparticles</article-title><source>Nanomaterials</source><year>2021</year><volume>11</volume><elocation-id>1355</elocation-id><pub-id pub-id-type="doi">10.3390/nano11051355</pub-id><pub-id pub-id-type="pmid">34065511</pub-id><pub-id pub-id-type="pmcid">PMC8160651</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="nanomaterials-15-01340-f001" orientation="portrait"><label>Figure 1</label><caption><p>Number of publications on Gd<sub>2</sub>O<sub>3</sub> NPs related to biomedical applications and T<sub>1</sub> MRI CAs, based on data from (<bold>a</bold>) Scopus and (<bold>b</bold>) Web of Science, up to 20 June 2025.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nanomaterials-15-01340-g001.jpg"/></fig><fig position="float" id="nanomaterials-15-01340-f002" orientation="portrait"><label>Figure 2</label><caption><p>Synthesis schemes for hydrophilic and biocompatible ligand-coated Gd<sub>2</sub>O<sub>3</sub> NPs: (<bold>a</bold>) one-pot polyol method, (<bold>b</bold>) one-pot DMSO method, (<bold>c</bold>) (<bold>I</bold>) thermal decomposition method yielding OA/OM-coated Gd<sub>2</sub>O<sub>3</sub> NPs and (<bold>II</bold>) subsequent ligand exchange with hydrophilic and biocompatible ligands, and (<bold>d</bold>) one-pot hydrothermal method.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nanomaterials-15-01340-g002.jpg"/></fig><fig position="float" id="nanomaterials-15-01340-f003" orientation="portrait"><label>Figure 3</label><caption><p>TEM images: (<bold>a</bold>) PAA-coated Gd<sub>2</sub>O<sub>3</sub> NPs synthesized via the polyol method [<xref rid="B51-nanomaterials-15-01340" ref-type="bibr">51</xref>], (<bold>b</bold>) Gd<sub>2</sub>O<sub>3</sub> NPs synthesized via the DMSO method [d<sub>222</sub> indicates the lattice spacing between the (222) planes] [<xref rid="B53-nanomaterials-15-01340" ref-type="bibr">53</xref>], (<bold>c</bold>) OA/OM-capped Gd<sub>2</sub>O<sub>3</sub> nanoplates synthesized via the thermal decomposition method [<xref rid="B55-nanomaterials-15-01340" ref-type="bibr">55</xref>], and (<bold>d</bold>) Gd(OH)<sub>3</sub> nanorods synthesized via the hydrothermal method [<xref rid="B56-nanomaterials-15-01340" ref-type="bibr">56</xref>]. XRD patterns: (<bold>e</bold>) PAA-coated Gd<sub>2</sub>O<sub>3</sub> NPs synthesized via the polyol method before (bottom spectrum) and after (top spectrum) TGA [<xref rid="B51-nanomaterials-15-01340" ref-type="bibr">51</xref>]. (<bold>f</bold>) Gd<sub>2</sub>O<sub>3</sub> NPs synthesized via the DMSO method (bottom spectrum) and bulk Gd<sub>2</sub>O<sub>3</sub> reference (top spectrum) [<xref rid="B53-nanomaterials-15-01340" ref-type="bibr">53</xref>]. (<bold>g</bold>) OA/OM-capped Gd<sub>2</sub>O<sub>3</sub> nanoplates synthesized via the thermal decomposition method (top spectrum) and reference pattern with monoclinic structure (JCPDS No 43-1015) (bottom spectrum) [<xref rid="B55-nanomaterials-15-01340" ref-type="bibr">55</xref>]. (<bold>h</bold>) Gd(OH)<sub>3</sub> nanorods synthesized via the hydrothermal method (top spectrum) and reference pattern with hexagonal structure (JCPDS No. 83-2037) (bottom spectrum) [<xref rid="B56-nanomaterials-15-01340" ref-type="bibr">56</xref>].</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nanomaterials-15-01340-g003.jpg"/></fig><fig position="float" id="nanomaterials-15-01340-f004" orientation="portrait"><label>Figure 4</label><caption><p>DLS patterns: (<bold>a</bold>) PAA-coated Gd<sub>2</sub>O<sub>3</sub> NPs (PAA = 1200, 5100, and 15,000 Da) [<xref rid="B75-nanomaterials-15-01340" ref-type="bibr">75</xref>], (<bold>b</bold>) FI-PEG-BBN-coated Gd<sub>2</sub>O<sub>3</sub> NPs [<xref rid="B77-nanomaterials-15-01340" ref-type="bibr">77</xref>], (<bold>c</bold>) Gd<sub>2</sub>O<sub>3</sub>@<italic toggle="yes">N</italic>-dodecyl-PEI-PEG nanoplate clusters [<xref rid="B55-nanomaterials-15-01340" ref-type="bibr">55</xref>], and (<bold>d</bold>) CA-coated hollow Gd<sub>2</sub>O<sub>3</sub> NPs [<xref rid="B93-nanomaterials-15-01340" ref-type="bibr">93</xref>]. a = hydrodynamic diameter.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nanomaterials-15-01340-g004.jpg"/></fig><fig position="float" id="nanomaterials-15-01340-f005" orientation="portrait"><label>Figure 5</label><caption><p>(<bold>a</bold>) FT-IR absorption spectra of PAA, PAA-UGNP, RGD, and RGD-PAA-UGNP (subscript labels &#8220;s&#8221; and &#8220;b&#8221; denote stretching and bending vibrations, respectively) [<xref rid="B95-nanomaterials-15-01340" ref-type="bibr">95</xref>]. (<bold>b</bold>) TGA curves of PEI, pimelic acid, azelaic acid, suberic acid, and sebacic acid coated-Gd<sub>2</sub>O<sub>3</sub> NPs [<xref rid="B99-nanomaterials-15-01340" ref-type="bibr">99</xref>]. (<bold>c</bold>) Zeta potential (&#950;) curve of PSA-coated Gd<sub>2</sub>O<sub>3</sub> NPs [<xref rid="B63-nanomaterials-15-01340" ref-type="bibr">63</xref>].</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nanomaterials-15-01340-g005.jpg"/></fig><fig position="float" id="nanomaterials-15-01340-f006" orientation="portrait"><label>Figure 6</label><caption><p>M&#8211;H curves of DEG-, TEG-, TeEG-, and PEG-coated Gd<sub>2</sub>O<sub>3</sub> NPs at (<bold>a</bold>) T = 5 and (<bold>b</bold>) 300 K. M&#8211;T curves of (<bold>c</bold>) DEG- and TEG-coated Gd<sub>2</sub>O<sub>3</sub> NPs, and (<bold>d</bold>) TeEG- and PEG-coated Gd<sub>2</sub>O<sub>3</sub> NPs at H = 100 Oe (T = 2&#8211;340 K) [<xref rid="B70-nanomaterials-15-01340" ref-type="bibr">70</xref>].</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nanomaterials-15-01340-g006.jpg"/></fig><fig position="float" id="nanomaterials-15-01340-f007" orientation="portrait"><label>Figure 7</label><caption><p>Inner and outer sphere water proton spin relaxation mechanisms. The dotted lines indicate Gd<sup>3+</sup>&#8211;water and NP magnetic moment&#8211;water interactions. O<sup>2&#8722;</sup> ions were omitted in Gd<sub>2</sub>O<sub>3</sub> NP.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nanomaterials-15-01340-g007.jpg"/></fig><fig position="float" id="nanomaterials-15-01340-f008" orientation="portrait"><label>Figure 8</label><caption><p>Plots of (<bold>a</bold>) inverse 1/T<sub>1</sub> and (<bold>b</bold>) 1/T<sub>2</sub> relaxation times of DEG-, TEG-, TeEG-, and PEG-coated Gd<sub>2</sub>O<sub>3</sub> NPs dispersed in water as functions of Gd concentration at 3 T. The slopes correspond to r<sub>1</sub> and r<sub>2</sub> values, respectively. Effect of glycol chain length on (<bold>c</bold>) r<sub>1</sub> and (<bold>d</bold>) r<sub>2</sub> values [<xref rid="B70-nanomaterials-15-01340" ref-type="bibr">70</xref>].</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nanomaterials-15-01340-g008.jpg"/></fig><fig position="float" id="nanomaterials-15-01340-f009" orientation="portrait"><label>Figure 9</label><caption><p>In vitro cell viabilities of (<bold>a</bold>) PAA-Gd<sub>2</sub>O<sub>3</sub> NPs in HEK293 and HepG2 cell lines after 48 h of incubation [<xref rid="B122-nanomaterials-15-01340" ref-type="bibr">122</xref>], (<bold>b</bold>) PAAMA-coated Gd<sub>2</sub>O<sub>3</sub> NPs in DU145 and NCTC1469 cell lines after 48 h of incubation [<xref rid="B61-nanomaterials-15-01340" ref-type="bibr">61</xref>], and (<bold>c</bold>) Gd<sub>2</sub>O<sub>3</sub>-FI-PEG-BBN and Gd<sub>2</sub>O<sub>3</sub>-FI-PEG in PC-3 cell line after 24 h (left) and 48 h (right) of incubation [<xref rid="B77-nanomaterials-15-01340" ref-type="bibr">77</xref>].</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nanomaterials-15-01340-g009.jpg"/></fig><fig position="float" id="nanomaterials-15-01340-f010" orientation="portrait"><label>Figure 10</label><caption><p>Histological analysis of the liver, kidney, spleen and heart 30 days after IV administration of Gd<sub>2</sub>O<sub>3</sub>@BSA NPs into mice tails (scale bar: 50 &#956;m; number of mice, <italic toggle="yes">N</italic> = 4) [<xref rid="B102-nanomaterials-15-01340" ref-type="bibr">102</xref>].</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nanomaterials-15-01340-g010.jpg"/></fig><fig position="float" id="nanomaterials-15-01340-f012" orientation="portrait"><label>Figure 12</label><caption><p>(<bold>a</bold>) Mean fluorescence intensity (MFI) obtained via flow cytometry to evaluate toxicity on innate immune markers (i.e., CD11b, CD206, CD40, CD80, and CD86) in monocytes/macrophages from peripheral blood 48 h after injection of PBS (100 &#181;L, negative control), Gd-DTPA (15 &#956;mol/kg), and Gd-NPs (15 &#956;mol/kg) in BALB/c mice (<italic toggle="yes">N</italic> = 5 per group). (<bold>b</bold>) Serum concentrations of cytokines such as IL-1&#946;, IL-2, and IL-4. (<bold>c</bold>) MFI of the adaptive immune marker CD69 in lymphocytes from peripheral blood and lymph nodes, and ROS levels in neutrophils from peripheral blood. Statistical significance determined by <italic toggle="yes">t</italic>-test (* <italic toggle="yes">p</italic> &lt; 0.05) [<xref rid="B129-nanomaterials-15-01340" ref-type="bibr">129</xref>].</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nanomaterials-15-01340-g012.jpg"/></fig><fig position="float" id="nanomaterials-15-01340-f014" orientation="portrait"><label>Figure 14</label><caption><p>(<bold>a</bold>) In vivo T<sub>1</sub> MR images of a mouse at 3 T before (&#8220;Pre&#8221;) and after IV administration of the solution sample via the mouse tail. Small circles indicate ROIs, and dotted circles indicate the liver and kidneys (administration dose = ~0.1 mmol Gd/kg) and (<bold>b</bold>) SNR plots of the ROIs in the liver and kidneys as a function of time [<xref rid="B58-nanomaterials-15-01340" ref-type="bibr">58</xref>]. (<bold>c</bold>) In vivo coronal and axial T<sub>1</sub> MR images of the (I) liver, (II) kidneys, and (III) bladder of mice before (labeled as pre) and after IV injection of Gd<sub>2</sub>O<sub>3</sub>@C NPs (administration dose = ~0.1 mmol Gd/kg) and (<bold>d</bold>) SNR-ROI plots as a function of time [<xref rid="B69-nanomaterials-15-01340" ref-type="bibr">69</xref>]. The red circles in MR images indicate ROIs.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nanomaterials-15-01340-g014.jpg"/></fig><fig position="float" id="nanomaterials-15-01340-f015" orientation="portrait"><label>Figure 15</label><caption><p>(<bold>a</bold>) In vivo axial T<sub>1</sub> MR images of U87MG tumor-bearing nude mice acquired at 1.5 T after IV injection of ES-GON5-PAA@RGD2 NPs (arrows indicate the tumor). (<bold>b</bold>) &#916;SNR in the tumor at various time points. The injection Gd dosage was 5.0 mgkg<sup>&#8722;1</sup> [<xref rid="B107-nanomaterials-15-01340" ref-type="bibr">107</xref>].</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nanomaterials-15-01340-g015.jpg"/></fig><table-wrap position="float" id="nanomaterials-15-01340-t001" orientation="portrait"><object-id pub-id-type="pii">nanomaterials-15-01340-t001_Table 1</object-id><label>Table 1</label><caption><p>Summary of synthesis methods with associated advantages and disadvantages.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Method</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Solvent</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Advantage</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Disadvantage</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polyol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polyol such as ethylene glycol, diethylene glycol, triethylene glycol, polyethylene glycol</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>&#8211;</label><p>surface modification in one-pot synthesis</p></list-item><list-item><label>&#8211;</label><p>ultrasmall NPs</p></list-item></list>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>&#8211;</label><p>small-scale synthesis</p></list-item><list-item><label>&#8211;</label><p>poor crystallinity</p></list-item></list>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B51-nanomaterials-15-01340" ref-type="bibr">51</xref>,<xref rid="B52-nanomaterials-15-01340" ref-type="bibr">52</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DMSO</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DMSO</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>&#8211;</label><p>low temperature synthesis (&lt;60 &#176;C)</p></list-item><list-item><label>&#8211;</label><p>surface modification in one-pot synthesis</p></list-item><list-item><label>&#8211;</label><p>ultrasmall NPs</p></list-item></list>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>&#8211;</label><p>small-scale synthesis</p></list-item><list-item><label>&#8211;</label><p>poor crystallinity</p></list-item></list>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B53-nanomaterials-15-01340" ref-type="bibr">53</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thermal decomposition</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">High boiling point organic solvent such as oleic acid, oleylamine</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>&#8211;</label><p>high crystallinity.</p></list-item><list-item><label>&#8211;</label><p>monodisperse NPs with particle size control</p></list-item></list>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>&#8211;</label><p>expensive (organic solvent, inert gas)</p></list-item><list-item><label>&#8211;</label><p>post synthesis surface modification</p></list-item><list-item><label>&#8211;</label><p>solvent waste</p></list-item><list-item><label>&#8211;</label><p>small-scale synthesis</p></list-item></list>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B55-nanomaterials-15-01340" ref-type="bibr">55</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hydrothermal</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Water</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>&#8211;</label><p>environmentally friendly</p></list-item><list-item><label>&#8211;</label><p>large-scale synthesis</p></list-item></list>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>&#8211;</label><p>requires autoclave</p></list-item></list>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B56-nanomaterials-15-01340" ref-type="bibr">56</xref>]</td></tr></tbody></table></table-wrap><table-wrap position="float" id="nanomaterials-15-01340-t002" orientation="portrait"><object-id pub-id-type="pii">nanomaterials-15-01340-t002_Table 2</object-id><label>Table 2</label><caption><p>Various characterization techniques and information.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Characterization Technique</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Information</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TEM</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Particle size, morphology</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ICP-AES</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gd concentration in aqueous solution sample</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">XRD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Crystal structure</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DLS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hydrodynamic diameter</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FT-IR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Surface coating</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TGA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Surface-coating amount</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zeta potential</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Surface charge</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VSM, MPMS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Magnetic properties</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MRI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">r<sub>1</sub>, r<sub>2</sub> values</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MTT, CCK-8, WST-1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">in vitro cellular toxicity</td></tr></tbody></table></table-wrap><table-wrap position="float" id="nanomaterials-15-01340-t003" orientation="portrait"><object-id pub-id-type="pii">nanomaterials-15-01340-t003_Table 3</object-id><label>Table 3</label><caption><p>r<sub>1</sub> and r<sub>2</sub> values of surface-coated Gd<sub>2</sub>O<sub>3</sub> NPs under various conditions, including coating ligands, particle size, hydrodynamic diameter, applied magnetic field, and temperature.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">NP</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Synthesis Method</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Ligand</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Size (nm)</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">r<sub>1</sub>
<break/>(s<sup>&#8722;1</sup>mM<sup>&#8722;1</sup>)</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">r<sub>2</sub><break/>(s<sup>&#8722;1</sup>mM<sup>&#8722;1</sup>)</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">H (tesla)</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">T (&#176;C)</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Ref.</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TEM</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DLS</th></tr></thead><tbody><tr><td rowspan="46" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Gd<sub>2</sub>O<sub>3</sub></td><td rowspan="46" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">polyol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Succinic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.4</td><td rowspan="6" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">1.5</td><td rowspan="6" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">22</td><td rowspan="6" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B71-nanomaterials-15-01340" ref-type="bibr">71</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glutaric acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.15</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Terephthalic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.19</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PEI-1300</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.71</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PEI-10,000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.87</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.6</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">D-glucuronic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.25</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27.11</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PAA-1200</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">36.6</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">1.5</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">22</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B75-nanomaterials-15-01340" ref-type="bibr">75</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PAA-5100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PAA-15,000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">29.2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PEGD-600</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.18</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19.15</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">1.5</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">22</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B136-nanomaterials-15-01340" ref-type="bibr">136</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">D-glucuronic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.56</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.95</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lactobionic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.57</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.38</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">D-glucuronic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B64-nanomaterials-15-01340" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DEG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17 &#177; 2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.8</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">1.5</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">25</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B137-nanomaterials-15-01340" ref-type="bibr">137</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PEG-phosphate (reaction in water)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">152 &#177; 20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PEG-phosphate (reaction in ethanol)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">68 &#177; 11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.5</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">PEG-polysiloxane</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.4</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">7</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">25</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B109-nanomaterials-15-01340" ref-type="bibr">109</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">28.8</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">28.9</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">D-glucuronic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.25</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27.11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B138-nanomaterials-15-01340" ref-type="bibr">138</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fluorescein-polyethyleneimine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.92</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.76</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20.27</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B139-nanomaterials-15-01340" ref-type="bibr">139</xref>]</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">PEG</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">1.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.47</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B73-nanomaterials-15-01340" ref-type="bibr">73</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.41</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">MSN</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">2.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">62.25</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45.08</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48.81</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B140-nanomaterials-15-01340" ref-type="bibr">140</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16.95</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">D-Glucuronic acid</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">1.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24 &#177; 2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60 &#177; 5</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">1.5</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">22</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B97-nanomaterials-15-01340" ref-type="bibr">97</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PEGD-250</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 &#177; 1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">55 &#177; 2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PEGD-600</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1 &#177; 0.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 &#177; 1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3,5-Diiodo-L-tyrosine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.24</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">38.27</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B141-nanomaterials-15-01340" ref-type="bibr">141</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Carbon</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16.26</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24.12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B69-nanomaterials-15-01340" ref-type="bibr">69</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PAA5100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">37.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B51-nanomaterials-15-01340" ref-type="bibr">51</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polyaspartic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B63-nanomaterials-15-01340" ref-type="bibr">63</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Apoferritin-D-Glucuronic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">29.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B142-nanomaterials-15-01340" ref-type="bibr">142</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PVP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.28</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.47</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B68-nanomaterials-15-01340" ref-type="bibr">68</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DEG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.14</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.5</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B70-nanomaterials-15-01340" ref-type="bibr">70</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TEG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TeEG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.99</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PEG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.75</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">28.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dextran</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">29.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B66-nanomaterials-15-01340" ref-type="bibr">66</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Poly(acrylic acid-co-maleic acid) (PAAMA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">63.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B61-nanomaterials-15-01340" ref-type="bibr">61</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Poly(methyl vinyl ether-alt-maleic acid) (PMVEMA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">36.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">74</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B58-nanomaterials-15-01340" ref-type="bibr">58</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PEG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.4</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">1.5</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">19.5</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B72-nanomaterials-15-01340" ref-type="bibr">72</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DEG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PEG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;40</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.6</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Gd<sub>2</sub>O<sub>3</sub></td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">DMSO</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5&#8211;10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.41</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B53-nanomaterials-15-01340" ref-type="bibr">53</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5(6)-carboxyfluorescein-polyethylene glycol-bombesin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">52.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">90.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.23</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B77-nanomaterials-15-01340" ref-type="bibr">77</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TEG based carboxylate ligand</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.41</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B76-nanomaterials-15-01340" ref-type="bibr">76</xref>]</td></tr><tr><td rowspan="9" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Gd<sub>2</sub>O<sub>3</sub></td><td rowspan="9" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Thermal decomposition</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PVP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.123</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33.184</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">36</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B78-nanomaterials-15-01340" ref-type="bibr">78</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">N</italic>-Dodecyl-PEI-PEG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">95</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.13</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B55-nanomaterials-15-01340" ref-type="bibr">55</xref>]</td></tr><tr><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">PAA-OA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">82.4</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">1.41</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B80-nanomaterials-15-01340" ref-type="bibr">80</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">28.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">75.1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">70.0</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">67.3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32.4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">poly (maleic anhydride-alt-1-octadecene) polymer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 &#215; 1.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16.95</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B81-nanomaterials-15-01340" ref-type="bibr">81</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CTX-PEG-TETT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.09</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.41</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B79-nanomaterials-15-01340" ref-type="bibr">79</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Gd<sub>2</sub>O<sub>3</sub></td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Hydrothermal</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hyaluronic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">105</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B46-nanomaterials-15-01340" ref-type="bibr">46</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100 &#177; 20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">233.7 &#177; 10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.41</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B93-nanomaterials-15-01340" ref-type="bibr">93</xref>]</td></tr></tbody></table></table-wrap></floats-group></article></pmc-articleset>